Mindie H. Nguyen, MD, MAS, AGAF, FAASLD

Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.

4.8/5

67 Patient Ratings »

111 Patient Reviews »

Mindie H. Nguyen, MD, MAS, AGAF, FAASLD

Hepatologist, Transplant hepatologist

Professor of Medicine (Gastroenterology and Hepatology) and, by courtesy, of Epidemiology and Population Health

View Professional Summary »

Insurance Coverage »

Resources for Referring Physicians »

Biography

Dr. Nguyen is Professor of Medicine, a Stanford Cancer Institute member and specializes in the treatment and prevention of primary liver cancer such as hepatocellular carcinoma (HCC).

Dr. Nguyen is also a Professor of Epidemiology and Population Health by courtesy at Stanford. Her clinical and research focus has been liver cancer for the past 20+ years. She is a frequent lecturer for the management and prevention of liver cancer for care providers and researchers at national and international conferences. She has published several key research papers to inform clinicians of the care and treatment of patients with liver cancer.

Dr. Nguyen’s clinical and research focus also include patients with cirrhosis, viral hepatitis, nonalcoholic fatty liver disease (NAFLD/NASH). Her goal is to promote early detection of liver tumors and to prevent and treat complications from chronic liver diseases and liver cancer. She has extensive experience in performing clinical trials on liver cancer, fatty liver, cirrhosis, and viral hepatitis. She has lead several multi-center US and international studies.

Dr. Nguyen is clinically active, seeing patients three full days a week, with a large and comprehensive practice of general liver, liver cancer, and transplant patients at Stanford University Medical Center, as well as weekly outreach clinics in the San Jose area.

Dr. Nguyen is Director of the Hepatology Fellowship Program in the Division of Gastroenterology and Hepatology and the Liver Transplant Program. In addition, she is Director of the Hepatology Fellowship and Clerkship, a member of Stanford Bio-X, and Stanford Population Science, a member of the Appointments and Promotions Committee and a Diversity LENS Advocate for the Department of Medicine, assisting in the promotion of equity and diversity in the professoriate search process.

Dr. Nguyen has mentored over 150 trainees of diverse racial, ethnic, and economic backgrounds and levels of training. Her research lab includes trainees who are high school students, undergraduate students, medical students, graduate students in the Master’s in Epidemiology or Public Health, PhD students in epidemiology, clinical interns and residents, clinical gastroenterology and hepatology fellows, postdoctoral research fellows, early and mid-career faculty, and international visiting scholars. She also serves as Pre-Major Academic Advisor for the undergraduate school. Her mentees are from Stanford as well as other institutions in the US and overseas.

Dr. Nguyen is a Fellow of the American Association for the Study of Liver Diseases (AASLD) and the American Gastroenterological Association (AGA), and a member of the American College of Gastroenterology (ACG), the European Association for the Study of Liver Diseases (EASL), and the Asia Pacific Association for the Study of Liver (APASL).

Dr. Nguyen is active in national and international professional society service and community outreach efforts locally, including service as an executive board of director for nonprofit organizations. She is very active in AASLD, having served as Chair of the Hepatitis B Special Interest Group and in the Education and Hepatology Associate Committees, as member of the Steering Committee for the Hepatobiliary Neoplasia and Hepatitis B Special Interest Group, and as a member of the Practice Guideline Committee. She is a member of the Research Award Panel for the AGA, and a member of the Practice Management Committee for the ACG, and Officer of the Global Governing Council of the International Association for the Study of Liver Diseases (IASL).

Dr. Nguyen has served in the editorial and advisory boards for several journals, including Gastroenterology, Hepatology, Lancet GI Hepatology, and as ad hoc reviewer for over thirty scientific journals including JAMA, AIM and the Lancet Group.

View Full Biography »

Professional Summary

Professional Education

Board Certification: American Board of Internal Medicine, Gastroenterology (2020)
Residency: UCSD Medical Center (1995) CA
Medical Education: University of California San Diego School of Medicine (1992) CA

Fellowship: Stanford University School of Medicine (2002) CA

Board Certification, American Board of Internal Medicine, Gastroenterology (2018)

Board Certification: American Board of Internal Medicine, Transplant Hepatology (2010)

B.S., University of California, Irvine, Biological Sciences (1988)

M.D., Univ. of California, San Diego, Medicine (1992)

M.A.S., Univ. of Calif., San Francisco, Masters of Advanced Studies in Clinical Research (2004)

Honors & Awards

2015 Divisional Teaching Award, Department of Medicine, Stanford University Medical Center, Palo Alto, CA (2015 Dec)
Advanced Hepatology Research Fellow Award, American Association for the Study of Liver Diseases (2001)
Chief Fellow in Gastroenterology and Hepatology, Stanford University Medical Center (2002)

Chief Resident, University of California, San Diego Medical Center (1996)

Excellence in Teaching Award, University of California, San Diego, School of Medicine (1996)

Magna Cum Laude, University of California, Irvine (1988)

Pacific Free Clinic Physician Service Award, Cardinal Free Clinics, Stanford University School of Medicine (2013 April)

Phi Beta Kappa, University of California, Irvine (1985)

Senior Fellow at the Center for Innovation in Global Health, Center for Innovation in Global Helath, Stanford University, Stanford, CA (2015 Oct)

Stanford Asian American Faculty Awards, The Asian American Activities Center, Stanford University, Stanford, CA (2015 May)

The Franklin Edbaugh Advising Award for Faculty, Stanford University School of Medicine (2013 May)

The Professor Mindie H. Nguyen Award for Excellent Clinical Research by Young Investigators, The American Association for the Study of Liver Diseases (AASLD) (2020-2031)

Administrative Appointments

Abstract review member for the Hepatitis B : Epidemiology/Prevention/Control review group, American Association for the Study of Liver Diseases (AASLD) (2011 - 2016)
Chair, Abstract Review Committee, Liver and Biliary Carcinoma (Treatment, Diagnosis, Nat Hx), Digestive Disease Week (American Gastroenterological Association) (2022 - Present)
Chair, Global Outreach Subcommittee, Hepatitis B Special Interest Group, American Association for the Study of Liver Disease (AASLD) (2018 - Present)

Chair, Hepatitis B SIG, American Association for the Study of Liver Disease (AASLD) (2019 - 2020)

CIGH Faculty Fellow, Center for Innovation in Global Health (CIGH), Stanford University (2015 - Present)

Clinical Practice Guideline Committee, AASLD (2019 - 2022)

Committee Chair, Abstract Review for Chronic Hepatitis B, American Association for the Study of Liver Diseases (AASLD) (2013 - 2019)

Director of Clinical Research, Pacific Health Foundation (2004 - Present)

Director of Continuing Medical Education, Pacific Health Foundation (2005 - 2012)

Director of Hepatology Clerkship, Stanford University School of Medicine (2013 - Present)

Director of Hepatology Fellowship, http://med.stanford.edu/gastrohepfellows/, Stanford University Medical Center (2014 - Present)

Editorial Board, Digestive Diseases and Sciences (2008 - Present)

Editorial Board, Gastroenterology (2011 - Present)

Editorial Board, Hepatology (2017 - 2019)

Education Committee, American Association for the Study of Liver Diseases (AASLD) (2013 - 2016)

Executive Board of Director, Asian Health Foundation (2013 - Present)

Faculty Search Diversity Advisor, Department of Medicine, Stanford University (2019 - Present)

Governing Council and Treasurer, International Association for the Study of Liver Diseases (IASL) (2019 - Present)

Hepatology Associates Committee , MD Liaison, American Association for the Study of Liver Diseases (AASLD) (2013 - 2016)

International Advisory Board, Lancet Gastroenterology and Hepatology (2018 - Present)

International Editorial Board, Alimentary Pharmacology and Therapeutics (2018 - Present)

Liver Section Editor, Journal of Clinical Gastroenterology (2013 - Present)

Medical Advisory Board, American Liver Foundation (2013 - Present)

Member, Advisory Task Force SIG, American Association for the Study of Liver Disease (AASLD) (2023 - 2025)

Practice Management Committee, American College of Gastroenterology (ACG) (2019 - Present)

Professoriate Appointments and Promotions Committee (DoM A&P Committee), Department of Medicine, Stanford University (2018 - Present)

Research Award Panel, American Gastroenterological Association (AGA) (2019 - 2021)

Steering Committee, HBV Special Interest Group, American Association for the Study of Liver Diseases (AASLD) (2015 - Present)

Steering Committee, HBV Special Interest Group, American Association for the Study of Liver Disease (AASLD) (2023 - 2025)

Steering Committee, Hepatobiliary Neoplasia Special Interest Group, American Association for the Study of Liver Diseases (AASLD) (2014 - 2016)

Steering Committee, Hepatobiliary Neoplasia Special Interest Group, American Association for the Study of Liver Disease (AASLD) (2023 - 2025)

Training and Workforce Committee, Member, American Association for the Study of Liver Diseases (AASLD) (2002 - 2004)

Vice-Chair, Hepatitis B SIG, American Association for the Study of Liver Disease (AASLD) (2018 - 2019)

Publications

Therapeutic advances in the management of hepatitis B and hepatitis C
Nguyen, M. H., & Wright, T. L. (2001). Therapeutic advances in the management of hepatitis B and hepatitis C. CURRENT OPINION IN INFECTIOUS DISEASES, 14(5), 593–601.
Does isoniazid cause more serious hepatotoxicity in hepatitis B virus carriers?
Nguyen, M. H., & Garcia, G. (2002). Does isoniazid cause more serious hepatotoxicity in hepatitis B virus carriers? AMERICAN JOURNAL OF GASTROENTEROLOGY, 97(5), 1092–1093.
Racial differences in effectiveness of alpha-fetoprotein for diagnosis of hepatocellular carcinoma in hepatitis C virus cirrhosis
Nguyen, M. H., Garcia, R. T., Simpson, P. W., Wright, T. L., & Keeffe, E. B. (2002). Racial differences in effectiveness of alpha-fetoprotein for diagnosis of hepatocellular carcinoma in hepatitis C virus cirrhosis. HEPATOLOGY, 36(2), 410–17.

Screening for hepatocellular carcinoma
Nguyen, M. H., & Keeffe, E. B. (2002). Screening for hepatocellular carcinoma. JOURNAL OF CLINICAL GASTROENTEROLOGY, 35(5), S86–S91.

Prophylaxis against chemotherapy-induced reactivation of hepatitis B virus infection with lamivudine
Simpson, N. D., Simpson, P. W., Ahmed, A. M., Nguyen, M. H., Garcia, G., Keeffe, E. B., & Ahmed, A. (2003). Prophylaxis against chemotherapy-induced reactivation of hepatitis B virus infection with lamivudine. JOURNAL OF CLINICAL GASTROENTEROLOGY, 37(1), 68–71.

Chronic hepatitis B and hepatitis C in Asian Americans.
Nguyen, M. H., & Keeffe, E. B. (2003). Chronic hepatitis B and hepatitis C in Asian Americans. Reviews in Gastroenterological Disorders, 3(3), 125–34.

Prophylactic clip application
Nguyen, M. H., & Soetikno, R. (2003). Prophylactic clip application. GASTROINTESTINAL ENDOSCOPY, 58(6), 941–941.

Unsedated ultrathin EGD is well accepted when compared with conventional sedated EGD: A multicenter randomized trial
Garcia, R. T., Cello, J. P., Nguyen, M. H., Rogers, S. J., Rodas, A., Trinh, H. N., … McQuaid, K. R. (2003). Unsedated ultrathin EGD is well accepted when compared with conventional sedated EGD: A multicenter randomized trial. GASTROENTEROLOGY, 125(6), 1606–12.

Use of endoclips in the treatment of massive colonic diverticular bleeding
Simpson, P. W., Nguyen, M. H., Lim, J. K., & Soetikno, R. M. (2004). Use of endoclips in the treatment of massive colonic diverticular bleeding. GASTROINTESTINAL ENDOSCOPY, 59(3), 433–437.

Epidemiology and treatment outcomes of patients with chronic hepatitis C and genotypes 4 to 9.
Nguyen, M. H., & Keeffe, E. B. (2004). Epidemiology and treatment outcomes of patients with chronic hepatitis C and genotypes 4 to 9. Reviews in Gastroenterological Disorders, 4, S14–21.

Role of Ethnicity in Risk for Hepatocellular Carcinoma in Patients With Chronic Hepatitis C and Cirrhosis
Nguyen, M. H., Whittemore, A. S., Garcia, R. T., Tawfeek, S. A., Ning, J., Lam, S., … Keeffe, E. B. (2004). Role of Ethnicity in Risk for Hepatocellular Carcinoma in Patients With Chronic Hepatitis C and Cirrhosis. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2(9), 820–24.

General management
Nguyen, M. H., & Keeffe, E. B. (2005). General management. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY, 19(1), 161–74.

The diagnosis and management of benign hepatic tumors
Choi, B. Y., & Nguyen, M. H. (2005). The diagnosis and management of benign hepatic tumors. JOURNAL OF CLINICAL GASTROENTEROLOGY, 39(5), 401–12.

Chronic hepatitis C: genotypes 4 to 9.
Nguyen, M. H., & Keeffe, E. B. (2005). Chronic hepatitis C: genotypes 4 to 9. Clinics in Liver Disease, 9(3), 411-?

Prevalence and treatment of hepatitis C virus genotypes 4, 5, and 6.
Nguyen, M. H., & Keeffe, E. B. (2005). Prevalence and treatment of hepatitis C virus genotypes 4, 5, and 6. Clinical Gastroenterology and Hepatology , 3(10), S97–S101.

Long-term survival of patients with unresectable hepatocellular carcinoma treated with transcatheter arterial chemoinfusion
Ha, B. Y., Ahmed, A., Sze, D. Y., Razavi, M. K., Simpson, N., Keeffe, E. B., & Nguyen, M. H. (2007). Long-term survival of patients with unresectable hepatocellular carcinoma treated with transcatheter arterial chemoinfusion. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 26(6), 839–46.

Significant prevalence of histologic disease in patients with chronic hepatitis B and mildly elevated serum alanine aminotransferase levels
Tsang, P. S. Y., Trinh, H., Garcia, R. T., Phan, J. T., Ha, N. B., Nguyen, H., … Nguyen, M. H. (2008). Significant prevalence of histologic disease in patients with chronic hepatitis B and mildly elevated serum alanine aminotransferase levels. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 6(5), 569–74.

Higher rate of sustained virologic response in chronic hepatitis C genotype 6 treated with 48 weeks versus 24 weeks of peginterferon plus ribavirin
Nguyen, M. H., Trinh, H. N., Garcia, R., Nguyen, G., Lam, K. D., & Keeffe, E. B. (2008). Higher rate of sustained virologic response in chronic hepatitis C genotype 6 treated with 48 weeks versus 24 weeks of peginterferon plus ribavirin. AMERICAN JOURNAL OF GASTROENTEROLOGY, 103(5), 1131–35.

Low proportion of Barrett's esophagus in Asian Americans
Lam, K. D., Phan, J. T., Garcia, R. T., Trinh, H., Nguyen, H., Nguyen, K., … Nguyen, M. H. (2008). Low proportion of Barrett's esophagus in Asian Americans. AMERICAN JOURNAL OF GASTROENTEROLOGY, 103(7), 1625–30.

Are Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis B and HBeAg-Negative Chronic Hepatitis B Distinct Diseases?
Nguyen, M. H., & Keeffe, E. B. (2008). Are Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis B and HBeAg-Negative Chronic Hepatitis B Distinct Diseases? CLINICAL INFECTIOUS DISEASES, 47(10), 1312–14.

Prevalence of Colorectal Neoplasms in Asian Americans
Lam, K. D., Garcia, R. T., Nguyen, L. H., Trinh, H., Triadafilopoulos, G., Phan, J. T., … Nguyen, M. H. (2009). Prevalence of Colorectal Neoplasms in Asian Americans. DIGESTIVE DISEASES AND SCIENCES, 54(1), 160–67.

Clinical course of hepatitis B virus infection during pregnancy
Nguyen, G., Garcia, R. T., Nguyen, N., Trinh, H., Keeffe, E. B., & Nguyen, M. H. (2009). Clinical course of hepatitis B virus infection during pregnancy. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 29(7), 755–64.

Chronic hepatitis B: early viral suppression and long-term outcomes of therapy with oral nucleos(t)ides
Nguyen, M. H., & Keeffe, E. B. (2009). Chronic hepatitis B: early viral suppression and long-term outcomes of therapy with oral nucleos(t)ides. JOURNAL OF VIRAL HEPATITIS, 16(3), 149–55.

Transarterial Chemoinfusion for Hepatocellular Carcinoma as Downstaging Therapy and a Bridge toward Liver Transplantation
De Luna, W., Sze, D. Y., Ahmed, A., Ha, B. Y., Ayoub, W., Keeffe, E. B., … Nguyen, M. H. (2009). Transarterial Chemoinfusion for Hepatocellular Carcinoma as Downstaging Therapy and a Bridge toward Liver Transplantation. AMERICAN JOURNAL OF TRANSPLANTATION, 9(5), 1158–68.

alpha-Fetoprotein, Des-gamma Carboxyprothrombin, and Lectin-Bound alpha-Fetoprotein in Early Hepatocellular Carcinoma
Marrero, J. A., Feng, Z., Wang, Y., Nguyen, M. H., Befeler, A. S., Roberts, L. R., … Schwartz, M. (2009). alpha-Fetoprotein, Des-gamma Carboxyprothrombin, and Lectin-Bound alpha-Fetoprotein in Early Hepatocellular Carcinoma. GASTROENTEROLOGY, 137(1), 110–18.

Histological Disease in Asian-Americans With Chronic Hepatitis B, High Hepatitis B Virus DNA, and Normal Alanine Aminotransferase Levels
Nguyen, M. H., Garcia, R. T., Trinh, H. N., Lam, K. D., Weiss, G., Nguyen, H. A., … Keeffe, E. B. (2009). Histological Disease in Asian-Americans With Chronic Hepatitis B, High Hepatitis B Virus DNA, and Normal Alanine Aminotransferase Levels. AMERICAN JOURNAL OF GASTROENTEROLOGY, 104(9), 2206–13.

Renal Dysfunction in Chronic Hepatitis B Patients Treated with Adefovir Dipivoxil
Ha, N. B., Ha, N. B., Garcia, R. T., Trinh, H. N., Vu, A. A., Nguyen, H. A., … Nguyen, M. H. (2009). Renal Dysfunction in Chronic Hepatitis B Patients Treated with Adefovir Dipivoxil. HEPATOLOGY, 50(3), 727–34.

Prevalence of hepatitis B virus genotype B in Vietnamese patients with chronic hepatitis B
Nguyen, L. H., Ha, N. B., Vutien, P., Ha, N. B., Garcia, R. T., Trinh, H. N., … Nguyen, M. H. (2009). Prevalence of hepatitis B virus genotype B in Vietnamese patients with chronic hepatitis B. HEPATOLOGY INTERNATIONAL, 3(3), 461–67.

Prevalence of hepatitis B virus DNA polymerase mutations in treatment-naive patients with chronic hepatitis B
Nguyen, M. H., Garcia, R. T., Trinh, H. N., Nguyen, H. A., Nguyen, K. K., Nguyen, L. H., & Levitt, B. (2009). Prevalence of hepatitis B virus DNA polymerase mutations in treatment-naive patients with chronic hepatitis B. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 30(11-12), 1150–58.

Combination of pharmacologic and endoscopic therapy for the secondary prevention of esophageal variceal bleeding
Ayoub, W. S., & Nguyen, M. H. (2009). Combination of pharmacologic and endoscopic therapy for the secondary prevention of esophageal variceal bleeding. GASTROINTESTINAL ENDOSCOPY, 70(4), 665–667.

Adherence to Screening for Hepatocellular Carcinoma Among Patients with Cirrhosis or Chronic Hepatitis B in a Community Setting
Wong, C. R., Garcia, R. T., Trinh, H. N., Lam, K. D., Ha, N. B., Nguyen, H. A., … Nguyen, M. H. (2009). Adherence to Screening for Hepatocellular Carcinoma Among Patients with Cirrhosis or Chronic Hepatitis B in a Community Setting. DIGESTIVE DISEASES AND SCIENCES, 54(12), 2712–21.

Similar Treatment Response to Peginterferon and Ribavirin in Asian and Caucasian Patients With Chronic Hepatitis C
Vutien, P., Nguyen, N. H., Trinh, H. N., Li, J., Garcia, R. T., Garcia, G., … Nguyen, M. H. (2010). Similar Treatment Response to Peginterferon and Ribavirin in Asian and Caucasian Patients With Chronic Hepatitis C. AMERICAN JOURNAL OF GASTROENTEROLOGY, 105(5), 1110–15.

Response to pegylated interferon and ribavirin in Asian American patients with Chronic hepatitis C genotypes 1 vs 2/3 vs 6
Nguyen, N. H., VuTien, P., Garcia, R. T., Trinh, H., Nguyen, H., Nguyen, K., … Nguyen, M. H. (2010). Response to pegylated interferon and ribavirin in Asian American patients with Chronic hepatitis C genotypes 1 vs 2/3 vs 6. JOURNAL OF VIRAL HEPATITIS, 17(10), 691–697.

Risk factors, genotype 6 prevalence, and clinical characteristics of chronic hepatitis C in Southeast Asian Americans
Nguyen, N. H., Vutien, P., Trinh, H. N., Garcia, R. T., Nguyen, L. H., Nguyen, H. A., … Nguyen, M. H. (2010). Risk factors, genotype 6 prevalence, and clinical characteristics of chronic hepatitis C in Southeast Asian Americans. HEPATOLOGY INTERNATIONAL, 4(2), 523–29.

Hepatitis B virus reverse transcriptase sequence variant database for sequence analysis and mutation discovery
Rhee, S.-Y., Margeridon-Thermet, S., Nguyen, M. H., Liu, T. F., Kagan, R. M., Beggel, B., … Shafer, R. W. (2010). Hepatitis B virus reverse transcriptase sequence variant database for sequence analysis and mutation discovery. ANTIVIRAL RESEARCH, 88(3), 269–75.

Randomized Controlled Trial of Pegylated Interferon-Alfa 2a and Ribavirin in Treatment-Naive Chronic Hepatitis C Genotype 6
Lam, K. D., Trinh, H. N., Do, S. T., Nguyen, T. T., Garcia, R. T., Nguyen, T., … Nguyen, M. H. (2010). Randomized Controlled Trial of Pegylated Interferon-Alfa 2a and Ribavirin in Treatment-Naive Chronic Hepatitis C Genotype 6. HEPATOLOGY, 52(5), 1573–80.

Screening for Hepatocellular Carcinoma After HBsAg Clearance Age Before Cirrhosis?
Lutchman, G. A., & Nguyen, M. A. (2011). Screening for Hepatocellular Carcinoma After HBsAg Clearance Age Before Cirrhosis? JOURNAL OF CLINICAL GASTROENTEROLOGY, 45(1), 4–5.

Medication Nonadherence with Long-Term Management of Patients with Hepatitis B e antigen-Negative Chronic Hepatitis B
Ha, N. B., Ha, N. B., Garcia, R. T., Trinh, H. N., Chaung, K. T., Nguyen, H. A., … Nguyen, M. H. (2011). Medication Nonadherence with Long-Term Management of Patients with Hepatitis B e antigen-Negative Chronic Hepatitis B. DIGESTIVE DISEASES AND SCIENCES, 56(8), 2423–31.

Ethnic Differences in Viral Dominance Patterns in Patients with Hepatitis B Virus and Hepatitis C Virus Dual Infection
Nguyen, L. H., Ko, S., Wong, S. S., Tran, P. S., Trinh, H. N., Garcia, R. T., … Nguyen, M. H. (2011). Ethnic Differences in Viral Dominance Patterns in Patients with Hepatitis B Virus and Hepatitis C Virus Dual Infection. HEPATOLOGY, 53(6), 1839–45.

Systematic review: epidemiology of hepatitis C genotype 6 and its management
Chao, D. T., Abe, K., & Nguyen, M. H. (2011). Systematic review: epidemiology of hepatitis C genotype 6 and its management. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 34(3), 286–296.

High Rate of Complete Viral Suppression With Combination Therapy in Patients With Chronic Hepatitis B and Prior Treatment Failure
Wong, C. R., Trinh, H. N., Yip, B., Nguyen, H. A., Garcia, R. T., Ahmed, A., … Nguyen, M. H. (2011). High Rate of Complete Viral Suppression With Combination Therapy in Patients With Chronic Hepatitis B and Prior Treatment Failure. JOURNAL OF CLINICAL GASTROENTEROLOGY, 45(10), 900–905.

The efficacy of entecavir therapy in chronic hepatitis B patients with suboptimal response to adevofir
SHEEN, E., Trinh, H. N., Nguyen, T. T., Do, S. T., Tran, P., Nguyen, H. A., … Nguyen, M. H. (2011). The efficacy of entecavir therapy in chronic hepatitis B patients with suboptimal response to adevofir. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 34(7), 767–74.

Prospective study of risk factors for hepatitis C virus acquisition by Caucasian, Hispanic, and Asian American patients
Ho, E. Y., Ha, N. B., Ahmed, A., Ayoub, W., Daugherty, T., Garcia, G., … Nguyen, M. H. (2012). Prospective study of risk factors for hepatitis C virus acquisition by Caucasian, Hispanic, and Asian American patients. JOURNAL OF VIRAL HEPATITIS, 19(2), E105–E111.

Risk factors for hepatocellular carcinoma in patients with chronic liver disease: a case-control study
Ha, N. B., Ha, N. B., Ahmed, A., Ayoub, W., Daugherty, T. J., Chang, E. T., … Nguyen, M. H. (2012). Risk factors for hepatocellular carcinoma in patients with chronic liver disease: a case-control study. CANCER CAUSES & CONTROL, 23(3), 455–462.

Undertreatment of Asian Chronic Hepatitis B Patients on the Basis of Standard Guidelines: A Community-Based Study
Zhang, S., Ristau, J. T., Trinh, H. N., Garcia, R. T., Nguyen, H. A., & Nguyen, M. H. (2012). Undertreatment of Asian Chronic Hepatitis B Patients on the Basis of Standard Guidelines: A Community-Based Study. DIGESTIVE DISEASES AND SCIENCES, 57(5), 1373–83.

Incidence of Hepatocellular Carcinoma Among US Patients With Cirrhosis of Viral or Nonviral Etiologies
Mair, R. D., Valenzuela, A., Ha, N. B., Ayoub, W. S., Daugherty, T., Lutchman, G. A., … Nguyen, M. H. (2012). Incidence of Hepatocellular Carcinoma Among US Patients With Cirrhosis of Viral or Nonviral Etiologies. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 10(12), 1412–17.

High Frequency of Recurrent Viremia After Hepatitis B e Antigen Seroconversion and Consolidation Therapy
Chaung, K. T., Ha, N. B., Trinh, H. N., Garcia, R. T., Nguyen, H. A., Nguyen, K. K., … Nguyen, M. H. (2012). High Frequency of Recurrent Viremia After Hepatitis B e Antigen Seroconversion and Consolidation Therapy. JOURNAL OF CLINICAL GASTROENTEROLOGY, 46(10), 865–70.

Tenofovir Monotherapy and Tenofovir Plus Entecavir Combination as Rescue Therapy for Entecavir Partial Responders
Yip, B., Chaung, K., Wong, C. R., Trinh, H. N., Nguyen, H. A., Ahmed, A., … Nguyen, M. H. (2012). Tenofovir Monotherapy and Tenofovir Plus Entecavir Combination as Rescue Therapy for Entecavir Partial Responders. DIGESTIVE DISEASES AND SCIENCES, 57(11), 3011–16.

High Proportion of Hepatitis C Virus in Community Asian American Patients With Non-Liver-related Complaints
Kin, K. C., Lin, B., Ha, N. B., Chaung, K. T., Trinh, H. N., Garcia, R. T., … Nguyen, M. H. (2013). High Proportion of Hepatitis C Virus in Community Asian American Patients With Non-Liver-related Complaints. JOURNAL OF CLINICAL GASTROENTEROLOGY, 47(4), 367–71.

Response to Higher Dose of Entecavir 1.0 mg Daily in Patients With Partial Response to Entecavir 0.5 mg Daily
Ha, N. B., Ha, N. B., Trinh, H. N., Nguyen, H. A., Nguyen, K. K., & Nguyen, M. H. (2013). Response to Higher Dose of Entecavir 1.0 mg Daily in Patients With Partial Response to Entecavir 0.5 mg Daily. JOURNAL OF CLINICAL GASTROENTEROLOGY, 47(5), 461–65.

Low hepatitis B envelope antigen seroconversion rate in chronic hepatitis B patients on long-term entecavir 0.5 mg daily in routine clinical practice
Liu, A., Ha, N. B., Lin, B., Yip, B., Trinh, H. N., Nguyen, H. A., … Nguyen, M. H. (2013). Low hepatitis B envelope antigen seroconversion rate in chronic hepatitis B patients on long-term entecavir 0.5 mg daily in routine clinical practice. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 25(3), 338–43.

Precore and basal core promoter mutations in Asian American patients with hepatitis B e antigen-positive chronic hepatitis B
VuTien, P., Trinh, H. N., Nguyen, K., Garcia, R. T., Nguyen, H. A., Levitt, B. S., … Nguyen, M. H. (2013). Precore and basal core promoter mutations in Asian American patients with hepatitis B e antigen-positive chronic hepatitis B. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 37(4), 464–72.

Low incidence of hepatitis B e antigen seroconversion in patients treated with oral nucleos(t)ides in routine practice.
Lin, B., Ha, N. B., Liu, A., Trinh, H. N., Nguyen, H. A., Nguyen, K. K., … Nguyen, M. H. (2013). Low incidence of hepatitis B e antigen seroconversion in patients treated with oral nucleos(t)ides in routine practice. Journal of Gastroenterology and Hepatology, 28(5), 855–60.

Treatment eligibility of patients with chronic hepatitis B initially ineligible for therapy.
Nguyen, N. H., Nguyen, V., Trinh, H. N., Lin, B., & Nguyen, M. H. (2013). Treatment eligibility of patients with chronic hepatitis B initially ineligible for therapy. Clinical Gastroenterology and Hepatology , 11(5), 565–71.

Systematic review: Asian patients with chronic hepatitis C infection.
Nguyen, L. H., & Nguyen, M. H. (2013). Systematic review: Asian patients with chronic hepatitis C infection. Alimentary Pharmacology & Therapeutics, 37(10), 921–36.

Prevalence, Risk Factors, and Disease Knowledge of Chronic Hepatitis B Infection in Vietnamese Americans in California
Ha, N. B., Trinh, H. N., Nguyen, T. T., Leduc, T.-S., Bui, C., Ha, N. B., … Nguyen, M. H. (2013). Prevalence, Risk Factors, and Disease Knowledge of Chronic Hepatitis B Infection in Vietnamese Americans in California. JOURNAL OF CANCER EDUCATION, 28(2), 319–324.

Prevention of mother-to-child transmission of hepatitis B virus: is elective cesarean section in highly viremic mothers an appropriate adjunct to immunoprophylaxis?
Nguyen, L. H., & Nguyen, M. H. (2013). Prevention of mother-to-child transmission of hepatitis B virus: is elective cesarean section in highly viremic mothers an appropriate adjunct to immunoprophylaxis? Clinical Gastroenterology and Hepatology , 11(10), 1356–57.

DIFFERENTIAL MIGRATION OF ASTROCYTES GRAFTED INTO THE DEVELOPING RAT-BRAIN
Hatton, J. D., Nguyen, M. H., & U, H. S. (1993). DIFFERENTIAL MIGRATION OF ASTROCYTES GRAFTED INTO THE DEVELOPING RAT-BRAIN. GLIA, 9(2), 113–119.

Treatment of Hepatocellular Carcinoma
Treatment of Hepatocellular Carcinoma. (2003). Rustgi AK and Crawford J, Eds. Gastrointestinal Cancer: A Companion to Sleisenger & Fordtran?s GI and Liver Diseases. Philadelphia: WB Saunders, 1st ed.

The role of steatosis in HBV infection
The role of steatosis in HBV infection. (2011). Curr Hepat Rep, 10.

Early virologic response in HCV genotype 6
Early virologic response in HCV genotype 6. (2011). Hepatology, 53.

Benign tumors and evaluation of liver masses
Benign tumors and evaluation of liver masses. (2005). In: Al Knawy B, Schiffman ML, and Wiesner R, Eds. Hepatology: A Practical Approach, 1st Ed. Amsterdam: Elsevier Science BV.

Chronic HBV infection and normal ALT levels: Underlying histological disease
Chronic HBV infection and normal ALT levels: Underlying histological disease. (2007). Curr Hepat Rep, 6.

Hepatitis C virus and cancers: How strong are the relationships?
Hepatitis C virus and cancers: How strong are the relationships? (2009). Curr Hepat Rep, 8.

Histologic Disease in Patients with Chronic Hepatitis B, HIgh HBV DNA, and Normal Alanine Aminotransferase Levels
Histologic Disease in Patients with Chronic Hepatitis B, HIgh HBV DNA, and Normal Alanine Aminotransferase Levels. (2010). Curr Hepat Rep, 9.

Relationship between HBsAg seroconversion and hepatocellular carcinoma
Relationship between HBsAg seroconversion and hepatocellular carcinoma. (2011). J Clin Gastroenterol, 45.

Ethnic differences in viral dominance patterns in patients with hepatitis B virus and hepatitis C virus dual infection
Ethnic differences in viral dominance patterns in patients with hepatitis B virus and hepatitis C virus dual infection. (2012). Hepatology, 55.

Incidence and Predictors of Recurrent Hepatocellular Carcinoma (HCC) Following Partial Hepatectomy
Vergara, A. M. V., Gallo, A., Nghiem Ha, N., Bonham, C., Esquivel, C., Concepcion, W., … Mindie Nguyen, M. (2011). Incidence and Predictors of Recurrent Hepatocellular Carcinoma (HCC) Following Partial Hepatectomy. Presented at the 76th Annual Scientific Meeting of the American-College-of-Gastroenterology, WASHINGTON,DC,DC,DC,DC,DC,DC,DC,DC,DC,DC,DC,DC,DC,DC,DC,DC,DC,DC: NATURE PUBLISHING GROUP.

Lead poisoning as an etiology of abdominal pain and intestinal pseudo-obstruction in adults
Tran, C. P., Garcia, R. T., Lam, V. T., Trong, T. H., Keeffe, E. B., & Nguyen, M. H. (2004). Lead poisoning as an etiology of abdominal pain and intestinal pseudo-obstruction in adults. AMERICAN JOURNAL OF GASTROENTEROLOGY, 99(10), S105–S105.

Unsedated ultrathin EGD is well accepted by most patients: A randomized trial of unsedated ultrathin EGD (UT-EGD) vs. sedated conventional EGD (C-EGD)
Garcia, R. T., Cello, J. P., Rogers, S. J., Rodas, A., Nguyen, M. H., Trinh, H., … McQuaid, K. R. (2002). Unsedated ultrathin EGD is well accepted by most patients: A randomized trial of unsedated ultrathin EGD (UT-EGD) vs. sedated conventional EGD (C-EGD). AMERICAN JOURNAL OF GASTROENTEROLOGY, 97(9), S306–S306.

Adefovir (ADV) Partial Response in Patients with Chronic Hepatitis B (CHB): Switch Versus Add-On Therapy
Yip, B., Huy Trinh, H., Khanh Nguyen, K., Huy Nguyen, H., Garcia, R., Keeffe, E., … Mindie Nguyen, M. (2011). Adefovir (ADV) Partial Response in Patients with Chronic Hepatitis B (CHB): Switch Versus Add-On Therapy. Presented at the 76th Annual Scientific Meeting of the American-College-of-Gastroenterology, WASHINGTON,DC,DC,DC,DC: NATURE PUBLISHING GROUP.

Risk Factors for Hepatitis C Virus (HCV) Infection in Asian American Patients: A Case-Control Study
Kin, K., Lin, B., Chaung, K., Nghiem Ha, N., Huy Trinh, H., Garcia, R., … Mindie Nguyen, M. (2011). Risk Factors for Hepatitis C Virus (HCV) Infection in Asian American Patients: A Case-Control Study. Presented at the 76th Annual Scientific Meeting of the American-College-of-Gastroenterology, WASHINGTON,DC,DC,DC,DC: NATURE PUBLISHING GROUP.

Both HCV and HBV are Major Causes of Liver Cancer in Southeast Asians.
Lin, H., Ha, N. B., Ahmed, A., Ayoub, W., Daugherty, T. J., Lutchman, G. A., … Nguyen, M. H. (2013). Both HCV and HBV are Major Causes of Liver Cancer in Southeast Asians. Journal of Immigrant and Minority Health , 15(6), 1023–29.

Less-established risk factors are common in asian americans with hepatitis C virus: a case-controlled study.
Kin, K. C., Lin, B., Chaung, K. T., Ha, N. B., Trinh, H. N., Garcia, R. T., … Nguyen, M. H. (2013). Less-established risk factors are common in asian americans with hepatitis C virus: a case-controlled study. Digestive Diseases and Sciences, 58(11), 3342–47.

Clinical Presentation and Survival of Asian and Non-Asian Patients with HCV-Related Hepatocellular Carcinoma
Yip, B., Wantuck, J. M., Kim, L. H., Wong, R. J., Ahmed, A., Garcia, G., & Nguyen, M. H. (2014). Clinical Presentation and Survival of Asian and Non-Asian Patients with HCV-Related Hepatocellular Carcinoma. DIGESTIVE DISEASES AND SCIENCES, 59(1), 192–200.

Review article: the epidemiology and therapy of chronic hepatitis C genotypes 4, 5 and 6
Wantuck, J. M., Ahmed, A., & Nguyen, M. H. (2014). Review article: the epidemiology and therapy of chronic hepatitis C genotypes 4, 5 and 6. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 39(2), 137–47.

Hepatocellular Carcinoma Incidence in Noncirrhotic Patients With Chronic Hepatitis B and Patients With Cirrhosis of All Etiologies.
Do, A. L., Wong, C. R., Nguyen, L. H., Nguyen, V. G., Trinh, H., & Nguyen, M. H. (2013). Hepatocellular Carcinoma Incidence in Noncirrhotic Patients With Chronic Hepatitis B and Patients With Cirrhosis of All Etiologies. Journal of Clinical Gastroenterology.

Primary surgical resection versus liver transplantation for transplant-eligible hepatocellular carcinoma patients.
Wong, R. J., Wantuck, J., Valenzuela, A., Ahmed, A., Bonham, C., Gallo, A., … Nguyen, M. H. (2014). Primary surgical resection versus liver transplantation for transplant-eligible hepatocellular carcinoma patients. Digestive Diseases and Sciences, 59(1), 183–91.

Mutations in HBV DNA polymerase associated with nucleos(t)ide resistance are rare in treatment-naive patients.
Vutien, P., Trinh, H. N., Garcia, R. T., Nguyen, H. A., Levitt, B. S., Nguyen, K., … Nguyen, M. H. (2014). Mutations in HBV DNA polymerase associated with nucleos(t)ide resistance are rare in treatment-naive patients. Clinical Gastroenterology and Hepatology , 12(8), 1363–70.

Similar Response to Entecavir 0.5 and 1.0 Mg in Treatment-Na < ve Chronic Hepatitis B Patients: A Case-Control Study
Ha, N. B., Ha, N. B., Chaung, K. T., Trinh, H. N., Nguyen, H. A., Nguyen, K. K., & Nguyen, M. H. (2014). Similar Response to Entecavir 0.5 and 1.0 Mg in Treatment-Na < ve Chronic Hepatitis B Patients: A Case-Control Study. DIGESTIVE DISEASES AND SCIENCES, 59(1), 168–73.

Chronic Hepatitis B Management Based on Standard Guidelines in Community Primary Care and Specialty Clinics
Ku, K. C., Li, J., Ha, N. B., Martin, M., Nguyen, V. G., & Nguyen, M. H. (2013). Chronic Hepatitis B Management Based on Standard Guidelines in Community Primary Care and Specialty Clinics. DIGESTIVE DISEASES AND SCIENCES, 58(12), 3626–33.

Increased Long-term Survival Among Patients With Hepatocellular Carcinoma After Implementation of Model for End-stage Liver Disease Score.
Wong, R. J., Devaki, P., Nguyen, L., Cheung, R., Cho-Phan, C., & Nguyen, M. H. (2014). Increased Long-term Survival Among Patients With Hepatocellular Carcinoma After Implementation of Model for End-stage Liver Disease Score. Clinical Gastroenterology and Hepatology , 12(9), 1534–40 e1.

Systematic review with meta-analysis: the proportion of chronic hepatitis B patients with normal alanine transaminase <= 40 IU/L and significant hepatic fibrosis
Chao, D. T., Lim, J. K., Ayoub, W. S., Nguyen, L. H., & Nguyen, M. H. (2014). Systematic review with meta-analysis: the proportion of chronic hepatitis B patients with normal alanine transaminase <= 40 IU/L and significant hepatic fibrosis. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 39(4), 349–358.

Histologic Changes in Liver Tissue From Patients With Chronic Hepatitis B and Minimal Increases in Levels of Alanine Aminotransferase: A Meta-analysis and Systematic Review
Nguyen, L. H., Chao, D., Lim, J. K., Ayoub, W., & Nguyen, M. H. (2014). Histologic Changes in Liver Tissue From Patients With Chronic Hepatitis B and Minimal Increases in Levels of Alanine Aminotransferase: A Meta-analysis and Systematic Review. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 12(8), 1262–66.

Ethnic disparities and liver transplantation rates in hepatocellular carcinoma patients in the recent era: Results from the surveillance, epidemiology, and end results registry
Wong, R. J., Devaki, P., Long Nguyen, L., Cheung, R., & Nguyen, M. H. (2014). Ethnic disparities and liver transplantation rates in hepatocellular carcinoma patients in the recent era: Results from the surveillance, epidemiology, and end results registry. LIVER TRANSPLANTATION, 20(5), 528–35.

Tenofovir is superior to entecavir for achieving complete viral suppression in HBeAg-positive chronic hepatitis B patients with high HBV DNA
Gao, L., Trinh, H. N., Li, J., & Nguyen, M. H. (2014). Tenofovir is superior to entecavir for achieving complete viral suppression in HBeAg-positive chronic hepatitis B patients with high HBV DNA. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 39(6), 629–37.

Isoniazid hepatotoxicity requiring liver transplantation.
Sheen, E., Huang, R. J., Uribe, L. A., & Nguyen, M. H. (2014). Isoniazid hepatotoxicity requiring liver transplantation. Digestive Diseases and Sciences, 59(7), 1370–74.

Recurrent Hepatocellular Carcinoma and Poorer Overall Survival in Patients Undergoing Left-sided Compared With Right-sided Partial Hepatectomy.
Valenzuela, A., Ha, N. B., Gallo, A., Bonham, C., Ahmed, A., Melcher, M., … Nguyen, M. H. (2015). Recurrent Hepatocellular Carcinoma and Poorer Overall Survival in Patients Undergoing Left-sided Compared With Right-sided Partial Hepatectomy. Journal of Clinical Gastroenterology, 49(2), 158–64.

Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection.
Afdhal, N., Reddy, K. R., Nelson, D. R., Lawitz, E., Gordon, S. C., Schiff, E., … Kwo, P. (2014). Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection. New England Journal of Medicine, 370(16), 1483–1493.

Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection.
Afdhal, N., Zeuzem, S., Kwo, P., Chojkier, M., Gitlin, N., Puoti, M., … Marcellin, P. (2014). Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection. The New England Journal of Medicine, 370(20), 1889–98.

Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis.
Kowdley, K. V., Gordon, S. C., Reddy, K. R., Rossaro, L., Bernstein, D. E., Lawitz, E., … Fried, M. W. (2014). Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis. The New England Journal of Medicine, 370(20), 1879–88.

Current treatment guidelines for chronic hepatitis B and their applications.
Uribe, L. A., O'Brien, C. G., Wong, R. J., Gish, R. R., Tsai, N., & Nguyen, M. H. (2014). Current treatment guidelines for chronic hepatitis B and their applications. Journal of Clinical Gastroenterology, 48(9), 773–83.

Treating hepatitis C in lower-income countries.
Jayasekera, C. R., Barry, M., Roberts, L. R., & Nguyen, M. H. (2014). Treating hepatitis C in lower-income countries. New England Journal of Medicine, 370(20), 1869–71.

Letter: Response-guided treatment of hepatitis C virus genotype 5 may be feasible--authors' reply.
Wantuck, J. M., & Nguyen, M. H. (2014). Letter: Response-guided treatment of hepatitis C virus genotype 5 may be feasible--authors' reply. Alimentary Pharmacology & Therapeutics, 39(11), 1338-?

Letter: Treatment of HBeAg+ chronic hepatitis B--is tenofovir truly superior to entecavir? Authors' reply.
Gao, L., Trinh, H. N., Li, J., & Nguyen, M. H. (2014). Letter: Treatment of HBeAg+ chronic hepatitis B--is tenofovir truly superior to entecavir? Authors' reply. Alimentary Pharmacology & Therapeutics, 39(11), 1339–40.

Low Treatment Rates in Patients Meeting Guideline Criteria in Diverse Practice Settings
Kim, L. H., Nguyen, V. G., Trinh, H. N., Li, J., Zhang, J. Q., & Nguyen, M. H. (2014). Low Treatment Rates in Patients Meeting Guideline Criteria in Diverse Practice Settings. DIGESTIVE DISEASES AND SCIENCES, 59(9), 2091–99.

Chronic Hepatitis B Treatment Eligibility and Actual Treatment Rates in Patients in Community Gastroenterology and Primary Care Settings
Nguyen, V. G., Wan, K., Trinh, H. N., Li, J., Zhang, J. Q., & Nguyen, M. H. (2015). Chronic Hepatitis B Treatment Eligibility and Actual Treatment Rates in Patients in Community Gastroenterology and Primary Care Settings. JOURNAL OF CLINICAL GASTROENTEROLOGY, 49(2), 145–49.

Hepatocellular Carcinoma Incidence in Noncirrhotic Patients With Chronic Hepatitis B and Patients With Cirrhosis of All Etiologies
Do, A. L., Wong, C. R., Nguyen, L. H., Nguyen, V. G., Huy Trinh, H., & Nguyen, M. H. (2014). Hepatocellular Carcinoma Incidence in Noncirrhotic Patients With Chronic Hepatitis B and Patients With Cirrhosis of All Etiologies. JOURNAL OF CLINICAL GASTROENTEROLOGY, 48(7), 644–49.

The genetic diversity and evolutionary history of hepatitis C virus in Vietnam.
Li, C., Yuan, M., Lu, L., Lu, T., Xia, W., Pham, V. H., … Abe, K. (2014). The genetic diversity and evolutionary history of hepatitis C virus in Vietnam. Virology, 468-470C, 197–206.

Meta-analysis: influence of host and viral factors in patients with chronic hepatitis C genotype 4 treated with pegylated interferon and ribavirin.
Yee, B. E., Nguyen, N. H., Zhang, B., Vutien, P., Wong, C. R., Lutchman, G. A., & Nguyen, M. H. (2014). Meta-analysis: influence of host and viral factors in patients with chronic hepatitis C genotype 4 treated with pegylated interferon and ribavirin. European Journal of Gastroenterology & Hepatology, 26(11), 1189–1201.

Safety and efficacy of entecavir in adefovir-experienced patients
Nguyen, N. H., Trinh, H. N., Nguyen, T. T., Do, S. T., Tran, P., Nguyen, H. A., … Nguyen, M. H. (2015). Safety and efficacy of entecavir in adefovir-experienced patients. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 30(1), 43–50.

Increased Long-term Survival Among Patients With Hepatocellular Carcinoma After Implementation of Model for End-stage Liver Disease Score
Wong, R. J., Devaki, P., Long Nguyen, L., Cheung, R., Cho-Phan, C., & Nguyen, M. H. (2014). Increased Long-term Survival Among Patients With Hepatocellular Carcinoma After Implementation of Model for End-stage Liver Disease Score. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 12(9), 1534–U323.

Fixed-dose combination of sofosbuvir and ledipasvir for the treatment of chronic hepatitis C genotype 1.
Kumari, R., & Nguyen, M. H. (2015). Fixed-dose combination of sofosbuvir and ledipasvir for the treatment of chronic hepatitis C genotype 1. Expert Opinion on Pharmacotherapy, 16(5), 739–48.

Tenofovir monotherapy after achieving complete viral suppression on entecavir plus tenofovir combination therapy.
Kim, L. H., Chaung, K. T., Ha, N. B., Kin, K. C., Vu, V. D., Trinh, H. N., … Nguyen, M. H. (2015). Tenofovir monotherapy after achieving complete viral suppression on entecavir plus tenofovir combination therapy. European Journal of Gastroenterology & Hepatology, 27(8), 871–76.

Renal Function in Chronic Hepatitis B Patients Treated With Tenofovir Disoproxil Fumarate or Entecavir Monotherapy A Matched Case-Cohort Study
Ha, N. B., Ku, K., Ha, N. B., Chaung, K. T., Trinh, H. N., & Nguyen, M. H. (2015). Renal Function in Chronic Hepatitis B Patients Treated With Tenofovir Disoproxil Fumarate or Entecavir Monotherapy A Matched Case-Cohort Study. JOURNAL OF CLINICAL GASTROENTEROLOGY, 49(10), 873–77.

Poor Sustained Virological Response in a Multicenter Real-Life Cohort of Chronic Hepatitis C Patients Treated with Pegylated Interferon and Ribavirin plus Telaprevir or Boceprevir
Vo, K. P., Vutien, P., Akiyama, M. J., Vu, V. D., Ha, N. B., Piotrowski, J. I., … Nguyen, M. H. (2015). Poor Sustained Virological Response in a Multicenter Real-Life Cohort of Chronic Hepatitis C Patients Treated with Pegylated Interferon and Ribavirin plus Telaprevir or Boceprevir. DIGESTIVE DISEASES AND SCIENCES, 60(4), 1045–51.

Efficacy and effectiveness of anti-HBV therapy with early withdrawal of HBIG prophylaxis to prevent HBV recurrence following liver transplantation
Ku, W., Wang, U., & Nguyen, M. H. (2015). Efficacy and effectiveness of anti-HBV therapy with early withdrawal of HBIG prophylaxis to prevent HBV recurrence following liver transplantation. EXPERT OPINION ON BIOLOGICAL THERAPY, 15(5), 665–77.

Meta-Analysis: Superior Treatment Response in Asian Patients with Hepatitis C Virus Genotype 6 versus Genotype 1 with Pegylated Interferon and Ribavirin
Nguyen, N. H., McCormack, S. A., Vutien, P., Yee, B. E., Devaki, P., Jencks, D., & Nguyen, M. H. (2015). Meta-Analysis: Superior Treatment Response in Asian Patients with Hepatitis C Virus Genotype 6 versus Genotype 1 with Pegylated Interferon and Ribavirin. INTERVIROLOGY, 58(1), 27–34.

Approximately One-Half of Patients With Early-Stage Hepatocellular Carcinoma Meeting Milan Criteria Did Not Receive Local Tumor Destructive or Curative Surgery in the Post-MELD Exception Era
Devaki, P., Wong, R. J., Marupakula, V., Nangia, S., Long Nguyen, L., Ditah, I. C., … Nguyen, M. H. (2014). Approximately One-Half of Patients With Early-Stage Hepatocellular Carcinoma Meeting Milan Criteria Did Not Receive Local Tumor Destructive or Curative Surgery in the Post-MELD Exception Era. CANCER, 120(11), 1725–32.

The genetic diversity and evolutionary history of hepatitis C virus in Vietnam
Li, C., Yuan, M., Lu, L., Lu, T., Xia, W., Pham, V. H., … Abe, K. (2014). The genetic diversity and evolutionary history of hepatitis C virus in Vietnam. VIROLOGY, 468, 197–206.

Sustained virologic response to standard interferon or pegylated interferon and ribavirin in patients with hepatitis C virus genotype 5: systematic review and meta-analysis of ten studies and 423 patients
Devaki, P., Jencks, D., Yee, B. E., & Nguyen, M. H. (2015). Sustained virologic response to standard interferon or pegylated interferon and ribavirin in patients with hepatitis C virus genotype 5: systematic review and meta-analysis of ten studies and 423 patients. HEPATOLOGY INTERNATIONAL, 9(3), 431–37.

Tenofovir-based alternate therapies for chronic hepatitis B patients with partial virological response to entecavir.
Lu, L., Yip, B., Trinh, H., Pan, C. Q., Han, S. B., Wong, C. C., … Nguyen, M. H. (2015). Tenofovir-based alternate therapies for chronic hepatitis B patients with partial virological response to entecavir. Journal of Viral Hepatitis, 22(8), 675–81.

A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2015 Update
Martin, P., Lau, D. T. Y., Nguyen, M. H., Janssen, H. la, Dieterich, D. T., Peters, M. G., & Jacobson, I. M. (2015). A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2015 Update. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 13(12), 2071-?

Meta-analysis of patients with hepatitis C virus genotype 6: 48 weeks with pegylated interferon and ribavirin is superior to 24 weeks.
Nguyen, N. H., McCormack, S. A., Yee, B. E., Devaki, P., Jencks, D., Chao, D. T., & Nguyen, M. H. (2014). Meta-analysis of patients with hepatitis C virus genotype 6: 48 weeks with pegylated interferon and ribavirin is superior to 24 weeks. Hepatology International, 8(4), 540–49.

Long-term follow-up and suboptimal treatment rates of treatment-eligible chronic hepatitis B patients in diverse practice settings: a gap in linkage to care.
Vu, V. D., Do, A., Nguyen, N. H., Kim, L. H., Trinh, H. N., Nguyen, H. A., … Nguyen, M. H. (2015). Long-term follow-up and suboptimal treatment rates of treatment-eligible chronic hepatitis B patients in diverse practice settings: a gap in linkage to care. BMJ Open Gastroenterology, 2(1).

Sustained virological response and its treatment predictors in hepatitis C virus genotype 4 compared to genotypes 1, 2, and 3: a meta-analysis.
Yee, B. E., Nguyen, N. H., Zhang, B., Lin, D., Vutien, P., Wong, C. R., … Nguyen, M. H. (2015). Sustained virological response and its treatment predictors in hepatitis C virus genotype 4 compared to genotypes 1, 2, and 3: a meta-analysis. BMJ Open Gastroenterology, 2(1).

Treatment of Acute Hepatitis C Infection with Pegylated Interferon and Ribavirin in Patients Coinfected with Human Immunodeficiency Virus: A Systematic Review and Meta-Analysis
Zhang, B., Nguyen, N. H., Yee, B. E., Yip, B., Ayoub, W. S., Lutchman, G. A., & Nguyen, M. H. (2015). Treatment of Acute Hepatitis C Infection with Pegylated Interferon and Ribavirin in Patients Coinfected with Human Immunodeficiency Virus: A Systematic Review and Meta-Analysis. INTERVIROLOGY, 58(4), 242–49.

Current Treatment Options in Patients with Hepatitis C Virus Genotype 6
Nguyen, N. H., & Nguyen, M. H. (2015). Current Treatment Options in Patients with Hepatitis C Virus Genotype 6. Gastroenterol Clin N Am, 44.

Rates of Treatment Eligibility in Follow-Up of Patients with Chronic Hepatitis B (CHB) Across Various Clinical Settings Who Were Initially Ineligible at Presentation.
Uribe, L. A., Nguyen, N., Kim, L., Trinh, H. N., Wong, C., Wong, C., … Nguyen, M. H. (2016). Rates of Treatment Eligibility in Follow-Up of Patients with Chronic Hepatitis B (CHB) Across Various Clinical Settings Who Were Initially Ineligible at Presentation. Digestive Diseases and Sciences, 61(2), 618–25.

Alternative Therapies for Chronic Hepatitis B Patients With Partial Virological Response to Standard Entecavir Monotherapy.
Chaung, K. T., O'Brien, C., Ha, N. B., Nguyen, N. H., Trinh, H. N., & Nguyen, M. H. (2016). Alternative Therapies for Chronic Hepatitis B Patients With Partial Virological Response to Standard Entecavir Monotherapy. Journal of Clinical Gastroenterology, 50(4), 338–44.

Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection.
Feld, J. J., Jacobson, I. M., Hézode, C., Asselah, T., Ruane, P. J., Gruener, N., … Zeuzem, S. (2015). Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection. The New England Journal of Medicine, 373(27), 2599–607.

HCV Prevalence in Asian Americans in California.
Lin, O. N., Chang, C., Lee, J., Do, A., Martin, M., Martin, A., & Nguyen, M. H. (2016). HCV Prevalence in Asian Americans in California. Journal of Immigrant and Minority Health, -?

Current Treatment Options in Patients with Hepatitis C Virus Genotype 6.
Nguyen, N. H., & Nguyen, M. H. (2015). Current Treatment Options in Patients with Hepatitis C Virus Genotype 6. Gastroenterology Clinics of North America, 44(4), 871–81.

Management of Chronic hepatitis C among Asian Americans.
Yip, B., Nguyen, L. H., & Nguyen, M. H. (2014). Management of Chronic hepatitis C among Asian Americans. . North Am J Med Sci. , 7.

Effects of Cirrhosis on Short-term and Long-term Survival of Patients With Hepatitis B-related Hepatocellular Carcinoma
Chen, V. L., Le, A. K., Kim, N. G., Kim, L. H., Nguyen, N. H., Nguyen, P. P., … Nguyen, M. H. (2016). Effects of Cirrhosis on Short-term and Long-term Survival of Patients With Hepatitis B-related Hepatocellular Carcinoma. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 14(6), 887-?

Entecavir safety and effectiveness in a national cohort of treatment-naive chronic hepatitis B patients in the US - the ENUMERATE study
Ahn, J., Lee, H. M., Lim, J. K., Pan, C. Q., Nguyen, M. H., Kim, W. R., … Lok, A. S. (2016). Entecavir safety and effectiveness in a national cohort of treatment-naive chronic hepatitis B patients in the US - the ENUMERATE study. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 43(1), 134–44.

Analysis of HCV-6 isolates among Asian-born immigrants in North America reveals their high genetic diversity and a new subtype
Lu, L., Wu, T., Xiong, L., Li, C., Nguyen, M. H., & Murphy, D. G. (2016). Analysis of HCV-6 isolates among Asian-born immigrants in North America reveals their high genetic diversity and a new subtype. VIROLOGY, 492, 25–31.

Hepatitis B surface antigen escape mutations: Indications for initiation of antiviral therapy revisited.
Leong, J., Lin, D., & Nguyen, M. H. (2016). Hepatitis B surface antigen escape mutations: Indications for initiation of antiviral therapy revisited. World Journal of Clinical Cases, 4(3), 71–75.

Tolerability and effectiveness of sofosbuvir and simeprevir in the post-transplant setting: systematic review and meta-analysis.
Nguyen, N. H., Yee, B. E., Chang, C., Jin, M., Lutchman, G., Lim, J. K., & Nguyen, M. H. (2016). Tolerability and effectiveness of sofosbuvir and simeprevir in the post-transplant setting: systematic review and meta-analysis. BMJ Open Gastroenterology, 3(1).

Lower response to simeprevir and sofosbuvir in HCV genotype 1 in routine practice compared with clinical trials.
Yee, B. E., Nguyen, N. H., Jin, M., Lutchman, G., Lim, J. K., & Nguyen, M. H. (2016). Lower response to simeprevir and sofosbuvir in HCV genotype 1 in routine practice compared with clinical trials. BMJ Open Gastroenterology, 3(1).

Treatment Outcomes With First-line Therapies With Entecavir and Tenofovir in Treatment-Naive Chronic Hepatitis B Patients in a Routine Clinical Practice
Ha, N. B., Trinh, H. N., Rosenblatt, L., Nghiem, D., & Nguyen, M. H. (2016). Treatment Outcomes With First-line Therapies With Entecavir and Tenofovir in Treatment-Naive Chronic Hepatitis B Patients in a Routine Clinical Practice. JOURNAL OF CLINICAL GASTROENTEROLOGY, 50(2), 169–74.

Hepatocellular Carcinoma Screening and Surveillance Practice Guidelines and Real-Life Practice
Zhao, C., & Nguyen, M. H. (2016). Hepatocellular Carcinoma Screening and Surveillance Practice Guidelines and Real-Life Practice. JOURNAL OF CLINICAL GASTROENTEROLOGY, 50(2), 120–33.

Racial Disparities in Treatment Rates for Chronic Hepatitis C Analysis of a Population-Based Cohort of 73,665 Patients in the United States
Vutien, P., Hoang, J., Brooks, L., Nguyen, N. H., & Nguyen, M. H. (2016). Racial Disparities in Treatment Rates for Chronic Hepatitis C Analysis of a Population-Based Cohort of 73,665 Patients in the United States. MEDICINE, 95(22).

Lower Observed Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Patients Treated With Entecavir: Results of the ENUMERATE Study.
Ahn, J., Lim, J. K., Lee, H. M., Lok, A. S., Nguyen, M., Pan, C. Q., … Kim, W. R. (2016). Lower Observed Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Patients Treated With Entecavir: Results of the ENUMERATE Study. American Journal of Gastroenterology, 111(9), 1297–1304.

Serum Alanine Aminotransferase and Hepatitis B DNA Flares in Pregnant and Postpartum Women with Chronic Hepatitis B.
Chang, C. Y., Aziz, N., Poongkunran, M., Javaid, A., Trinh, H. N., Lau, D., & Nguyen, M. H. (2016). Serum Alanine Aminotransferase and Hepatitis B DNA Flares in Pregnant and Postpartum Women with Chronic Hepatitis B. American Journal of Gastroenterology, 111(10), 1410–15.

Ethnic differences in incidence of hepatitis B surface antigen seroclearance in a real-life multicenter clinical cohort of 4737 patients with chronic hepatitis B infection
Nguyen, L. H., Hoang, J., Nguyen, N. H., Vu, V. D., Wang, C., Trinh, H. N., … Nguyen, M. H. (2016). Ethnic differences in incidence of hepatitis B surface antigen seroclearance in a real-life multicenter clinical cohort of 4737 patients with chronic hepatitis B infection. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 44(4), 390–99.

Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Hepatitis C Virus Genotype 2, 3, 4, or 6 Infections in an Open-label, Phase 2 Trial.
Gane, E., Kowdley, K. V., Pound, D., Stedman, C. A. M., Davis, M., Etzkorn, K., … Nguyen, M. H. (2016). Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Hepatitis C Virus Genotype 2, 3, 4, or 6 Infections in an Open-label, Phase 2 Trial. Gastroenterology.

Sex differences in disease presentation, treatment and clinical outcomes of patients with hepatocellular carcinoma: a single-centre cohort study.
Ladenheim, M. R., Kim, N. G., Nguyen, P., Le, A., Stefanick, M. L., Garcia, G., & Nguyen, M. H. (2016). Sex differences in disease presentation, treatment and clinical outcomes of patients with hepatocellular carcinoma: a single-centre cohort study. BMJ Open Gastroenterology, 3(1).

Lower liver cancer risk with antiviral therapy in chronic hepatitis B patients with normal to minimally elevated ALT and no cirrhosis.
Hoang, J. K., Yang, H.-I., Le, A., Nguyen, N. H., Lin, D., Vu, V. D., … Nguyen, M. H. (2016). Lower liver cancer risk with antiviral therapy in chronic hepatitis B patients with normal to minimally elevated ALT and no cirrhosis. Medicine, 95(31).

Effectiveness and tolerability of simeprevir and sofosbuvir in nontransplant and post-liver transplant patients with hepatitis C genotype 1.
Lutchman, G., Nguyen, N. H., Chang, C. Y., Ahmed, A., Daugherty, T., Garcia, G., … Nguyen, M. H. (2016). Effectiveness and tolerability of simeprevir and sofosbuvir in nontransplant and post-liver transplant patients with hepatitis C genotype 1. Alimentary Pharmacology & Therapeutics, 44(7), 738–46.

Reduction of chronic hepatitis B-related hepatocellular carcinoma with anti-viral therapy, including low risk patients.
LIN, D., Yang, H., Nguyen, N., Hoang, J., Kim, Y., Vu, V., … Nguyen, M. H. (2016). Reduction of chronic hepatitis B-related hepatocellular carcinoma with anti-viral therapy, including low risk patients. Alimentary Pharmacology & Therapeutics, 44(8), 846–55.

Impact of country of birth on age at the time of diagnosis of hepatocellular carcinoma in the United States.
Yang, J. D., Altekruse, S. F., Nguyen, M. H., Gores, G. J., & Roberts, L. R. (2016). Impact of country of birth on age at the time of diagnosis of hepatocellular carcinoma in the United States. Cancer.

Poor adherence and low persistency rates for hepatocellular carcinoma surveillance in patients with chronic hepatitis B.
Wang, C., Chen, V., Vu, V., Le, A., Nguyen, L., Zhao, C., … Nguyen, M. H. (2016). Poor adherence and low persistency rates for hepatocellular carcinoma surveillance in patients with chronic hepatitis B. Medicine, 95(35).

Increased Prevalence of Metabolic Risk Factors in Asian Americans With Hepatocellular Carcinoma.
Kutsenko, A., Ladenheim, M. R., Kim, N., Nguyen, P., Chen, V., Jayasekera, C., … Nguyen, M. H. (2017). Increased Prevalence of Metabolic Risk Factors in Asian Americans With Hepatocellular Carcinoma. Journal of Clinical Gastroenterology, 51(4), 384–90.

Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease
Wong, C. R., Nguyen, M. H., & Lim, J. K. (2016). Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease. WORLD JOURNAL OF GASTROENTEROLOGY, 22(37), 8294–8303.

Non-alcoholic fatty liver diseases: update on the challenge of diagnosis and treatment.
Oh, H., Jun, D. W., Saeed, W. K., & Nguyen, M. H. (2016). Non-alcoholic fatty liver diseases: update on the challenge of diagnosis and treatment. Clinical and Molecular Hepatology, 22(3), 327–35.

Mutations in HBV DNA Polymerase Associated With Nucleos(t)ide Resistance Are Rare in Treatment-naive Patients.
Vutien, P., Trinh, H. N., Garcia, R. T., Nguyen, H. A., Levitt, B. S., Nguyen, K., … Nguyen, M. H. (2014). Mutations in HBV DNA Polymerase Associated With Nucleos(t)ide Resistance Are Rare in Treatment-naive Patients. Clinical Gastroenterology and Hepatology , 12(8), 1363–70.

Letter: reduction in chronic hepatitis B-related hepatocellular carcinoma with anti-viral therapy, including low-risk patients - more questions than answers. Authors' reply.
Lin, D., Yang, H.-I. I., Hoang, J., & Nguyen, M. H. (2017). Letter: reduction in chronic hepatitis B-related hepatocellular carcinoma with anti-viral therapy, including low-risk patients - more questions than answers. Authors' reply. Alimentary Pharmacology & Therapeutics, 45(1), 186–87.

Letter: should anti-viral therapy be recommended for individuals chronically infected with hepatitis B virus and at low risk of hepatocellular carcinoma? Authors' reply.
Lin, D., Yang, H.-I. I., Hoang, J., & Nguyen, M. H. (2017). Letter: should anti-viral therapy be recommended for individuals chronically infected with hepatitis B virus and at low risk of hepatocellular carcinoma? Authors' reply. Alimentary Pharmacology & Therapeutics, 45(1), 182–83.

Screening and management of viral hepatitis and hepatocellular carcinoma in Mongolia: results from a survey of Mongolian physicians from all major provinces of Mongolia.
Kim, Y. A., Estevez, J., Le, A., Israelski, D., Baatarkhuu, O., Sarantuya, T., … Nguyen, M. H. (2016). Screening and management of viral hepatitis and hepatocellular carcinoma in Mongolia: results from a survey of Mongolian physicians from all major provinces of Mongolia. BMJ Open Gastroenterology, 3(1), e000119.

Antibody-dependent and -independent uptake of HBsAg across human leukocyte subsets is similar between individuals with chronic hepatitis B Virus infection and healthy donors.
Tharinger, H., Rebbapragada, I., Samuel, D., Novikov, N., Nguyen, M., Jordan, R., … Pflanz, S. (2016). Antibody-dependent and -independent uptake of HBsAg across human leukocyte subsets is similar between individuals with chronic hepatitis B Virus infection and healthy donors. Journal of Viral Hepatitis.

The Cascade of Care in Chronic Hepatitis B
Liou, I. W., & Nguyen, M. H. (2016). The Cascade of Care in Chronic Hepatitis B. Current Hepatitis Reports, 15.

Isoniazid Hepatotoxicity Requiring Liver Transplantation
Sheen, E., Huang, R. J., Uribe, L. A., & Nguyen, M. H. (2014). Isoniazid Hepatotoxicity Requiring Liver Transplantation. DIGESTIVE DISEASES AND SCIENCES, 59(7), 1370–74.

Real-world experience with interferon-free, direct acting antiviral therapies in Asian Americans with chronic hepatitis C and advanced liver disease.
Chang, C. Y., Nguyen, P., Le, A., Zhao, C., Ahmed, A., Daugherty, T., … Nguyen, M. H. (2017). Real-world experience with interferon-free, direct acting antiviral therapies in Asian Americans with chronic hepatitis C and advanced liver disease. Medicine, 96(6).

Improved Performance of Serum Alpha-Fetoprotein for Hepatocellular Carcinoma Diagnosis in HCV cirrhosis with Normal Alanine Transaminase.
Yang, J. D., Dai, J., Singal, A. G., Gopal, P., Addissie, B., Nguyen, M. H., … Roberts, L. R. (2017). Improved Performance of Serum Alpha-Fetoprotein for Hepatocellular Carcinoma Diagnosis in HCV cirrhosis with Normal Alanine Transaminase. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.

Ledipasvir and sofosbuvir combination for hepatitis C virus infection in three patients aged 85 years and older.
Ji, F., Tian, C., Li, Z., Deng, H., & Nguyen, M. H. (2017). Ledipasvir and sofosbuvir combination for hepatitis C virus infection in three patients aged 85 years and older. European Journal of Gastroenterology & Hepatology.

Serum Aminotransferase Flares in Pregnant and Postpartum Women With Current or Prior Treatment for Chronic Hepatitis B.
Chang, C. Y., Aziz, N., Poongkunran, M., Javaid, A., Trinh, H. N., Lau, D. T., & Nguyen, M. H. (2017). Serum Aminotransferase Flares in Pregnant and Postpartum Women With Current or Prior Treatment for Chronic Hepatitis B. Journal of Clinical Gastroenterology.

Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States
Le, M. H., Devaki, P., Ha, N. B., Jun, D. W., Te, H. S., Cheung, R. C., & Nguyen, M. H. (2017). Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States. PLOS ONE, 12(3).

HCV Genotype 6 Increased the Risk for Hepatocellular Carcinoma Among Asian Patients With Liver Cirrhosis.
Lee, M.-H., Hsiao, T. I., Subramaniam, S. R., Le, A. K., Vu, V. D., Trinh, H. N., … Nguyen, M. H. (2017). HCV Genotype 6 Increased the Risk for Hepatocellular Carcinoma Among Asian Patients With Liver Cirrhosis. American Journal of Gastroenterology.

Lower Observed Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Patients Treated With Entecavir: Results of the ENUMERATE Study
Ahn, J., Lim, J. K., Lee, H. M., Lok, A. S., Mindie Nguyen, M., Pan, C. Q., … Kim, W. R. (2016). Lower Observed Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Patients Treated With Entecavir: Results of the ENUMERATE Study. AMERICAN JOURNAL OF GASTROENTEROLOGY, 111(9), 1297–1304.

HCV Prevalence in Asian Americans in California
Lin, O. N., Chang, C., Lee, J., Ailinh Do, A., Martin, M., Martin, A., & Nguyen, M. H. (2017). HCV Prevalence in Asian Americans in California. JOURNAL OF IMMIGRANT AND MINORITY HEALTH, 19(1), 91–97.

Thyroid cancer mortality higher in Filipinos in United States: an analysis using national mortality records from 2003-2012.
Nguyen, M.-L., Hu, J., Hastings, K., Daza, E., Cullen, M., Orloff, L., & Palaniappan, L. (2017). Thyroid cancer mortality higher in Filipinos in United States: an analysis using national mortality records from 2003-2012. Cancer.

Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation: Analysis of 3601 Patients from the US Multicenter HCC Transplant Consortium.
Agopian, V. G., Harlander-Locke, M. P., Ruiz, R. M., Klintmalm, G. B., Senguttuvan, S., Florman, S. S., … Busuttil, R. W. (2017). Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation: Analysis of 3601 Patients from the US Multicenter HCC Transplant Consortium. Annals of Surgery.

Effects of antiviral therapy in patients with chronic hepatitis B and cirrhosis.
Okada, M., Enomoto, M., Kawada, N., & Nguyen, M. H. (2017). Effects of antiviral therapy in patients with chronic hepatitis B and cirrhosis. Expert Review of Gastroenterology & Hepatology.

Epidemiology of hepatitis B and the role of vaccination.
Chang, M. S., & Nguyen, M. H. (2017). Epidemiology of hepatitis B and the role of vaccination. Best Practice & Research. Clinical Gastroenterology, 31(3), 239–47.

Physician perspectives on the management of viral hepatitis and hepatocellular carcinoma in Myanmar.
Kim, Y. A., Trinh, S., Thura, S., Kyi, K. P., Lee, T., Sze, S., … Nguyen, M. H. (2017). Physician perspectives on the management of viral hepatitis and hepatocellular carcinoma in Myanmar. PloS One, 12(8), e0181603.

Ethnic disparities in progression to advanced liver disease and overall survival in patients with chronic hepatitis C: impact of a sustained virological response.
Le, A. K., Zhao, C., Hoang, J. K., Tran, S. A., Chang, C. Y., Jin, M., … Nguyen, M. H. (2017). Ethnic disparities in progression to advanced liver disease and overall survival in patients with chronic hepatitis C: impact of a sustained virological response. Alimentary Pharmacology & Therapeutics.

Management of Chronic Hepatitis B in Pregnancy.
Li, J., Chang, M. S., Tran, T. T., & Nguyen, M. H. (2017). Management of Chronic Hepatitis B in Pregnancy. Journal of Clinical Gastroenterology.

Poor adherence to hepatocellular carcinoma surveillance: a systematic review and meta-analysis of a complex issue.
Zhao, C., Jin, M., Le, R. H., Le, M. H., Chen, V. L., Jin, M., … Nguyen, M. H. (2017). Poor adherence to hepatocellular carcinoma surveillance: a systematic review and meta-analysis of a complex issue. Liver International : Official Journal of the International Association for the Study of the Liver.

Regional differences in treatment rates for patients with chronic hepatitis C infection: Systematic review and meta-analysis.
Vutien, P., Jin, M., Le, M. H., Nguyen, P., Trinh, S., Huang, J.-F. F., … Nguyen, M. H. (2017). Regional differences in treatment rates for patients with chronic hepatitis C infection: Systematic review and meta-analysis. PloS One, 12(9), e0183851.

Soluble intercellular adhesion molecule-1 is associated with hepatocellular carcinoma risk: multiplex analysis of serum markers.
Chen, V. L., Le, A. K., Podlaha, O., Estevez, J., Li, B., Vutien, P., … Nguyen, M. H. (2017). Soluble intercellular adhesion molecule-1 is associated with hepatocellular carcinoma risk: multiplex analysis of serum markers. Scientific Reports, 7(1), 11169.

Differential Serum Cytokine Profiles in Patients with Chronic Hepatitis B, C, and Hepatocellular Carcinoma.
Estevez, J., Chen, V. L., Podlaha, O., Li, B., Le, A., Vutien, P., … Nguyen, M. H. (2017). Differential Serum Cytokine Profiles in Patients with Chronic Hepatitis B, C, and Hepatocellular Carcinoma. Scientific Reports, 7(1), 11867.

Survival after treatment with curative intent for hepatocellular carcinoma among patients with vs without non-alcoholic fatty liver disease.
Wong, C. R., Njei, B., Nguyen, M. H., Nguyen, A., & Lim, J. K. (2017). Survival after treatment with curative intent for hepatocellular carcinoma among patients with vs without non-alcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics.

Tenofovir alafenamide as compared to tenofovir disoproxil fumarate in the management of chronic hepatitis B with recent trends in patient demographics.
Hsu, Y.-C. C., Wei, M. T., & Nguyen, M. H. (2017). Tenofovir alafenamide as compared to tenofovir disoproxil fumarate in the management of chronic hepatitis B with recent trends in patient demographics. Expert Review of Gastroenterology & Hepatology.

Systematic review with meta-analysis: rifaximin for the prophylaxis of spontaneous bacterial peritonitis.
Goel, A., Rahim, U., Nguyen, L. H., Stave, C., & Nguyen, M. H. (2017). Systematic review with meta-analysis: rifaximin for the prophylaxis of spontaneous bacterial peritonitis. Alimentary Pharmacology & Therapeutics.

More advanced disease and worse survival in cryptogenic compared to viral hepatocellular carcinoma.
Jun, T. W., Yeh, M.-L. L., Yang, J. D., Chen, V. L., Nguyen, P., Giama, N. H., … Nguyen, M. H. (2017). More advanced disease and worse survival in cryptogenic compared to viral hepatocellular carcinoma. Liver International : Official Journal of the International Association for the Study of the Liver.

Editorial: hepatitis C virus (HCV) disease progression - HCV cure and the elimination of the "ethnic slope". Authors' reply.
Le, A. K., Garcia, G., & Nguyen, M. H. (2017). Editorial: hepatitis C virus (HCV) disease progression - HCV cure and the elimination of the "ethnic slope". Authors' reply. Alimentary Pharmacology & Therapeutics, 46(10), 1012–13.

Open Label Study of 8 vs. 12 Weeks of Ledipasvir/Sofosbuvir in Genotype 6 Treatment Naïve or Experienced Patients.
Nguyen, M. H., Trinh, H., Do, S., Nguyen, T., Nguyen, P., & Henry, L. (2017). Open Label Study of 8 vs. 12 Weeks of Ledipasvir/Sofosbuvir in Genotype 6 Treatment Naïve or Experienced Patients. The American Journal of Gastroenterology.

Tenofovir alafenamide in the treatment of chronic hepatitis B: design, development, and place in therapy.
Ogawa, E., Furusyo, N., & Nguyen, M. H. (2017). Tenofovir alafenamide in the treatment of chronic hepatitis B: design, development, and place in therapy. Drug Design, Development and Therapy, 11, 3197–3204.

Hepatocellular carcinoma decreases the effectiveness of hepatitis C antiviral treatment: does direct-acting antiviral regimens matter?
Ji, F., Yeo, Y. H., Wei, M. T., Wei, B., Dang, S., Li, Z., & Nguyen, M. H. (2017). Hepatocellular carcinoma decreases the effectiveness of hepatitis C antiviral treatment: does direct-acting antiviral regimens matter? Hepatology (Baltimore, Md.).

Systematic review with meta-analysis: effectiveness and tolerability of interferon-free direct-acting antiviral regimens for chronic hepatitis C genotype 1 in routine clinical practice in Asia.
Ji, F., Wei, B., Yeo, Y. H., Ogawa, E., Zou, B., Stave, C. D., … Nguyen, M. H. (2018). Systematic review with meta-analysis: effectiveness and tolerability of interferon-free direct-acting antiviral regimens for chronic hepatitis C genotype 1 in routine clinical practice in Asia. Alimentary Pharmacology & Therapeutics.

Editorial: rifaximin-a kick in the gut for spontaneous bacterial peritonitis? Authors' reply.
Goel, A., & Nguyen, M. H. (2018). Editorial: rifaximin-a kick in the gut for spontaneous bacterial peritonitis? Authors' reply. Alimentary Pharmacology & Therapeutics, 47(2), 303.

Barriers to care for chronic hepatitis C in the direct-acting antiviral era: a single-centre experience.
Nguyen, P., Vutien, P., Hoang, J., Trinh, S., Le, A., Yasukawa, L. A., … Nguyen, M. H. (2017). Barriers to care for chronic hepatitis C in the direct-acting antiviral era: a single-centre experience. BMJ Open Gastroenterology, 4(1), e000181.

Hospital Cirrhosis Volume and Readmission in Patients with Cirrhosis in California.
Wei, M., Ford, J., Li, Q., Jeong, D., Kwong, A. J., Nguyen, M. H., & Chang, M. S. (2018). Hospital Cirrhosis Volume and Readmission in Patients with Cirrhosis in California. Digestive Diseases and Sciences.

Increasing co-morbidities in chronic hepatitis B patients: experience in primary care and referral practices during 2000-2015.
Liu, A., Le, A., Zhang, J., Wong, C., Wong, C., Henry, L., & Nguyen, M. H. (2018). Increasing co-morbidities in chronic hepatitis B patients: experience in primary care and referral practices during 2000-2015. Clinical and Translational Gastroenterology, 9(3), 141.

Ezetimibe decreased nonalcoholic fatty liver disease activity score but not hepatic steatosis.
Lee, H. Y., Jun, D. W., Kim, H. J., Oh, H., Saeed, W. K., Ahn, H., … Nguyen, M. H. (2018). Ezetimibe decreased nonalcoholic fatty liver disease activity score but not hepatic steatosis. The Korean Journal of Internal Medicine.

Effects of Treatment of Chronic HBV Infection on Patient-reported Outcomes.
Younossi, Z. M., Stepanova, M., Janssen, H. L., Agarwal, K., Nguyen, M. H., Gane, E., … Racila, A. (2018). Effects of Treatment of Chronic HBV Infection on Patient-reported Outcomes. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

Rate of hepatocellular carcinoma surveillance remains low for a large, real-life cohort of patients with hepatitis C cirrhosis.
Tran, S. A., Le, A., Zhao, C., Hoang, J., Yasukawa, L. A., Weber, S., … Nguyen, M. H. (2018). Rate of hepatocellular carcinoma surveillance remains low for a large, real-life cohort of patients with hepatitis C cirrhosis. BMJ Open Gastroenterology, 5(1), e000192.

Regional differences in the presentation and management of patients with hepatocellular carcinoma by liver disease etiology
Kim, N. G., Yeh, M.-L., Yang, J. D., Leong, J., Jun, M., Saeed, W., … Nguyen, M. H. (2017). Regional differences in the presentation and management of patients with hepatocellular carcinoma by liver disease etiology. JOURNAL OF HEPATOLOGY, 66(1), S458.

Is antiviral treatment for chronic hepatitis B (CHB) in Asian patients associated with osteopenia/osteoporosis? A comparison study of tenofovir (TDF), entecavir (ETV) and untreated (UTx) patients
Wei, M., Le, A. K., Nguyen, P., Zhang, J. Q., Wong, C., Wong, C., … Nguyen, M. H. (2017). Is antiviral treatment for chronic hepatitis B (CHB) in Asian patients associated with osteopenia/osteoporosis? A comparison study of tenofovir (TDF), entecavir (ETV) and untreated (UTx) patients. HEPATOLOGY, 66, 516A–517A.

A Single Center Experience with Hepatocellular Carcinoma (HCC): Shifts in Patient Ethnicity and HCC Etiology but No Improvement in Survival over Time
Chen, V. L., Kim, N. G., Le, A. K., Ladenheim, M. R., Nguyen, P., Zhao, C., & Nguyen, M. H. (2015). A Single Center Experience with Hepatocellular Carcinoma (HCC): Shifts in Patient Ethnicity and HCC Etiology but No Improvement in Survival over Time. HEPATOLOGY, 62, 425A.

Differential Progression to Cirrhosis and Hepatic Decompensation in Asian Americans (AA) and Non-Asian (NA) Patients with Chronic Hepatitis C (CHC)
Le, A. K., Nguyen, N. H., Zhao, C., Hoang, J. K., Chang, C. Y., Jin, M., … Nguyen, M. H. (2015). Differential Progression to Cirrhosis and Hepatic Decompensation in Asian Americans (AA) and Non-Asian (NA) Patients with Chronic Hepatitis C (CHC). HEPATOLOGY. WILEY-BLACKWELL.

Association of different types of chronic liver diseases with hepatocellular carcinoma in the United States
Park, H., Jeong, D., Nguyen, P., Kim, Y., & Nguyen, M. H. (2017). Association of different types of chronic liver diseases with hepatocellular carcinoma in the United States. HEPATOLOGY, 66, 541A–542A.

Black hepatocellular carcinoma patients diagnosed after 2010 have worse long-term survival than white patients
Estevez, J., Yang, J. D., Leong, J., Nguyen, P., Giama, N., Roberts, L., … Nguyen, M. (2017). Black hepatocellular carcinoma patients diagnosed after 2010 have worse long-term survival than white patients. JOURNAL OF HEPATOLOGY, 66(1), S447–S448.

RISING INPATIENT ENCOUNTERS AND HOSPITAL CHARGES FOR PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE IN THE UNITED STATES
Nguyen, A. L., Nguyen, P., Sheen, E., Jin, M., Jin, M., Kim, Y., & Nguyen, M. H. (2016). RISING INPATIENT ENCOUNTERS AND HOSPITAL CHARGES FOR PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE IN THE UNITED STATES. JOURNAL OF HEPATOLOGY, 64, S472.

Significantly lower rates of cirrhosis and worse long-term survival in cryptogenic hepatocellular carcinoma compared to viral etiologies: results of a multi-center international cohort
Jun, T., Yeh, M.-L., Chen, V., Yang, J. D., Nguyen, P., Chung, M., … Yu, M.-L. (2017). Significantly lower rates of cirrhosis and worse long-term survival in cryptogenic hepatocellular carcinoma compared to viral etiologies: results of a multi-center international cohort. JOURNAL OF HEPATOLOGY, 66(1), S623.

Differences in Presentation and Long-Term Survival of Patients with Hepatocellular Carcinoma (HCC) with Hepatitis B Virus (HBV) Compared to Hepatitis C Virus (HCV) or Non-Viral Etiology
Chen, V. L., Kim, N. G., Le, A. K., Ladenheim, M. R., Nguyen, P., Zhao, C., & Nguyen, M. H. (2015). Differences in Presentation and Long-Term Survival of Patients with Hepatocellular Carcinoma (HCC) with Hepatitis B Virus (HBV) Compared to Hepatitis C Virus (HCV) or Non-Viral Etiology. HEPATOLOGY, 62, 406A.

DIAGNOSIS BY SCREENING RATHER THAN SYMPTOMS IN HBV-RELATED HCC IS ASSOCIATED WITH IMPROVED OUTCOMES, REGARDLESS OF CIRRHOSIS STATUS BUT SCREENING HISTORY WAS ONLY PRESENT IN ONE-HALF OF CIRRHOSIS AND ONE-THIRD OF NONCIRRHOSIS CASES
Chen, V. L., Kim, L., Nguyen, P., Zhao, C., & Nguyen, M. H. (2015). DIAGNOSIS BY SCREENING RATHER THAN SYMPTOMS IN HBV-RELATED HCC IS ASSOCIATED WITH IMPROVED OUTCOMES, REGARDLESS OF CIRRHOSIS STATUS BUT SCREENING HISTORY WAS ONLY PRESENT IN ONE-HALF OF CIRRHOSIS AND ONE-THIRD OF NONCIRRHOSIS CASES. JOURNAL OF HEPATOLOGY, 62, S548.

Letter: lessons from the "real-world' entecavir therapy in chronic hepatitis B patients - authors' reply
Ahn, J., Nguyen, M. H., Lim, J. K., Lee, H. M., Pan, C. Q., & Lok, A. S. (2016). Letter: lessons from the "real-world' entecavir therapy in chronic hepatitis B patients - authors' reply. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 43(7), 847–48.

LOWER RISK OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B PATIENTS TREATED WITH ENTECAVIR: A REACH-B ANALYSIS OF THE ENUMERATE STUDY
Ahn, J., Nguyen, M., Lee, H., Lim, J., Pan, C., Te, H., … Kim, W. R. (2015). LOWER RISK OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B PATIENTS TREATED WITH ENTECAVIR: A REACH-B ANALYSIS OF THE ENUMERATE STUDY. JOURNAL OF HEPATOLOGY, 62, S562.

Incidence of Hepatocellular Carcinoma in a National Cohort of Chronic Hepatitis B Patients on Long Term Entecavir Treatment- the ENUMERATE study
Ahn, J., Lim, J. K., Lee, H., Pan, C. Q., Nguyen, M. H., Trinh, H. N., … Kim, W. R. (2014). Incidence of Hepatocellular Carcinoma in a National Cohort of Chronic Hepatitis B Patients on Long Term Entecavir Treatment- the ENUMERATE study. HEPATOLOGY. WILEY-BLACKWELL.

Entecavir Safety and Effectiveness in a National Cohort of Chronic Hepatitis B Patients in the United States - the ENUMERATE study
Ahn, J., Lee, H., Lim, J. K., Pan, C. Q., Nguyen, M. H., Kim, W. R., … Lok, A. S. (2014). Entecavir Safety and Effectiveness in a National Cohort of Chronic Hepatitis B Patients in the United States - the ENUMERATE study. HEPATOLOGY. WILEY-BLACKWELL.

Antiviral Therapy for Chronic Hepatitis B (CHB) Reduces the Incidence of Hepatocellular Carcinoma (HCC) Regardless of Cirrhosis Status: Analysis with Adjustment for REACH-B Risk Score
Lin, D., Yang, H.-I., Nguyen, N. H., Hoang, J. K., Kim, Y., Vu, V. D., … Nguyen, M. H. (2015). Antiviral Therapy for Chronic Hepatitis B (CHB) Reduces the Incidence of Hepatocellular Carcinoma (HCC) Regardless of Cirrhosis Status: Analysis with Adjustment for REACH-B Risk Score. HEPATOLOGY. WILEY-BLACKWELL.

THE APPLICABILITY OF HEPATOCELLULAR CARCINOMA RISK PREDICTION SCORING SYSTEM IN A US PATIENT COHORT WITH CHRONIC HEPATITIS C INFECTION
Jin, M., Zhao, C., Lee, M.-H., Le, A. K., Hoang, J., Ha, N. B., … Nguyen, M. (2016). THE APPLICABILITY OF HEPATOCELLULAR CARCINOMA RISK PREDICTION SCORING SYSTEM IN A US PATIENT COHORT WITH CHRONIC HEPATITIS C INFECTION. JOURNAL OF HEPATOLOGY, 64, S621–S622.

DEVELOPMENT AND VALIDATION OF A RISK SCORE SYSTEM INCLUSIVE OF ANTIVIRAL THERAPY FOR PREDICTING LIVER CIRRHOSIS RISK IN DIVERSE PATIENTS WITH CHRONIC HEPATITIS B INFECTION
Jin, M., Yang, H.-I., Le, A. K., Lee, M.-H., Hoang, J., Nguyen, N. H., … Nguyen, M. (2016). DEVELOPMENT AND VALIDATION OF A RISK SCORE SYSTEM INCLUSIVE OF ANTIVIRAL THERAPY FOR PREDICTING LIVER CIRRHOSIS RISK IN DIVERSE PATIENTS WITH CHRONIC HEPATITIS B INFECTION. JOURNAL OF HEPATOLOGY, 64, S372.

ANTIVIRAL THERAPY FOR THE PREVENTION OF LONG-TERM CIRRHOSIS RISK IN PATIENTS WITH CHRONIC HEPATITIS B
Yang, H.-I., Hoang, J., Lin, D., Liu, J., Hu, H.-H., Lee, M.-H., … Nguyen, M. H. (2016). ANTIVIRAL THERAPY FOR THE PREVENTION OF LONG-TERM CIRRHOSIS RISK IN PATIENTS WITH CHRONIC HEPATITIS B. JOURNAL OF HEPATOLOGY, 64, S591.

Temporal trends in disease presentation and survival of patients with hepatocellular carcinoma: A real-world experience from 1998 to 2015.
Kim, N. G., Nguyen, P. P., Dang, H., Kumari, R., Garcia, G., Esquivel, C. O., & Nguyen, M. H. (2018). Temporal trends in disease presentation and survival of patients with hepatocellular carcinoma: A real-world experience from 1998 to 2015. Cancer.

Viral kinetics in women of child bearing potential with chronic hepatitis B virus following treatment with tenofovir alafenamide or tenofovir disoproxil fumarate
Pan, C., Chang, T.-T., Bae, S.-H., Brunetto, M., Coffin, C., Lau, A., … Gane, E. J. (2017). Viral kinetics in women of child bearing potential with chronic hepatitis B virus following treatment with tenofovir alafenamide or tenofovir disoproxil fumarate. JOURNAL OF HEPATOLOGY, 66(1), S258–S259.

Antiviral Therapy, Treatment Eligibility, and Treatment Rates in Patients Meeting Treatment Criteria in Chronic Hepatitis B in Diverse Practice Settings: A Systematic Review and Meta-analysis of 9 Studies and 22,768 Patients
Mahajan, V., Jin, M., Le, M., Nghia Nguyen, Wong, C., Leong, J., & Nguyen, M. H. (2015). Antiviral Therapy, Treatment Eligibility, and Treatment Rates in Patients Meeting Treatment Criteria in Chronic Hepatitis B in Diverse Practice Settings: A Systematic Review and Meta-analysis of 9 Studies and 22,768 Patients. AMERICAN JOURNAL OF GASTROENTEROLOGY, 110, S959–S961.

Economic and clinical burden of viral hepatitis in California: A population-based study with longitudinal analysis.
Park, H., Jeong, D., Nguyen, P., Henry, L., Hoang, J., Kim, Y., … Nguyen, M. H. (2018). Economic and clinical burden of viral hepatitis in California: A population-based study with longitudinal analysis. PloS One, 13(4), e0196452.

Higher risk of hepatocellular carcinoma in Hispanic patients with hepatitis C cirrhosis and metabolic risk factors.
Wong, A., Le, A., Lee, M.-H. H., Lin, Y.-J. J., Nguyen, P., Trinh, S., … Nguyen, M. H. (2018). Higher risk of hepatocellular carcinoma in Hispanic patients with hepatitis C cirrhosis and metabolic risk factors. Scientific Reports, 8(1), 7164.

Autoantibodies in chronic hepatitis C virus infection: impact on clinical outcomes and extrahepatic manifestations.
Gilman, A. J., Le, A. K., Zhao, C., Hoang, J., Yasukawa, L. A., Weber, S. C., … Nguyen, M. H. (2018). Autoantibodies in chronic hepatitis C virus infection: impact on clinical outcomes and extrahepatic manifestations. BMJ Open Gastroenterology, 5(1), e000203.

Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study.
Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. (2018). The Lancet. Gastroenterology & Hepatology, 3(6), 383–403.

SHORT DURATION TREATMENT WITH SOFOSBUVIR/VELPATASVIR PLUS GS-9857 IN TREATMENT-NAIVE GENOTYPE 1-6 HCV-INFECTED PATIENTS WITH OR WITHOUT CIRRHOSIS
Gane, E. J., Nguyen, M., Kwo, P., Kowdley, K., Reau, N., Jacobson, I., … Lawitz, E. (2016). SHORT DURATION TREATMENT WITH SOFOSBUVIR/VELPATASVIR PLUS GS-9857 IN TREATMENT-NAIVE GENOTYPE 1-6 HCV-INFECTED PATIENTS WITH OR WITHOUT CIRRHOSIS. JOURNAL OF HEPATOLOGY. ELSEVIER SCIENCE BV.

A COMPARISON OF PRIMARY SURGICAL RESECTION TO LIVER TRANSPLANTATION (LT) AMONG TRANSPLANT-ELIGIBLE HEPATOCELLULAR CARCINOMA (HCC) PATIENTS USING AN INTENTION-TO-TREAT MODEL
Wong, R. J., Wantuck, J., Valenzuela, A., Ahmed, A., Bonham, C., Gallo, A., … Nguyen, M. H. (2013). A COMPARISON OF PRIMARY SURGICAL RESECTION TO LIVER TRANSPLANTATION (LT) AMONG TRANSPLANT-ELIGIBLE HEPATOCELLULAR CARCINOMA (HCC) PATIENTS USING AN INTENTION-TO-TREAT MODEL. JOURNAL OF HEPATOLOGY, 58, S117.

The Effect of Gastric Acid Suppression on Ledipasivir-Sofosbuvir Effectiveness in Chronic Hepatitis C Infection
Swanner, A., Kumari, R., Garcia, G., Daugherty, T., Nguyen, M. H., Ahmed, A., … Lutchman, G. A. (2016). The Effect of Gastric Acid Suppression on Ledipasivir-Sofosbuvir Effectiveness in Chronic Hepatitis C Infection. HEPATOLOGY, 64, 947A.

Safety and Efficacy of Vesatolimod (GS-9620) in Patients with Chronic Hepatitis B Who Are Not Currently on Antiviral Treatment.
Agarwal, K., Ahn, S. H., Elkhashab, M., Lau, A. H., Gaggar, A., Bulusu, A., … Nguyen, M. H. (2018). Safety and Efficacy of Vesatolimod (GS-9620) in Patients with Chronic Hepatitis B Who Are Not Currently on Antiviral Treatment. Journal of Viral Hepatitis.

Anti-viral therapy is associated with improved survival but underutilised in patients with hepatitis B virus-related hepatocellular carcinoma: real-world east and west experience.
Chen, V. L., Yeh, M.-L. L., Le, A. K., Jun, M., Saeed, W. K., Yang, J. D., … Nguyen, M. H. (2018). Anti-viral therapy is associated with improved survival but underutilised in patients with hepatitis B virus-related hepatocellular carcinoma: real-world east and west experience. Alimentary Pharmacology & Therapeutics.

Author response to "Cryptogenic hepatocellular carcinoma (HCC) had worse overall survival of disease than viral HCC patients".
Jun, T. W., Nguyen, M. H., & Yu, M.-L. L. (2018). Author response to "Cryptogenic hepatocellular carcinoma (HCC) had worse overall survival of disease than viral HCC patients". Liver International : Official Journal of the International Association for the Study of the Liver, 38(6), 1141.

Editorial: the durability of seroconversion of hepatitis B e antigen in the treatment of chronic hepatitis B with PEG-interferon alfa-2a.
Wei, M. T., & Nguyen, M. H. (2018). Editorial: the durability of seroconversion of hepatitis B e antigen in the treatment of chronic hepatitis B with PEG-interferon alfa-2a. Alimentary Pharmacology & Therapeutics, 47(11), 1556–57.

Prevalence and predictors of hepatitis B immunization in adults without immunity for hepatitis B from 1999-2014: a population-based study of 27,713 adults in the US
Le, M. H., Toy, M., Gane, E. J., So, S., & Nguyen, M. H. (2017). Prevalence and predictors of hepatitis B immunization in adults without immunity for hepatitis B from 1999-2014: a population-based study of 27,713 adults in the US. HEPATOLOGY, 66, 1004A.

Suboptimal rates, trends and predictors of hepatitis B vaccination in a population-based sample of children and adolescents in the United States (US) between 1999 and 2014
Le, M. H., Toy, M., Gane, E. J., So, S., & Nguyen, M. H. (2017). Suboptimal rates, trends and predictors of hepatitis B vaccination in a population-based sample of children and adolescents in the United States (US) between 1999 and 2014. HEPATOLOGY, 66, 1003A.

Recurrence-Free Survival in Liver Transplant Recipients with Non-Alcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: Results from the US Multicenter HCC Transplant Consortium
Verna, E. C., Abdelmessih, R. M., Florman, S. S., Haydel, B. M., Ruiz, R., Klintmalm, G., … Agopian, V. (2017). Recurrence-Free Survival in Liver Transplant Recipients with Non-Alcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: Results from the US Multicenter HCC Transplant Consortium. HEPATOLOGY. WILEY.

The impact of treatment of chronic hepatitis B (CHB) on patient-reported outcomes (PROs)
Younossi, Z. M., Stepanova, M., Janssen, H. L., Agarwal, K., Nguyen, M. H., Gane, E. J., … Hunt, S. (2017). The impact of treatment of chronic hepatitis B (CHB) on patient-reported outcomes (PROs). HEPATOLOGY, 66, 1020A.

Real-world Effectiveness (RWE) and Adverse Events with Sofosbuvir plus Ribavirin (SOF plus RBV) Based Therapies in Chronic Hepatitis C Genotype 3 (CHC GT 3) Patients in Asia-A Systematic Review of 8 Studies and 3510 Patient
Wei, B., Ji, F., Yeo, Y. H., Ogawa, E., Henry, L., Li, Z., … Nguyen, M. H. (2017). Real-world Effectiveness (RWE) and Adverse Events with Sofosbuvir plus Ribavirin (SOF plus RBV) Based Therapies in Chronic Hepatitis C Genotype 3 (CHC GT 3) Patients in Asia-A Systematic Review of 8 Studies and 3510 Patient. HEPATOLOGY, 66, 857A–858A.

Real-world Effectiveness (RWE) of Sofosbuvir plus Ribavirin (SOF plus RBV) Chronic Hepatitis C Genotype 2 (CHC GT 2) in Asia: A Systemic Review and Meta-analysis of Pooled SVR12
Wei, B., Ji, F., Yeo, Y. H., Zou, B., Ogawa, E., Henry, L., … Nguyen, M. H. (2017). Real-world Effectiveness (RWE) of Sofosbuvir plus Ribavirin (SOF plus RBV) Chronic Hepatitis C Genotype 2 (CHC GT 2) in Asia: A Systemic Review and Meta-analysis of Pooled SVR12. HEPATOLOGY, 66, 811A.

Sustained Virological Response 12 Weeks after Therapy (SVR12) with Direct-Acting Antivirals (DAA) in Select Asian Populations with Chronic Hepatitis C Genotype 1 (HCV GT 1): A Meta-Analysis of Real-World Effectiveness from Asia
Ji, F., Wei, B., Yeo, Y. H., Zou, B., Ogawa, E., Henry, L., … Nguyen, M. H. (2017). Sustained Virological Response 12 Weeks after Therapy (SVR12) with Direct-Acting Antivirals (DAA) in Select Asian Populations with Chronic Hepatitis C Genotype 1 (HCV GT 1): A Meta-Analysis of Real-World Effectiveness from Asia. HEPATOLOGY, 66, 812A–813A.

Real Life Effectiveness of Direct-Acting Antivirals (DAAs) in Asian Patients with Chronic Hepatitis C Genotype 1: Systematic Review and Meta-analysis of 33 Published Articles and 7942 patients
Ji, F., Wei, B., Yeo, Y. H., Zou, B., Ogawa, E., Henry, L., … Nguyen, M. H. (2017). Real Life Effectiveness of Direct-Acting Antivirals (DAAs) in Asian Patients with Chronic Hepatitis C Genotype 1: Systematic Review and Meta-analysis of 33 Published Articles and 7942 patients. HEPATOLOGY, 66, 596A–597A.

Long-Term Follow-Up of Patient-Reported Outcomes (PROs) in Chronic Hepatitis C (HCV) Patients with Compensated and Decompensated Cirrhosis with Sustained Virologic Response (SVR)
Younossi, Z. M., Stepanova, M., Tapper, E. B., Henry, L., Sheikh, A. M., Nguyen, M. H., … Lawitz, E. (2017). Long-Term Follow-Up of Patient-Reported Outcomes (PROs) in Chronic Hepatitis C (HCV) Patients with Compensated and Decompensated Cirrhosis with Sustained Virologic Response (SVR). HEPATOLOGY, 66, 599A.

A multicenter study revealing chronic hepatitis B comorbidity trends over the last 15 years in the United States
Liu, A. F., Le, A. K., Zhang, J. Q., Wong, C., Wong, C., & Nguyen, M. H. (2017). A multicenter study revealing chronic hepatitis B comorbidity trends over the last 15 years in the United States. HEPATOLOGY, 66, 990A.

Hepatitis B DNA level for guidance of antiviral initiation timing in pregnant women for MTCT reduction
Aziz, N., Chang, C., Poongkunran, M., Javaid, A., Trinh, H., Lau, D., & Nguyen, M. (2017). Hepatitis B DNA level for guidance of antiviral initiation timing in pregnant women for MTCT reduction. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 216(1), S242–S243.

Effect of Tenofovir Disoproxyl (TDF) on Hepatocellular Carcinoma (HCC) Incidence in Patients with Chronic Hepatitis B (CHB) compared to Untreated Patients: a Multicenter Study with Propensity Score Matching (PSM)
Nguyen, M. H., Yang, H.-I., Le, A. K., Nguyen, N. H., Zhang, J. Q., Wong, C., … Trinh, H. N. (2017). Effect of Tenofovir Disoproxyl (TDF) on Hepatocellular Carcinoma (HCC) Incidence in Patients with Chronic Hepatitis B (CHB) compared to Untreated Patients: a Multicenter Study with Propensity Score Matching (PSM). HEPATOLOGY, 66, 482A–483A.

Cirrhotic patients with acute respiratory illness in the United States encounter substantial hospital charge burden
Zou, B., Yeo, Y. H., Jeong, D., Henry, L., Park, H., & Nguyen, M. H. (2017). Cirrhotic patients with acute respiratory illness in the United States encounter substantial hospital charge burden. HEPATOLOGY, 66, 408A.

Age and gender-specific disease progression rates to cirrhosis and hepatocellular carcinoma (HCC) in treated and untreated patients with chronic hepatitis B
Le, A. K., Toy, M., Yang, H.-I., Trinh, H. N., Zhang, J. Q., Wong, C., … Nguyen, M. H. (2017). Age and gender-specific disease progression rates to cirrhosis and hepatocellular carcinoma (HCC) in treated and untreated patients with chronic hepatitis B. HEPATOLOGY. WILEY.

Progression to advanced liver disease in nonalcoholic fatty liver disease (NAFLD) differs among Asians compared to Caucasians and Hispanics
Ha, N. B., Trinh, S., Le, R. H., Hoang, J. K., Lee, M.-H., Henry, L., … Nguyen, M. H. (2017). Progression to advanced liver disease in nonalcoholic fatty liver disease (NAFLD) differs among Asians compared to Caucasians and Hispanics. HEPATOLOGY, 66, 1172A–1173A.

Serum Biomarkers Improve Prognostic Ability of BCLC Staging System
Bangaru, S., Wei, W., Schwartz, M. E., Parikh, N., Nguyen, M. H., Roberts, L. R., … Marrero, J. A. (2017). Serum Biomarkers Improve Prognostic Ability of BCLC Staging System. HEPATOLOGY, 66, 754A–755A.

REAL-B (Real-world Effectiveness from the Asia Pacific Rim Liver Consortium for HBV) - A Risk Score for the Prediction of Hepatocellular Carcinoma (HCC) in Chronic Hepatitis (CHB) Patients Treated with Oral Anti-HBV Therapy
Nguyen, M. H., Yang, H.-I., Yeh, M.-L., Wong, G. L., Peng, C.-Y., Chen, C.-H., … Yu, M.-L. (2017). REAL-B (Real-world Effectiveness from the Asia Pacific Rim Liver Consortium for HBV) - A Risk Score for the Prediction of Hepatocellular Carcinoma (HCC) in Chronic Hepatitis (CHB) Patients Treated with Oral Anti-HBV Therapy. HEPATOLOGY. WILEY.

Hepatitis B DNA level for guidance of antiviral initiation timing in pregnant women for MTCT reduction
Aziz, N., Chang, C. Y., Poongkunran, M., Javaid, A., Trinh, H. N., Lau, D., & Nguyen, M. H. (2017). Hepatitis B DNA level for guidance of antiviral initiation timing in pregnant women for MTCT reduction. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 217(6), 720.

Safety and Efficacy of Vesatolimod (GS-9620) in Patients with Chronic Hepatitis B (CHB) Who Are Not Currently on Antiviral Treatment
Agarwal, K., Ahn, S. H., Elkhashab, M., Kim, K., Lau, A. H., Gaggar, A., … Nguyen, M. H. (2017). Safety and Efficacy of Vesatolimod (GS-9620) in Patients with Chronic Hepatitis B (CHB) Who Are Not Currently on Antiviral Treatment. HEPATOLOGY. WILEY.

Racial/ethnic- and county-specific prevalence of chronic hepatitis B and its burden in California
Toy, M., Wei, B., Virdi, T. S., Le, A., Trinh, H., Li, J., … Nguyen, M. H. (2018). Racial/ethnic- and county-specific prevalence of chronic hepatitis B and its burden in California. Hepatology, Medicine and Policy, 3(6).

Higher mortality and hospital charges in patients with cirrhosis and acute respiratory illness: a population-based study.
Zou, B., Yeo, Y. H., Jeong, D., Sheen, E., Park, H., Nguyen, P., … Nguyen, M. H. (2018). Higher mortality and hospital charges in patients with cirrhosis and acute respiratory illness: a population-based study. Scientific Reports, 8(1), 9969.

Antiviral Therapy and the Development of Hepatocellular Carcinoma (HCC) in Chronic Hepatitis B (CHB) Patients with and without Cirrhosis in a US Population
Lin, D., Nguyen, N. H., Hoang, J., Vu, V. D., Trinh, H. N., Li, J., … Nguyen, M. H. (2014). Antiviral Therapy and the Development of Hepatocellular Carcinoma (HCC) in Chronic Hepatitis B (CHB) Patients with and without Cirrhosis in a US Population. HEPATOLOGY. WILEY-BLACKWELL.

Incidence of Hepatocellular Carcinoma (HCC) in non-cirrhotic chronic hepatitis B (CHB) patients with low ALT levels in a multicenter US Cohort
Hoang, J. K., Nguyen, N. H., Lin, D., Vu, V. D., Trinh, H. N., Li, J., … Nguyen, M. H. (2014). Incidence of Hepatocellular Carcinoma (HCC) in non-cirrhotic chronic hepatitis B (CHB) patients with low ALT levels in a multicenter US Cohort. HEPATOLOGY. WILEY-BLACKWELL.

Long-term Follow-up and Treatment Rates of Treatment-Eligible Chronic Hepatitis B (CHB) Patients: A Multicenter Cohort Study
Vu, V. D., Do, A., Nguyen, N. H., Kim, L. H., Trinh, H. N., Nguyen, H. A., … Nguyen, M. H. (2014). Long-term Follow-up and Treatment Rates of Treatment-Eligible Chronic Hepatitis B (CHB) Patients: A Multicenter Cohort Study. HEPATOLOGY. WILEY-BLACKWELL.

Incidence of Hepatocellular Carcinoma (HCC) in a US Cohort of Chronic Hepatitis B (CHB) Patients by Age, Gender, Cirrhosis and Antiviral Treatment Status
Lin, D., Nguyen, N. H., Hoang, J., Vu, V. D., Trinh, H. N., Li, J., … Nguyen, M. H. (2014). Incidence of Hepatocellular Carcinoma (HCC) in a US Cohort of Chronic Hepatitis B (CHB) Patients by Age, Gender, Cirrhosis and Antiviral Treatment Status. HEPATOLOGY. WILEY-BLACKWELL.

RESPONSE TO HIGHER DOSE OF ENTECAVIR (ETV) 1.0 MG DAILY IN PATIENTS WITH CHRONIC HEPATITIS B (CHB) AND PARTIAL RESPONSE TO ETV 0.5 MG DAILY
Ha, N. B., Trinh, H. N., Ha, N. B., Nguyen, H. A., Nguyen, K., & Nguyen, M. H. (2010). RESPONSE TO HIGHER DOSE OF ENTECAVIR (ETV) 1.0 MG DAILY IN PATIENTS WITH CHRONIC HEPATITIS B (CHB) AND PARTIAL RESPONSE TO ETV 0.5 MG DAILY. HEPATOLOGY. WILEY-BLACKWELL.

Reduced Incidence of Hepatocellular Carcinoma with Tenofovir in Chronic Hepatitis B Patients with and without Cirrhosis - a Propensity Score Matched Study.
Nguyen, M. H., Yang, H.-I. I., Le, A., Henry, L., Nguyen, N., Lee, M.-H. H., … Trinh, H. (2018). Reduced Incidence of Hepatocellular Carcinoma with Tenofovir in Chronic Hepatitis B Patients with and without Cirrhosis - a Propensity Score Matched Study. The Journal of Infectious Diseases.

GENDER DISPARITY AND REAL-LIFE PRACTICE SETTING DIFFERENCES IN ACTUAL TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS B MEETING CRITERIA FOR ANTIVIRAL THERAPY
Kim, L. H., Nguyen, V. G., Trinh, H. N., Li, J., Zhang, J. Q., & Nguyen, M. (2014). GENDER DISPARITY AND REAL-LIFE PRACTICE SETTING DIFFERENCES IN ACTUAL TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS B MEETING CRITERIA FOR ANTIVIRAL THERAPY. JOURNAL OF HEPATOLOGY, 60(1), S13–S14.

Real-world effectiveness of sofosbuvir plus ribavirin for chronic hepatitis C genotype 2 in Asia: a systematic review and meta-analysis.
Wei, B., Ji, F., Yeo, Y. H., Ogawa, E., Zou, B., Stave, C. D., … Nguyen, M. H. (2018). Real-world effectiveness of sofosbuvir plus ribavirin for chronic hepatitis C genotype 2 in Asia: a systematic review and meta-analysis. BMJ Open Gastroenterology, 5(1), e000207.

Racial/ethnic- and county-specific prevalence of chronic hepatitis B and its burden in California
Toy, M., Wei, B., Virdi, T., Le, A., Tirnh, H., Li, J., … Nguyen, M. H. (2018). Racial/ethnic- and county-specific prevalence of chronic hepatitis B and its burden in California . Hepatology, Medicine and Policy, 3(6).

A New Conception-Pre-HCC Disease.
Yang, Y., Feng, Y., Zhao, X., Wang, L., Xie, X., Li, J., … Zhu, Q. (2018). A New Conception-Pre-HCC Disease. Hepatology (Baltimore, Md.).

Disparities in Hepatocellular Carcinoma Incidence by Race/Ethnicity and Geographic Area in California: Implications for Prevention.
Yang, B., Liu, J. B., So, S. K., Han, S. S., Wang, S. S., Hertz, A., … Hsing, A. W. (2018). Disparities in Hepatocellular Carcinoma Incidence by Race/Ethnicity and Geographic Area in California: Implications for Prevention. Cancer.

Changes in Renal Function in Patients With Chronic HBV infection Treated with Tenofovir Disoproxil Fumarate vs Entecavir.
Trinh, S., Le, A. K., Chang, E. T., Hoang, J., Jeong, D., Chung, M., … Nguyen, M. H. (2018). Changes in Renal Function in Patients With Chronic HBV infection Treated with Tenofovir Disoproxil Fumarate vs Entecavir. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

Systematic review and meta-analysis: real-world effectiveness of direct-acting antiviral therapies in chronic hepatitis C genotype 3 in Asia.
Wei, B., Ji, F., Yeo, Y. H., Ogawa, E., Stave, C. D., Dang, S., … Nguyen, M. H. (2018). Systematic review and meta-analysis: real-world effectiveness of direct-acting antiviral therapies in chronic hepatitis C genotype 3 in Asia. BMJ Open Gastroenterology, 5(1), e000209.

Advancing age and comorbidity in a United States insured population-based cohort of patients with chronic hepatitis B.
Nguyen, M. H., Lim, J. K., Ozbay, A. B., Fraysse, J., Liou, I., Meyer, N., … Gordon, S. C. (2018). Advancing age and comorbidity in a United States insured population-based cohort of patients with chronic hepatitis B. Hepatology (Baltimore, Md.).

Comparison of Renal safety of Tenofovir (TDF) and Entecavir (ETV) in Patients with Chronic Hepatitis B (CHB): A Systematic Review with Meta-Analysis
Lee, H. Y., Jun, D. W., Cheung, R., & Nguyen, M. H. (2016). Comparison of Renal safety of Tenofovir (TDF) and Entecavir (ETV) in Patients with Chronic Hepatitis B (CHB): A Systematic Review with Meta-Analysis. HEPATOLOGY, 64, 935A.

High Prevalence of Hepatitis C Virus in Asian-Americans: Results of Office-Based Primary Care Screening
Lin, O., Chang, C. Y., Lee, J. Y., Do, A., Martin, M. H., Martin, A. B., & Nguyen, M. H. (2013). High Prevalence of Hepatitis C Virus in Asian-Americans: Results of Office-Based Primary Care Screening. HEPATOLOGY. WILEY-BLACKWELL.

The prevalence of undetectable vaccine-induced immunity against hepatitis B virus in US adults at high risk for infection.
Yeo, Y. H., Le, M. H., Chang, E. T., Henry, L., & Nguyen, M. H. (2018). The prevalence of undetectable vaccine-induced immunity against hepatitis B virus in US adults at high risk for infection. Hepatology (Baltimore, Md.).

Healthcare Resource Utilization and Costs by Disease Severity in an Insured National Sample of US Patients with Chronic Hepatitis B.
Nguyen, M. H., Ozbay, A. B., Liou, I., Meyer, N., Gordon, S. C., Dusheiko, G., & Lim, J. K. (2018). Healthcare Resource Utilization and Costs by Disease Severity in an Insured National Sample of US Patients with Chronic Hepatitis B. Journal of Hepatology.

Similar Tolerability and Effectiveness with SMV plus SOF Therapy in Asians and Non-Asians with Chronic Hepatitis C Genotype 1 (CHC-1) but Anemia and Fatigue were Common with SOF plus RBV in Both Groups
Chang, C. Y., Nguyen, N. H., Zhao, C., Lutchman, G. A., Ahmed, A., Daugherty, T., … Nguyen, M. H. (2015). Similar Tolerability and Effectiveness with SMV plus SOF Therapy in Asians and Non-Asians with Chronic Hepatitis C Genotype 1 (CHC-1) but Anemia and Fatigue were Common with SOF plus RBV in Both Groups. HEPATOLOGY, 62, 794A.

IFN and/or RBV-Free Therapy (Rx) with Simeprevir plus Sofosbuvir (SMV plus SOF) was Well-Tolerated and Effective for Chronic Hepatitis C Genotype 1 (CHC-1) Including Post-Liver Transplant (LT) and Decompensated Non-Liver Transplant (Non-LT) Patients: A Single-Center Experience
Lutchman, G. A., Nguyen, N. H., Chang, C. Y., Ahmed, A., Daugherty, T., Garcia, G., … Nguyen, M. H. (2015). IFN and/or RBV-Free Therapy (Rx) with Simeprevir plus Sofosbuvir (SMV plus SOF) was Well-Tolerated and Effective for Chronic Hepatitis C Genotype 1 (CHC-1) Including Post-Liver Transplant (LT) and Decompensated Non-Liver Transplant (Non-LT) Patients: A Single-Center Experience. HEPATOLOGY, 62, 797A–798A.

Safety and Effectiveness of Sofosbuvir (SOF) in Combination with Simeprevir (SIM) or Ribavirin (RBV) for the Treatment of Hepatitis C Virus (HCV) Recurrence after Liver Transplant (LT)
Lutchman, G. A., Nguyen, N. H., Hsiao, T. I., Vu, V. D., Chen, V., Ahmed, A., … Nguyen, M. H. (2014). Safety and Effectiveness of Sofosbuvir (SOF) in Combination with Simeprevir (SIM) or Ribavirin (RBV) for the Treatment of Hepatitis C Virus (HCV) Recurrence after Liver Transplant (LT). HEPATOLOGY, 60, 670A.

Serum M2BPGi level and risk of hepatocellular carcinoma after oral anti-viral therapy in patients with chronic hepatitis B.
Hsu, Y.-C. C., Jun, T., Huang, Y.-T. T., Yeh, M.-L. L., Lee, C.-L. L., Ogawa, S., … Tanaka, Y. (2018). Serum M2BPGi level and risk of hepatocellular carcinoma after oral anti-viral therapy in patients with chronic hepatitis B. Alimentary Pharmacology & Therapeutics.

A Comparison Between Community and Academic Practices in the USA in the Management of Chronic Hepatitis B Patients Receiving Entecavir: Results of the ENUMERATE Study.
Lee, H. M., Ahn, J., Kim, W. R., Lim, J. K., Nguyen, M., Pan, C. Q., … Lok, A. S. (2018). A Comparison Between Community and Academic Practices in the USA in the Management of Chronic Hepatitis B Patients Receiving Entecavir: Results of the ENUMERATE Study. Digestive Diseases and Sciences.

Poor Adherence to Guidelines for Treatment of Chronic HBV Infection at Primary Care and Referral Practices.
Nguyen, V. H., Le, A. K., Trinh, H. N., Chung, M., Johnson, T., Wong, C., … Nguyen, M. H. (2018). Poor Adherence to Guidelines for Treatment of Chronic HBV Infection at Primary Care and Referral Practices. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

Prevalence of Hepatitis B Vaccination Coverage Versus Serologic Evidence of Hepatitis B Immunity in Children and Adolescents in the United States, 1999-2016
Le, M., Yeo, Y. H., So, S. K., Gane, E. J., Cheung, R., & Nguyen, M. H. (2018). Prevalence of Hepatitis B Vaccination Coverage Versus Serologic Evidence of Hepatitis B Immunity in Children and Adolescents in the United States, 1999-2016. HEPATOLOGY, 68, 1192A–1193A.

National Estimates of Overall and Liver-Related Inpatient Care Cost in Cirrhotic Patients with Diverse Etiologies and Ethnicities in the United States (US)
Zou, B., Yeo, Y. H., Jeong, D., Cheung, R., Sheen, E., Park, H., … Nguyen, M. H. (2018). National Estimates of Overall and Liver-Related Inpatient Care Cost in Cirrhotic Patients with Diverse Etiologies and Ethnicities in the United States (US). HEPATOLOGY, 68, 110A.

The Prevalence, Diagnosis Rate, and Treatment Rate of Hepatitis C Infection in the United States: A Nationwide Study
Yeo, Y. H., Jeong, D., Sally Tran, Ogawa, E., Cheung, R., & Nguyen, M. H. (2018). The Prevalence, Diagnosis Rate, and Treatment Rate of Hepatitis C Infection in the United States: A Nationwide Study. HEPATOLOGY, 68, 281A.

Estimations of the Total Number of Undiagnosed Patients and Antiviral Treatment Rate for Chronic Hepatitis B in the United States
Ogawa, E., Jeong, D., Yeo, Y. H., Henry, L., Tran, S., Cheung, R., … Furusyo, N. (2018). Estimations of the Total Number of Undiagnosed Patients and Antiviral Treatment Rate for Chronic Hepatitis B in the United States. HEPATOLOGY, 68, 1214A.

Prevalence of Hepatitis C Infection in Ethnically Diverse US Population Including Asian Americans and US-Born Vs Foreign-Born Persons: A Population-Base Study during 2011-2016
Zou, B., Le, M., Yeo, Y. H., Cheung, R., & Nguyen, M. H. (2018). Prevalence of Hepatitis C Infection in Ethnically Diverse US Population Including Asian Americans and US-Born Vs Foreign-Born Persons: A Population-Base Study during 2011-2016. HEPATOLOGY, 68, 931A–932A.

Sex, Time-Period and Birthplace Specific Prevalence of Hepatitis B and Hepatitis C Virus Infection in Children and Adolescents in the United States during 1999-2016
Zou, B., Yeo, Y. H., Le, M., Cheung, R., & Nguyen, M. H. (2018). Sex, Time-Period and Birthplace Specific Prevalence of Hepatitis B and Hepatitis C Virus Infection in Children and Adolescents in the United States during 1999-2016. HEPATOLOGY, 68, 1193A.

Medical Monitoring Among Cirrhotic Patients in Real World Practice: A Nationwide US Study with 43,915 Cirrhotics
Yeo, Y. H., Jeong, D., Tran, S., Cheung, R., & Nguyen, M. H. (2018). Medical Monitoring Among Cirrhotic Patients in Real World Practice: A Nationwide US Study with 43,915 Cirrhotics. HEPATOLOGY, 68, 283A.

Initial Evaluation, Laboratory Monitoring, and Surveillance of Chronic Hepatitis B (CHB) Patients: Results of a Real-World Analysis of 85,922 Commercially-Insured Patients
Tran, S., Jeong, D., Yeo, Y. H., Le, M., Henry, L., Cheung, R., & Nguyen, M. H. (2018). Initial Evaluation, Laboratory Monitoring, and Surveillance of Chronic Hepatitis B (CHB) Patients: Results of a Real-World Analysis of 85,922 Commercially-Insured Patients. HEPATOLOGY, 68, 82A.

Distribution of Etiologies in Cirrhosis Admissions and Its Year Trend Burden in California (CA): A Population-Based Study with the Office of Statewide Health Planning and Development (OSHPD)
Wei, B., Wei, M., Jeong, D., Henry, L., Cheung, R., & Nguyen, M. H. (2018). Distribution of Etiologies in Cirrhosis Admissions and Its Year Trend Burden in California (CA): A Population-Based Study with the Office of Statewide Health Planning and Development (OSHPD). HEPATOLOGY, 68, 461A.

Nonalcoholic Fatty Liver Disease Increases Risk of Incident Chronic Kidney Disease in a Large Cohort of U.S Population
Park, H., Liu, X., & Nguyen, M. H. (2018). Nonalcoholic Fatty Liver Disease Increases Risk of Incident Chronic Kidney Disease in a Large Cohort of U.S Population. HEPATOLOGY, 68, 967A–968A.

The Impact of Non-Alcoholic Fatty Liver Disease ( NAFLD) on the Rates of Biochemical and Virological Responses in Chronic Hepatitis B Patients Under Antiviral Therapy
Chaung, K. T., Li, J., Le, A. K., Hoang, J. K., & Nguyen, M. H. (2018). The Impact of Non-Alcoholic Fatty Liver Disease ( NAFLD) on the Rates of Biochemical and Virological Responses in Chronic Hepatitis B Patients Under Antiviral Therapy. HEPATOLOGY, 68, 259A–260A.

The Impact of Nonalcoholic Fatty Liver Disease (NAFLD) on the Development of Hepatocellular Carcinoma (HCC) in Chronic Hepatitis B Infection Patients
Li, J., Chaung, K. T., Nguyen, P., Le, A. K., Hoang, J. K., Yang, H.-I., & Nguyen, M. H. (2018). The Impact of Nonalcoholic Fatty Liver Disease (NAFLD) on the Development of Hepatocellular Carcinoma (HCC) in Chronic Hepatitis B Infection Patients. HEPATOLOGY, 68, 1189A.

Ethnic-Specific Prevalence of HBV Infection and Exposure in US-Born and Foreign-Born Persons in the United States from 2011-2016
Le, M., Yeo, Y. H., & Nguyen, M. H. (2018). Ethnic-Specific Prevalence of HBV Infection and Exposure in US-Born and Foreign-Born Persons in the United States from 2011-2016. HEPATOLOGY, 68, 1212A–1213A.

Serial Changes in Serum Levels of Mac-2 Binding Protein Glycosylation Isomer and Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated with Nucleos(t)Ide Analogues
Hsu, Y.-C., Jun, T., Huang, Y.-T., Yeh, M.-L., Lin, J.-T., Yu, M.-L., … Tanaka, Y. (2018). Serial Changes in Serum Levels of Mac-2 Binding Protein Glycosylation Isomer and Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated with Nucleos(t)Ide Analogues. HEPATOLOGY, 68, 230A–231A.

Effectiveness and Safety of DAA Treatment for Chronic Hepatitis C Patients with Previous Hepatocellular Carcinoma: Results from a Real-World, Multicenter Study of Asian Countries
Ogawa, E., Iio, E., Jun, D. W., Huang, C.-F., Haga, H., Enomoto, M., … Yoon, E. (2018). Effectiveness and Safety of DAA Treatment for Chronic Hepatitis C Patients with Previous Hepatocellular Carcinoma: Results from a Real-World, Multicenter Study of Asian Countries. HEPATOLOGY. WILEY.

A Phenome- Wide Association Study of Patatin-like Phospholipase Domain Containing 3 (PNPLA3) I148M Variant in 337,536 Participants of the UK Biobank Study
Yeo, Y. H., Rao, A., Liu, B., Nguyen, M. H., & Ingelsson, E. (2018). A Phenome- Wide Association Study of Patatin-like Phospholipase Domain Containing 3 (PNPLA3) I148M Variant in 337,536 Participants of the UK Biobank Study. HEPATOLOGY, 68, 65A–66A.

Incidence and Predictors of HBsAg Seroclearance in 10,614 Untreated Patients on Long-Term Follow-up: A Collaborative Study from North America and Asia Pacific
Yeo, Y. H., Ho, H. J., Yang, H.-I., Tseng, T.-C., Trinh, H. N., Park, Y. M., … Nguyen, M. H. (2018). Incidence and Predictors of HBsAg Seroclearance in 10,614 Untreated Patients on Long-Term Follow-up: A Collaborative Study from North America and Asia Pacific. HEPATOLOGY. WILEY.

Prevalence of NAFLD and Liver Fibrosis in Asian Americans: A Population Based US Study from Nhanes, 2011-2014
Le, M., Yeo, Y. H., Tran, S., & Nguyen, M. H. (2018). Prevalence of NAFLD and Liver Fibrosis in Asian Americans: A Population Based US Study from Nhanes, 2011-2014. HEPATOLOGY, 68, 1293A.

Development and Validation of a Risk Score System Inclusive of Antiviral Therapy for Liver Cirrhosis Risk in Chronic Hepatitis B Infection
Liu, A. F., Le, A. K., Yang, H.-I., Jin, M., Trinh, H. N., Zhang, J., … Nguyen, M. H. (2018). Development and Validation of a Risk Score System Inclusive of Antiviral Therapy for Liver Cirrhosis Risk in Chronic Hepatitis B Infection. HEPATOLOGY. WILEY.

The Majority of Previously Uninfected High-Risk Adults in the United States Do Not Have Immunity Against Hepatitis B Virus: A Population-Based Study
Yeo, Y. H., Le, M., Chang, E. T., Henry, L., & Nguyen, M. H. (2018). The Majority of Previously Uninfected High-Risk Adults in the United States Do Not Have Immunity Against Hepatitis B Virus: A Population-Based Study. HEPATOLOGY, 68, 134A–135A.

Real-World Experience of All-Oral Directly Acting Antivirals in Asian Chronic Hepatitis C Patients-Real-World Evidence from the Asia Liver Consortium for HCV (REAL-C)
Huang, C.-F., Iio, E., Jun, D. W., Ogawa, E., Haga, H., Enomoto, M., … Yoon, E. (2018). Real-World Experience of All-Oral Directly Acting Antivirals in Asian Chronic Hepatitis C Patients-Real-World Evidence from the Asia Liver Consortium for HCV (REAL-C). HEPATOLOGY. WILEY.

Hepatitis B Core-Related Antigen and the Novel Scale-B Score to Predict Relapse Risk after Cessation of Nucleos(t)Ide Analogs in Patients with Chronic Hepatitis B
Hsu, Y.-C., Nguyen, M. H., Mou, L.-J., Wu, M.-S., Yang, T.-H., Chen, C.-C., … Chang, C.-Y. (2018). Hepatitis B Core-Related Antigen and the Novel Scale-B Score to Predict Relapse Risk after Cessation of Nucleos(t)Ide Analogs in Patients with Chronic Hepatitis B. HEPATOLOGY, 68, 236A–237A.

Differential Presentation and Survival of Asian and Non-Asian Patients with HBV-Related Hepatocellular Carcinoma: A Multicenter United States (US) Study.
Hoang, J. K., Leong, J., Yang, J. D., Nguyen, P., Le, A. K., Henry, L., … Nguyen, M. H. (2018). Differential Presentation and Survival of Asian and Non-Asian Patients with HBV-Related Hepatocellular Carcinoma: A Multicenter United States (US) Study. HEPATOLOGY, 68, 1233A.

High Prevalence of CKD and Associations between Fibrosis and Mortality in Patients with NAFLD
Le, M., Yeo, Y. H., Tran, S., & Nguyen, M. H. (2018). High Prevalence of CKD and Associations between Fibrosis and Mortality in Patients with NAFLD. HEPATOLOGY, 68, 956A.

High Proportion and Long-Term Outcomes of Patients with Chronic Hepatitis B Have Indeterminate Clinical Phenotype As per AASLD 2018 Guidelines
Li, X., Yeo, Y. H., Le, A. K., Lee, D. H., Trinh, H. N., Zhang, J., … Nguyen, M. H. (2018). High Proportion and Long-Term Outcomes of Patients with Chronic Hepatitis B Have Indeterminate Clinical Phenotype As per AASLD 2018 Guidelines. HEPATOLOGY. WILEY.

Increased Prevalence of Non-Alcoholic Fatty Liver Disease (NAFLD) in Asia: A Systematic Review and Meta-Analysis of 164 Studies and 1,704,963 Subjects from 13 Countries
Li, J., Zou, B., Yeo, Y. H., Fujii, H., Lee, D. H., Ji, F., … Nguyen, M. H. (2018). Increased Prevalence of Non-Alcoholic Fatty Liver Disease (NAFLD) in Asia: A Systematic Review and Meta-Analysis of 164 Studies and 1,704,963 Subjects from 13 Countries. HEPATOLOGY, 68, 983A.

Increasing Age and Comorbidities in a Population-Based Study of Chronic Hepatitis B (CHB) Patients from 2007 to 2016 in Korea
Jun, D. W., Oh, H. W., Ahn, H. J., Kim, B. O., & Nguyen, M. H. (2018). Increasing Age and Comorbidities in a Population-Based Study of Chronic Hepatitis B (CHB) Patients from 2007 to 2016 in Korea. HEPATOLOGY, 68, 1224A–1225A.

Clinical Features Associated with Survival Outcome in African-American Patients with Hepatocellular Carcinoma.
Estevez, J., Yang, J. D., Leong, J., Nguyen, P., Giama, N. H., Zhang, N., … Nguyen, M. H. (2018). Clinical Features Associated with Survival Outcome in African-American Patients with Hepatocellular Carcinoma. The American Journal of Gastroenterology.

Rising Inpatient Encounters and Economic Burden for Patients with Nonalcoholic Fatty Liver Disease in the USA.
Nguyen, M. H., Nguyen, A. L., Park, H., Nguyen, P., Sheen, E., & Kim, Y. A. (2018). Rising Inpatient Encounters and Economic Burden for Patients with Nonalcoholic Fatty Liver Disease in the USA. Digestive Diseases and Sciences.

Factors Associated with Rates of HBsAg Seroclearance in Adults with Chronic HBV Infection: A systematic review and meta-analysis.
Yeo, Y. H., Ho, H. J., Yang, H.-I. I., Tseng, T.-C. C., Hosaka, T., Trinh, H. N., … Nguyen, M. H. (2018). Factors Associated with Rates of HBsAg Seroclearance in Adults with Chronic HBV Infection: A systematic review and meta-analysis. Gastroenterology.

Individual surveillance using model-based hepatocellular carcinoma risk estimates in chronic hepatitis C patients after antiviral treatment.
Ji, F., Yeo, Y. H., He, C., Li, J., Gao, X., Li, Z., … Nguyen, M. H. (2018). Individual surveillance using model-based hepatocellular carcinoma risk estimates in chronic hepatitis C patients after antiviral treatment. Journal of Hepatology.

Long-term outcome of chronic hepatitis B patients initially treated with adefovir dipivoxil in a community practice
Ha, N., Ha, N., Garcia, R., Trinh, H., Nguyen, H., Nguyen, K., … Nguyen, M. (2008). Long-term outcome of chronic hepatitis B patients initially treated with adefovir dipivoxil in a community practice. AMERICAN JOURNAL OF GASTROENTEROLOGY. NATURE PUBLISHING GROUP.

Risk factors (Rfs), novel genotypes, and treatment outcomes in Southeast Asians (Seas) with chronic hepatitis C
Nguyen, N., Vutien, P., Trinh, H., Garcia, R., Nguyen, L., Nguyen, H., … Nguyen, M. (2008). Risk factors (Rfs), novel genotypes, and treatment outcomes in Southeast Asians (Seas) with chronic hepatitis C. AMERICAN JOURNAL OF GASTROENTEROLOGY. NATURE PUBLISHING GROUP.

Re-treatment of patients with chronic hepatitis C virus genotype 4 infection with pegylated interferon and ribavirin: a meta-analysis
Zhang, B., Nguyen, N. H., Yee, B. E., Yip, B., & Nguyen, M. H. (2015). Re-treatment of patients with chronic hepatitis C virus genotype 4 infection with pegylated interferon and ribavirin: a meta-analysis. BMJ OPEN GASTROENTEROLOGY, 2(1), e000057.

Poor Adherence to Hepatocellular Carcinoma (HCC) Surveillance in a US Cohort of 2376 Patients with Chronic Hepatitis C (CHC) and Cirrhosis
Tran, S. A., Hoang, J. K., Le, A. K., Zhao, C., Yasukawa, L. A., Weber, S. C., & Nguyen, M. H. (2016). Poor Adherence to Hepatocellular Carcinoma (HCC) Surveillance in a US Cohort of 2376 Patients with Chronic Hepatitis C (CHC) and Cirrhosis. HEPATOLOGY, 64, 30A.

Nonalcoholic steatohepatitis (NASH) or high probability of fibrosis based on noninvasive marker panels (APRI, FIB-4, NFS) at disease presentation is associated with increased all-cause mortality in patients with nonalcoholic fatty liver disease (NAFLD)
Ha, N. B., Le, R. H., Trinh, S., Nguyen, M. D., Yip, B., Hoang, J. K., & Nguyen, M. H. (2016). Nonalcoholic steatohepatitis (NASH) or high probability of fibrosis based on noninvasive marker panels (APRI, FIB-4, NFS) at disease presentation is associated with increased all-cause mortality in patients with nonalcoholic fatty liver disease (NAFLD). HEPATOLOGY, 64, 592A.

Predictors of Nonalcoholic Fatty Liver Disease (NAFLD) and Advanced Fibrosis Stage 3-4 in Patients with NAFLD in the United States: Results of a Population Based Sample of 6,000 Patients
Le, M. H., Devaki, P., Ha, N. B., Jun, D. W., Te, H. S., Cheung, R., & Nguyen, M. H. (2016). Predictors of Nonalcoholic Fatty Liver Disease (NAFLD) and Advanced Fibrosis Stage 3-4 in Patients with NAFLD in the United States: Results of a Population Based Sample of 6,000 Patients. HEPATOLOGY, 64, 535A.

Higher Prevalence of Existing Comorbidities and Medication Use in Untreated Patients with Chronic Hepatitis C (CHC) compared to Treated Patients: A Population-Based Study in Post-Oral Direct-Acting Antivirals (DAAs) Era
Vutien, P., Tran, N. (J. Q., Cao, F., Peichel, V., & Nguyen, M. H. (2016). Higher Prevalence of Existing Comorbidities and Medication Use in Untreated Patients with Chronic Hepatitis C (CHC) compared to Treated Patients: A Population-Based Study in Post-Oral Direct-Acting Antivirals (DAAs) Era. HEPATOLOGY, 64, 413A–414A.

COST-EFFECTIVENESS ANALYSIS OF FIRST-LINE ADMINISTRATION OF TENOFOVIR ALAFENAMIDE (TAF), A NOVEL NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITOR (NRTI), FOR THE MANAGEMENT OF CHRONIC HEPATITIS B (CHB) IN THE UNITED STATES (US)
Dusheiko, G., Lim, J., Liou, Tafazzoli, A., Deniz, B., Thibault, S.-L. C., … Nguyen, M. H. (2017). COST-EFFECTIVENESS ANALYSIS OF FIRST-LINE ADMINISTRATION OF TENOFOVIR ALAFENAMIDE (TAF), A NOVEL NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITOR (NRTI), FOR THE MANAGEMENT OF CHRONIC HEPATITIS B (CHB) IN THE UNITED STATES (US). VALUE IN HEALTH, 20(5), A78.

High Frequency of Flares in Alanine Aminotransferase (ALT) And Hepatitis B Virus (HBV) DNA During Pregnancy And Postpartum in Women With Chronic Hepatitis B (CHB) Who Discontinued Therapy Prior to or During Early Pregnancy
Chang, C. Y., Aziz, N., Poongkunran, M., Javaid, A., Trinh, H. N., Lau, D., & Nguyen, M. H. (2016). High Frequency of Flares in Alanine Aminotransferase (ALT) And Hepatitis B Virus (HBV) DNA During Pregnancy And Postpartum in Women With Chronic Hepatitis B (CHB) Who Discontinued Therapy Prior to or During Early Pregnancy. HEPATOLOGY, 64, 920A.

Integrated Resistance Analyses of HCV-infected Patients treated with Sofosbuvir, Velpatasvir and Voxilaprevir for 8 and 12 weeks from Phase 2 Studies
Reau, N., Nguyen, M. H., Kowdley, K. V., Gane, E. J., Dvory-Sobol, H., Svarovskaia, E. S., … Jacobson, I. M. (2016). Integrated Resistance Analyses of HCV-infected Patients treated with Sofosbuvir, Velpatasvir and Voxilaprevir for 8 and 12 weeks from Phase 2 Studies. HEPATOLOGY, 64, 415A–416A.

Integrated analysis of controlled clinical trials evaluating efficacy and safety of sofosbuvir-based regimens in chronic hepatitis C genotype 6 (HCV GT 6)
Nguyen, M. H., Chuang, W.-L., Hassanein, T., Kowdley, K., Lai, C.-L., Chan, H. L.-Y., … Gane, E. J. (2017). Integrated analysis of controlled clinical trials evaluating efficacy and safety of sofosbuvir-based regimens in chronic hepatitis C genotype 6 (HCV GT 6). JOURNAL OF HEPATOLOGY, 66(1), S723.

Higher and rising prevalence and incidence of renal impairment and chronic kidney disease in chronic hepatitis B patients compared to matched non-chronic hepatitis B controls in the United States: results of a real-world analysis
Nguyen, M. H., Lim, J., Liou, I., Ozbay, A. B., Fraysse, J., Meyer, N., … Gordon, S. (2017). Higher and rising prevalence and incidence of renal impairment and chronic kidney disease in chronic hepatitis B patients compared to matched non-chronic hepatitis B controls in the United States: results of a real-world analysis. JOURNAL OF HEPATOLOGY, 66(1), S677–S678.

High rate of progression to cirrhosis in patients with chronic hepatitis B (CHB) and non-alcoholic fatty liver (FL)
Li, J., Chaung, K. T., Le, A. K., Hoang, J. K., & Nguyen, M. H. (2017). High rate of progression to cirrhosis in patients with chronic hepatitis B (CHB) and non-alcoholic fatty liver (FL). JOURNAL OF HEPATOLOGY, 66(1), S488.

3 times higher healthcare cost in chronic hepatitis B patients compared to non-chronic hepatitis B controls especially those with decompensated liver disease: United States real world healthcare utilization and cost analysis
Nguyen, M. H., Lim, J., Ozbay, A. B., Shreay, S., Liou, I., Meyer, N., … Gordon, S. (2017). 3 times higher healthcare cost in chronic hepatitis B patients compared to non-chronic hepatitis B controls especially those with decompensated liver disease: United States real world healthcare utilization and cost analysis. JOURNAL OF HEPATOLOGY, 66(1), S369–S370.

SVR reduces ethnic disparities in progression to advanced liver disease in patients with chronic hepatitis C
Le, A. K., Zhao, C., Hoang, J., Yasukawa, L. A., Zhang, J., Weber, S. C., & Nguyen, M. (2017). SVR reduces ethnic disparities in progression to advanced liver disease in patients with chronic hepatitis C. JOURNAL OF HEPATOLOGY, 66(1), S283–S284.

Rising healthcare utilization and cost of chronic hepatitis B: real-world analysis of 44,026 chronic hepatitis B patients and 121,568 matched non-chronic hepatitis B controls in the United States
Lim, J., Nguyen, M., Liou, I., Ozbay, A. B., Moore-Schiltz, L., Dusheiko, G., & Gordon, S. (2017). Rising healthcare utilization and cost of chronic hepatitis B: real-world analysis of 44,026 chronic hepatitis B patients and 121,568 matched non-chronic hepatitis B controls in the United States. JOURNAL OF HEPATOLOGY, 66(1), S266–S267.

Metabolic risk factors increase the risk of hepatocellular carcinoma in patients with hepatitis C cirrhosis
Kutsenko, A., Le, A., Trinh, S., Dang, H., & Nguyen, M. (2017). Metabolic risk factors increase the risk of hepatocellular carcinoma in patients with hepatitis C cirrhosis. JOURNAL OF HEPATOLOGY, 66(1), S125–S126.

Prevalence of osteoporosis and bone fracturewas 2-fold higher in chronic hepatitis B compared to non-chronic hepatitis B patients and continued to increase in the last decade: results of a United States population-based cohort study
Gordon, S. C., Lim, J., Liou, I., Ozbay, A. B., Moore-Schiltz, L., Dusheiko, G., & Nguyen, M. H. (2017). Prevalence of osteoporosis and bone fracturewas 2-fold higher in chronic hepatitis B compared to non-chronic hepatitis B patients and continued to increase in the last decade: results of a United States population-based cohort study. JOURNAL OF HEPATOLOGY, 66(1), S61.

Advancing age and comorbidities in chronic hepatitis B patients: results of 10-year longitudinal analysis of a diverse population-based cohort of 44,026 chronic hepatitis B patients in the United States
Nguyen, M. H., Lim, J., Ozbay, A. B., Fraysse, J., Liou, I., Meyer, N., … Gordon, S. (2017). Advancing age and comorbidities in chronic hepatitis B patients: results of 10-year longitudinal analysis of a diverse population-based cohort of 44,026 chronic hepatitis B patients in the United States. JOURNAL OF HEPATOLOGY, 66(1), S60.

Features of the metabolic syndrome are associated with lack of serum ALT normalization during therapy for chronic hepatitis B
Fung, S., Yatsuhashi, H., Tak, W. Y., Celen, M. K., Flaherty, J. F., Kim, K., … Nguyen, M. H. (2016). Features of the metabolic syndrome are associated with lack of serum ALT normalization during therapy for chronic hepatitis B. HEPATOLOGY, 64, 914A–915A.

SOFOSBUVIR/VELPATASVIR FIXED DOSE COMBINATION FOR 12 WEEKS IN HCV INFECTED PATIENTS PREVIOUSLY TREATED WITH PLACEBO: RESULTS OF THE DEFERRED TREATMENT STUDY (GS-US-342-1446 STUDY)
Asselah, T., Shafran, S., Bourgeois, S., Lai, C.-L., Cramp, M., Mathurin, P., … Tran, T. T. (2016). SOFOSBUVIR/VELPATASVIR FIXED DOSE COMBINATION FOR 12 WEEKS IN HCV INFECTED PATIENTS PREVIOUSLY TREATED WITH PLACEBO: RESULTS OF THE DEFERRED TREATMENT STUDY (GS-US-342-1446 STUDY). JOURNAL OF HEPATOLOGY, 64, S827–S828.

ONLY ONE-THIRD OF PATIENTS WITH HEPATOCELLULAR CARCINOMA WERE DIAGNOSED BY SCREENING, SURVEILLANCE, OR WITHOUT SYMPTOMS: A META-ANALYSIS OF 40 STUDIES AND 20,349 PATIENTS WITH DIVERSE UNDERLYING LIVER DISEASE AND WORLD REGIONS
Jin, M. Q., Le, R. H., Jin, M., Zhao, C., Le, M. H., Nguyen, A., … Nguyen, M. (2016). ONLY ONE-THIRD OF PATIENTS WITH HEPATOCELLULAR CARCINOMA WERE DIAGNOSED BY SCREENING, SURVEILLANCE, OR WITHOUT SYMPTOMS: A META-ANALYSIS OF 40 STUDIES AND 20,349 PATIENTS WITH DIVERSE UNDERLYING LIVER DISEASE AND WORLD REGIONS. JOURNAL OF HEPATOLOGY, 64, S336.

VALIDATION OF THE GALAD SCORE FOR HEPATOCELLULAR CARCINOMA DIAGNOSIS IN A US COHORT
Yang, J. D., Dai, J., Addissie, B., Nguyen, M. H., Befeler, A. S., Reddy, R., … Roberts, L. R. (2016). VALIDATION OF THE GALAD SCORE FOR HEPATOCELLULAR CARCINOMA DIAGNOSIS IN A US COHORT. JOURNAL OF HEPATOLOGY, 64, S330.

High Efficacy of Sofosbuvir/Velpatasvir Plus GS-9857 for 12 Weeks in Treatment-Experienced Genotype 1-6 HCV-Infected Patients, Including Those Previously Treated with Direct-Acting Antivirals
Lawitz, E., Kowdley, K., Curry, M., Reau, N., Nguyen, M., Kwo, P., … Gane, E. (2016). High Efficacy of Sofosbuvir/Velpatasvir Plus GS-9857 for 12 Weeks in Treatment-Experienced Genotype 1-6 HCV-Infected Patients, Including Those Previously Treated with Direct-Acting Antivirals. AMERICAN JOURNAL OF GASTROENTEROLOGY, 111, S380.

Chrome-Colonoscopy (CC), in a Single Operator Community Practice, Significantly Increases Polyp Detection Rate: a Call for Wider Adoption.
Balaa, M. A., Al-Manaseer, F., Lin, O. N., Vinh Vu, Syriani, L., & Nguyen, M. H. (2015). Chrome-Colonoscopy (CC), in a Single Operator Community Practice, Significantly Increases Polyp Detection Rate: a Call for Wider Adoption. GASTROINTESTINAL ENDOSCOPY, 81(5), AB209–AB210.

HIGH EFFICACY OF SOFOSBUVIR/VELPATASVIR PLUS GS-9857 FOR 12 WEEKS IN TREATMENT-EXPERIENCED GENOTYPE 1-6 HCV-INFECTED PATIENTS, INCLUDING THOSE PREVIOUSLY TREATED WITH DIRECT-ACTING ANTIVIRALS
Lawitz, E., Kowdley, K., Curry, M., Reau, N., Nguyen, M., Kwo, P., … Gane, E. J. (2016). HIGH EFFICACY OF SOFOSBUVIR/VELPATASVIR PLUS GS-9857 FOR 12 WEEKS IN TREATMENT-EXPERIENCED GENOTYPE 1-6 HCV-INFECTED PATIENTS, INCLUDING THOSE PREVIOUSLY TREATED WITH DIRECT-ACTING ANTIVIRALS. JOURNAL OF HEPATOLOGY. ELSEVIER SCIENCE BV.

Characteristics and Clinical Outcomes of A Diverse Cohort of Patients with Biopsy-Proven Non-Alcoholic Fatty Liver Disease (NAFLD)
Yip, B., Yee, B. E., Do, A., Nguyen, N. H., Hoang, J. K., & Nguyen, M. H. (2015). Characteristics and Clinical Outcomes of A Diverse Cohort of Patients with Biopsy-Proven Non-Alcoholic Fatty Liver Disease (NAFLD). HEPATOLOGY, 62, 1303A.

Low HCV Treatment for Chronic Hepatitis C (CHC) Patients in Pre-Protease Inhibitor (PI) and Post-PI/Pre-Direct Acting Antiviral (DAA) Eras Compared to Post-DAA Era, Especially in African Americans: Analysis of A Large Real-World Cohort of 7105 Patients
Nguyen, P. T., Nguyen, N. H., Hoang, J. K., Zhao, C., Le, A. K., Chang, C. Y., … Nguyen, M. H. (2015). Low HCV Treatment for Chronic Hepatitis C (CHC) Patients in Pre-Protease Inhibitor (PI) and Post-PI/Pre-Direct Acting Antiviral (DAA) Eras Compared to Post-DAA Era, Especially in African Americans: Analysis of A Large Real-World Cohort of 7105 Patients. HEPATOLOGY. WILEY-BLACKWELL.

Racial Differences in Socioeconomic Status (SES), Cirrhosis, and Treatment of Chronic Hepatitis C (CHC): Highest Treatment Rates in Caucasian Americans (CA), followed by Hispanic Americans (HA), African Americans (AFA) and Lowest in Asian Americans (AA)
Vutien, P., Hoang, J. K., Brooks, L., & Nguyen, M. H. (2015). Racial Differences in Socioeconomic Status (SES), Cirrhosis, and Treatment of Chronic Hepatitis C (CHC): Highest Treatment Rates in Caucasian Americans (CA), followed by Hispanic Americans (HA), African Americans (AFA) and Lowest in Asian Americans (AA). HEPATOLOGY, 62, 1088A–1089A.

Progression to liver cirrhosis in patients with chronic hepatitis C (CHC) in a large United States cohort: a natural history study
Nguyen, N. H., Hoang, J. K., Le, A. K., Zhao, C., Chang, C. Y., Le, R. H., … Nguyen, M. H. (2015). Progression to liver cirrhosis in patients with chronic hepatitis C (CHC) in a large United States cohort: a natural history study. HEPATOLOGY, 62, 1089A.

Differential Serum Cytokine Profiles in Patients with Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), and Non-Viral Non-Autoimmune Liver Disease, with or without Hepatocellular Carcinoma (HCC)
Chen, V. L., Vutien, P., Li, B., Podlaha, O., Chang, E. T., Jiang, Z., … Nguyen, M. H. (2015). Differential Serum Cytokine Profiles in Patients with Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), and Non-Viral Non-Autoimmune Liver Disease, with or without Hepatocellular Carcinoma (HCC). HEPATOLOGY, 62, 1022A.

Lower Incidence of Hepatocellular Carcinoma (HCC) with Antiviral Therapy in Chronic Hepatitis B (CHB) Patients without Cirrhosis and Normal to Minimally Elevated Alanine Aminotransferase (ALT) Levels (< 2x upper limit of normal or ULN)
Hoang, J. K., Nguyen, N. H., Yang, H.-I., Lin, D., Vu, V. D., Chaung, K. T., … Nguyen, M. H. (2015). Lower Incidence of Hepatocellular Carcinoma (HCC) with Antiviral Therapy in Chronic Hepatitis B (CHB) Patients without Cirrhosis and Normal to Minimally Elevated Alanine Aminotransferase (ALT) Levels (< 2x upper limit of normal or ULN). HEPATOLOGY. WILEY-BLACKWELL.

Higher Incidence of Hepatocellular Carcinoma (HCC) in Patients with Hepatitis B Virus (HBV) -related Liver Cirrhosis (LC) Compared to Hepatitis C Virus (HCV)-LC and Non-Viral LC
Zhao, C., Nguyen, N. H., Nguyen, M. D., Hoang, J. K., Nguyen, L. H., Le, R. H., … Nguyen, M. H. (2015). Higher Incidence of Hepatocellular Carcinoma (HCC) in Patients with Hepatitis B Virus (HBV) -related Liver Cirrhosis (LC) Compared to Hepatitis C Virus (HCV)-LC and Non-Viral LC. HEPATOLOGY. WILEY-BLACKWELL.

Regional and Etiological Differences in the Adherence to Hepatocellular Carcinoma (HCC) Surveillance among Patients of Chronic Hepatitis B (CHB) and Cirrhosis of All Etiologies: A Meta-Analysis of 15,429 Patients from 14 Individual Studies
Zhao, C., Jin, M., Le, R. H., Le, M. H., Chen, V. L., Wong, G., … Nguyen, M. H. (2015). Regional and Etiological Differences in the Adherence to Hepatocellular Carcinoma (HCC) Surveillance among Patients of Chronic Hepatitis B (CHB) and Cirrhosis of All Etiologies: A Meta-Analysis of 15,429 Patients from 14 Individual Studies. HEPATOLOGY, 62, 440A–441A.

Higher Risk for Hepatocellular Carcinoma (HCC) in Asian Americans (AA) with Chronic Hepatitis C (CHC) compared to Non-Asians (NA), Regardless of Cirrhosis Status
Le, R. H., Nguyen, N. H., Hoang, J. K., Le, A. K., Nguyen, P. T., Zhao, C., … Nguyen, M. H. (2015). Higher Risk for Hepatocellular Carcinoma (HCC) in Asian Americans (AA) with Chronic Hepatitis C (CHC) compared to Non-Asians (NA), Regardless of Cirrhosis Status. HEPATOLOGY, 62, 406A–407A.

Racial Differences in the Presentation and the Incidence of Hepatocellular Carcinoma (HCC) in a Large Cohort of Patients with Cirrhosis in the United States
Nguyen, L. H., Zhao, C., Nguyen, N. H., Hoang, J. K., Nguyen, M. D., Le, R. H., … Nguyen, M. H. (2015). Racial Differences in the Presentation and the Incidence of Hepatocellular Carcinoma (HCC) in a Large Cohort of Patients with Cirrhosis in the United States. HEPATOLOGY. WILEY-BLACKWELL.

Meta-Analysis: Proportions of Hepatocellular Carcinoma (HCC) Diagnosed by Screening, Surveillance, or Without Symptoms is Dismally Low Across Different World Regions and Underlying Liver Diseases
Jin, M. Q., Le, R. H., Jin, M., Zhao, C., Le, M. H., Chen, V. L., … Nguyen, M. H. (2015). Meta-Analysis: Proportions of Hepatocellular Carcinoma (HCC) Diagnosed by Screening, Surveillance, or Without Symptoms is Dismally Low Across Different World Regions and Underlying Liver Diseases. HEPATOLOGY, 62, 396A.

Effect of Antiviral Therapy and REACH-B Risk Score on Hepatocellular Carcinoma (HCC) Incidence in Chronic Hepatitis B (CHB) Patients Who Did Not Meet Treatment Criteria by AASLD, US Panel, EASL, or APASL Guideline
Nguyen, N. H., Vu, V. D., Lin, D., Hoang, J. K., Le, A. K., Chaung, K. T., … Nguyen, M. H. (2015). Effect of Antiviral Therapy and REACH-B Risk Score on Hepatocellular Carcinoma (HCC) Incidence in Chronic Hepatitis B (CHB) Patients Who Did Not Meet Treatment Criteria by AASLD, US Panel, EASL, or APASL Guideline. HEPATOLOGY. WILEY-BLACKWELL.

Risk Differences of Hepatocellular Carcinoma (HCC) Among Patients with Chronic Hepatitis C (CHC) of Different Viral Genotypes: a Historical Cohort Study in the United States
Jin, M., Zhao, C., Hoang, J. K., Nguyen, N. H., Le, A. K., Chang, C. Y., … Nguyen, M. H. (2015). Risk Differences of Hepatocellular Carcinoma (HCC) Among Patients with Chronic Hepatitis C (CHC) of Different Viral Genotypes: a Historical Cohort Study in the United States. HEPATOLOGY, 62, 392A.

Serum Alanine Aminotransferase (ALT) and Hepatitis B Virus (HBV) DNA Flares In Pregnant and Postpartum Women With Chronic Hepatitis B (CHB)
Chang, C. Y., Aziz, N., Trinh, H. N., & Nguyen, M. H. (2015). Serum Alanine Aminotransferase (ALT) and Hepatitis B Virus (HBV) DNA Flares In Pregnant and Postpartum Women With Chronic Hepatitis B (CHB). HEPATOLOGY, 62, 272A.

META-ANALYSIS: SVR12 WITH SIMEPREVIR AND SOFOSBUVIR (SMV+SOF) FOR 12 WEEKS IN 225 LIVER TRANSPLANT (LT) RECIPIENTS WITH HCV GENOTYPE 1 (HCV-1)
Nguyen, N. H., Yee, B. E., Lutchman, G. A., Lim, J. K., & Nguyen, M. (2015). META-ANALYSIS: SVR12 WITH SIMEPREVIR AND SOFOSBUVIR (SMV+SOF) FOR 12 WEEKS IN 225 LIVER TRANSPLANT (LT) RECIPIENTS WITH HCV GENOTYPE 1 (HCV-1). JOURNAL OF HEPATOLOGY, 62, S314.

OUTCOMES OF 12-WEEK THERAPY WITH SIMEPREVIR plus SOFOSBUVIR plus /- RIBAVIRIN (SMV plus SOF +/- RBV): A META-ANALYSIS OF 7 STUDIES AND 715 HCV GENOTYPE 1 (HCV-1) PATIENTS
Yee, B. E., Nguyen, N. H., Lutchman, G. A., Lim, J. K., & Nguyen, M. H. (2015). OUTCOMES OF 12-WEEK THERAPY WITH SIMEPREVIR plus SOFOSBUVIR plus /- RIBAVIRIN (SMV plus SOF +/- RBV): A META-ANALYSIS OF 7 STUDIES AND 715 HCV GENOTYPE 1 (HCV-1) PATIENTS. JOURNAL OF HEPATOLOGY, 62, S668–S669.

GENDER DIFFERENCES IN HEPATOCELLULAR CARCINOMA (HCC) SURVEILLANCE ADHERENCE PATTERNS IN PATIENTS WITH CHRONIC HEPATITIS B (CHB) IN A MULTICENTER ACADEMIC AND COMMUNITY COHORT STUDY
Nguyen, L., Wang, C., Hoang, J., Trinh, H. N., Li, J., Zhang, J. Q., & Nguyen, M. (2015). GENDER DIFFERENCES IN HEPATOCELLULAR CARCINOMA (HCC) SURVEILLANCE ADHERENCE PATTERNS IN PATIENTS WITH CHRONIC HEPATITIS B (CHB) IN A MULTICENTER ACADEMIC AND COMMUNITY COHORT STUDY. JOURNAL OF HEPATOLOGY, 62, S535.

Retreatment of Patients With Chronic Hepatitis C Genotype 4 (HCV-4) Infection With Pegylated Interferon and Ribavirin (P/R): A Systematic Review and Meta-Analysis
Zhang, B., Yee, B., Nguyen, N., Yip, B., Ayoub, W., Nguyen, M., & Lutchman, G. (2014). Retreatment of Patients With Chronic Hepatitis C Genotype 4 (HCV-4) Infection With Pegylated Interferon and Ribavirin (P/R): A Systematic Review and Meta-Analysis. AMERICAN JOURNAL OF GASTROENTEROLOGY, 109, S185.

Similar Renal Function Profile in Chronic Hepatitis B (CHB) Patients Treated with Tenofovir (TDF) vs. Entecavir (ETV) Monotherapy - A Multicenter Matched Case Cohort Study
Ha, N. B., Ku, K., Ha, N. B., Chaung, K. T., Trinh, H. N., & Nguyen, M. H. (2014). Similar Renal Function Profile in Chronic Hepatitis B (CHB) Patients Treated with Tenofovir (TDF) vs. Entecavir (ETV) Monotherapy - A Multicenter Matched Case Cohort Study. HEPATOLOGY, 60, 1124A.

Higher rates of hepatitis B surface antigen (HBsAg) seroclearance among males and non-Asian patients with chronic hepatitis B (CHB) in a large, multi-center US cohort study
Nguyen, L. H., Wang, C., Vu, V. D., Trinh, H. N., Li, J., Zhang, J. Q., & Nguyen, M. H. (2014). Higher rates of hepatitis B surface antigen (HBsAg) seroclearance among males and non-Asian patients with chronic hepatitis B (CHB) in a large, multi-center US cohort study. HEPATOLOGY. WILEY-BLACKWELL.

High Rates of Comorbidities and Polypharmacy in Patients with Chronic Hepatitis C (CHC) in a Real-World Setting: a Consequence of an Aging Population
Vutien, P., Brooks, L., Livornese, R. C., & Nguyen, M. H. (2014). High Rates of Comorbidities and Polypharmacy in Patients with Chronic Hepatitis C (CHC) in a Real-World Setting: a Consequence of an Aging Population. HEPATOLOGY, 60, 910A–911A.

Treatment of Acute Hepatitis C (HCV) Infection with Pegylated Interferon and Ribavirin (P/R) in Patients Co-infected with Human Immunodeficiency Virus (HIV): a systematic review and meta-analysis
Zhang, B., Yip, B., Nguyen, N. H., Yee, B. E., Ayoub, W. S., Nguyen, M. H., & Lutchman, G. A. (2014). Treatment of Acute Hepatitis C (HCV) Infection with Pegylated Interferon and Ribavirin (P/R) in Patients Co-infected with Human Immunodeficiency Virus (HIV): a systematic review and meta-analysis. HEPATOLOGY, 60, 706A.

Meta-analysis: Predictors for response-guided therapy (RGT) in hepatitis C genotype 4 (HCV-4) patients treated with pegylated interferon and ribavirin (PEG IFN plus RBV)
Yee, B. E., Nguyen, N. H., Zhang, B., Vutien, P., Wong, C. R., Lutchman, G. A., & Nguyen, M. H. (2014). Meta-analysis: Predictors for response-guided therapy (RGT) in hepatitis C genotype 4 (HCV-4) patients treated with pegylated interferon and ribavirin (PEG IFN plus RBV). HEPATOLOGY, 60, 690A.

Higher sustained virologic response (SVR) in patients with early virologic response (EVR) and hepatitis C genotype 4 (HCV-4) compared to genotype 1 (HCV-1) with pegylated interferon and ribavirin (PEG IFN plus RBV): a comparative analysis from a meta-analysis
Yee, B. E., Lin, D., Nguyen, N. H., Zhang, B., Vutien, P., Wong, C. R., … Nguyen, M. H. (2014). Higher sustained virologic response (SVR) in patients with early virologic response (EVR) and hepatitis C genotype 4 (HCV-4) compared to genotype 1 (HCV-1) with pegylated interferon and ribavirin (PEG IFN plus RBV): a comparative analysis from a meta-analysis. HEPATOLOGY, 60, 686A.

Poor Sustained Virologic Response (SVR) in a Multicenter Real-Life Cohort of Chronic Hepatitis C (CHC) Patients Treated with Pegylated Interferon (PEG IFN) and Ribavirin (RBV) plus Telaprevir (TVR) or Boceprevir (BOC)
Vo, K. P., Vutien, P., Akiyama, M. J., Vu, V. D., Piotrowski, J. I., Ha, N. B., … Nguyen, M. H. (2014). Poor Sustained Virologic Response (SVR) in a Multicenter Real-Life Cohort of Chronic Hepatitis C (CHC) Patients Treated with Pegylated Interferon (PEG IFN) and Ribavirin (RBV) plus Telaprevir (TVR) or Boceprevir (BOC). HEPATOLOGY. WILEY-BLACKWELL.

POOR ADHERENCE TO HCV MEDICATION IN A MEDICAID POPULATION
Kim, Y. A., Nguyen, M., Richards, K. M., Wilson, J. P., & Rascati, K. L. (2014). POOR ADHERENCE TO HCV MEDICATION IN A MEDICAID POPULATION. VALUE IN HEALTH, 17(3), A277.

Letter: gender-associated cell-free microRNA profiles in non-alcoholic fatty liver disease
Chao, D., & Nguyen, M. H. (2014). Letter: gender-associated cell-free microRNA profiles in non-alcoholic fatty liver disease. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 39(9), 997–98.

Hepatocellular Carcinoma (HCC) Caused by Non-Viral Etiologies Is Associated with Higher Stage at Presentation
Wantuck, J., Ha, N., Ahmed, A., & Mindie Nguyen. (2012). Hepatocellular Carcinoma (HCC) Caused by Non-Viral Etiologies Is Associated with Higher Stage at Presentation. AMERICAN JOURNAL OF GASTROENTEROLOGY, 107, S189–S190.

Treatment Tolerability in Chronic Hepatitis C (CHC) Patients Treated with Pegylated Interferon (PEG IFN) and Ribavirin (RBV) Plus Telaprevir (TVR) versus Boceprevir (BOC)
Ha, N., Vo, K., Wantuck, J., Ahmed, A., & Mindie Nguyen. (2012). Treatment Tolerability in Chronic Hepatitis C (CHC) Patients Treated with Pegylated Interferon (PEG IFN) and Ribavirin (RBV) Plus Telaprevir (TVR) versus Boceprevir (BOC). AMERICAN JOURNAL OF GASTROENTEROLOGY, 107, S183–S184.

Maintenance of Complete Viral Suppression (CVS) with Tenofovir (TDF) Monotherapy Following CVS with Entecavir (ETV) plus TDF Combination in Patients with Prior ETV Partial Response
Chaung, K., Ha, N., Kin, K., Huy Trinh, Huy Nguyen, & Mindie Nguyen. (2012). Maintenance of Complete Viral Suppression (CVS) with Tenofovir (TDF) Monotherapy Following CVS with Entecavir (ETV) plus TDF Combination in Patients with Prior ETV Partial Response. AMERICAN JOURNAL OF GASTROENTEROLOGY, 107, S187.

Significantly Higher Long-Term Survival in Hepatocellular Carcinoma (HCC) Patients in the Post-MELD Era: A Population-Based Cohort Study
Wong, R., Devaki, P., Nguyen, L. H., Cheung, R., Cho, C., & Nguyen, M. H. (2013). Significantly Higher Long-Term Survival in Hepatocellular Carcinoma (HCC) Patients in the Post-MELD Era: A Population-Based Cohort Study. HEPATOLOGY, 58, 1232A–1233A.

Suboptimal Treatment Rates and Treatment Completion Rates of Chronic Hepatitis C Virus Therapy in Patients with Comorbidities: Analysis of a Large Real-World US Cohort
Nguyen, M. H., Brooks, L., & Livornese, R. C. (2013). Suboptimal Treatment Rates and Treatment Completion Rates of Chronic Hepatitis C Virus Therapy in Patients with Comorbidities: Analysis of a Large Real-World US Cohort. HEPATOLOGY, 58, 1194A–1195A.

Ethnic Disparity and Liver Transplantation (LT) Rates in Hepatocellular Carcinoma (HCC) Patients in the Recent Era (2009-2010): Results from the Surveillance, Epidemiology, and End Results (SEER) Cancer Registry
Wong, R., Devaki, P., Nguyen, L. H., Cheung, R., Ahmed, A., & Nguyen, M. H. (2013). Ethnic Disparity and Liver Transplantation (LT) Rates in Hepatocellular Carcinoma (HCC) Patients in the Recent Era (2009-2010): Results from the Surveillance, Epidemiology, and End Results (SEER) Cancer Registry. HEPATOLOGY, 58, 1191A–1192A.

Tenofovir (TDF) Monotherapy Rescue Therapy is Comparable to Tenofovir and Entecavir (ETV) Combination Rescue Therapy in ETV Partial Responders
Lu, L., Nguyen, V. G., Trinh, H. N., Li, J., & Nguyen, M. H. (2013). Tenofovir (TDF) Monotherapy Rescue Therapy is Comparable to Tenofovir and Entecavir (ETV) Combination Rescue Therapy in ETV Partial Responders. HEPATOLOGY. WILEY-BLACKWELL.

Significant Fibrosis Among Patients with Chronic Hepatitis B Infection and Only Normal Serum Alanine Transaminase Levels: A Systematic Review and Meta-Analysis
Chao, D. T., Ayoub, W., Lim, J. K., Nguyen, L. H., & Nguyen, M. H. (2013). Significant Fibrosis Among Patients with Chronic Hepatitis B Infection and Only Normal Serum Alanine Transaminase Levels: A Systematic Review and Meta-Analysis. HEPATOLOGY, 58, 646A.

Suboptimal Vaccination Rates for Hepatitis B Virus (HBV) among U. S. Adults at High Risk for HBV Infection in National Health and Nutrition Examination Survey (NHANES) from 2001-2010
Devaki, P., Wong, R., Nguyen, L. H., Nangia, S., Sinha, S., Marupakula, V., … Nguyen, M. H. (2013). Suboptimal Vaccination Rates for Hepatitis B Virus (HBV) among U. S. Adults at High Risk for HBV Infection in National Health and Nutrition Examination Survey (NHANES) from 2001-2010. HEPATOLOGY, 58, 611A–612A.

Changes in Hepatitis B (HBV) Vaccination Rates and Differences in Various General Demographics across National Health and Nutrition Examination Surveys (NHANES) from 1999-2010
Devaki, P., Nguyen, L. H., Wong, R., Sinha, S., Marupakula, V., Nangia, S., … Nguyen, M. H. (2013). Changes in Hepatitis B (HBV) Vaccination Rates and Differences in Various General Demographics across National Health and Nutrition Examination Surveys (NHANES) from 1999-2010. HEPATOLOGY, 58, 607A–608A.

Treatment Tolerability and Persistency Rate in Chronic Hepatitis C (CHC) Patients Treated with Pegylated Interferon (PEG IFN) and Ribavirin (RBV) plus Telaprevir (TVR) versus Boceprevir (BOC)
Vo, K., Akiyama, M., Ha, N., Vutien, P., Piotrowski, J., Wantuck, J., … Nguyen, M. (2013). Treatment Tolerability and Persistency Rate in Chronic Hepatitis C (CHC) Patients Treated with Pegylated Interferon (PEG IFN) and Ribavirin (RBV) plus Telaprevir (TVR) versus Boceprevir (BOC). AMERICAN JOURNAL OF GASTROENTEROLOGY. NATURE PUBLISHING GROUP.

LOW TREATMENT RATES AND SUBOPTIMAL TREATMENT COMPLETION RATES TO HEPATITIS C VIRUS (HCV) THERAPY: A REAL-WORLD ANALYSIS OF A LARGE US COHORT
Brooks, L. H., Schwebke, K., Livornese, R., Van Caster, K., & Nguyen, M. H. (2013). LOW TREATMENT RATES AND SUBOPTIMAL TREATMENT COMPLETION RATES TO HEPATITIS C VIRUS (HCV) THERAPY: A REAL-WORLD ANALYSIS OF A LARGE US COHORT. JOURNAL OF HEPATOLOGY, 58, S363.

Clinical Characteristics and Treatment in Asian and Non-Asians with Hepatocellular Carcinoma (HCC)
Wantuck, J. M., Ha, N. B., Ahmed, A., Yip, B., & Nguyen, M. H. (2012). Clinical Characteristics and Treatment in Asian and Non-Asians with Hepatocellular Carcinoma (HCC). HEPATOLOGY, 56, 465A.

Efficacy and Tolerability of Entecavir (ETV) after Liver Transplantation (LT) for Chronic Hepatitis B (CHB)
Kin, K., Nghiem Ha, Ayoub, W., Daugherty, T., Keeffe, E., Mindie Nguyen, & Aijaz, A. (2011). Efficacy and Tolerability of Entecavir (ETV) after Liver Transplantation (LT) for Chronic Hepatitis B (CHB). AMERICAN JOURNAL OF GASTROENTEROLOGY, 106, S107–S108.

The Importance of the Definition of Early Virological Response for Predicting Treatment Efficacy for Chronic Hepatitis C Reply
Nguyen, M., & Lam, K. (2011). The Importance of the Definition of Early Virological Response for Predicting Treatment Efficacy for Chronic Hepatitis C Reply. HEPATOLOGY, 53(4), 1403.

ALPHA-FETOPROTEIN AND DES-GAMMA CARBOXYPROTHROMBIN ARE INDEPENDENT PREDICTORS OF EARLY STAGE HEPATOCELLULAR CARCINOMA
Marrero, J., Schwartz, M. E., Nguyen, M. H., Befeler, A., Reddy, K. R., Roberts, L. R., … Feng, Z. (2009). ALPHA-FETOPROTEIN AND DES-GAMMA CARBOXYPROTHROMBIN ARE INDEPENDENT PREDICTORS OF EARLY STAGE HEPATOCELLULAR CARCINOMA. HEPATOLOGY, 50(4), 1091A–1092A.

Phase 2 validation of AFP, DCP and AFP-L3 in early stage hepatocellular carcinoma
Marrero, J. A., Llovet, J. M., Nguyen, M., Befeler, A., Roberts, L. R., Reddy, R. R., … Schwartz, M. (2008). Phase 2 validation of AFP, DCP and AFP-L3 in early stage hepatocellular carcinoma. CANCER BIOMARKERS, 4(3), 183.

Rationale and design of the Hepatocellular carcinoma Early Detection Strategy study: A multi-center longitudinal initiative of the National Cancer Institute's early Detection Research Network.
Borges, K. A., Dai, J., Parikh, N. D., Schwartz, M., Nguyen, M. H., Roberts, L. R., … Rajender Reddy, K. (2018). Rationale and design of the Hepatocellular carcinoma Early Detection Strategy study: A multi-center longitudinal initiative of the National Cancer Institute's early Detection Research Network. Contemporary Clinical Trials.

Hepatitis B virus reverse transcriptase mutation search engine for queries (HBVseq): an online database and program for sequence analysis and mutation discovery
Rhee, S. Y., Margeridon-Thermet, S., Liu, T. F., Nguyen, M. H., Kagan, R. M., & Shafer, R. W. (2010). Hepatitis B virus reverse transcriptase mutation search engine for queries (HBVseq): an online database and program for sequence analysis and mutation discovery. ANTIVIRAL THERAPY, 15(4), A107.

Combining hepatitis B core-related and surface antigens at end of nucleos(t)ide analogue treatment to predict off-therapy relapse risk.
Hsu, Y.-C., Nguyen, M. H., Mo, L.-R., Wu, M.-S., Yang, T.-H., Chen, C.-C., … Chang, C.-Y. (2018). Combining hepatitis B core-related and surface antigens at end of nucleos(t)ide analogue treatment to predict off-therapy relapse risk. Alimentary Pharmacology & Therapeutics.

Hepatitis B and Renal Function: A Matched Study Comparing Non-Hepatitis B, Untreated, Treated and Cirrhotic Hepatitis Patients.
Vu, V., Trinh, S., Le, A., Johnson, T., Hoang, J., Jeong, D., … Nguyen, M. H. (2018). Hepatitis B and Renal Function: A Matched Study Comparing Non-Hepatitis B, Untreated, Treated and Cirrhotic Hepatitis Patients. Liver International : Official Journal of the International Association for the Study of the Liver.

GALAD Score for Hepatocellular Carcinoma Detection in Comparison to Liver Ultrasound and Proposal of GALADUS Score.
Yang, J. D., Addissie, B. D., Mara, K. C., Harmsen, W. S., Dai, J., Zhang, N., … Roberts, L. R. (2018). GALAD Score for Hepatocellular Carcinoma Detection in Comparison to Liver Ultrasound and Proposal of GALADUS Score. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.

Sustained virologic response rates in patients with chronic hepatitis C genotype 6 treated with ledipasvir+sofosbuvir or sofosbuvir+velpatasvir.
Nguyen, E., Trinh, S., Trinh, H., Nguyen, H., Nguyen, K., Do, A., … Nguyen, M. H. (2018). Sustained virologic response rates in patients with chronic hepatitis C genotype 6 treated with ledipasvir+sofosbuvir or sofosbuvir+velpatasvir. Alimentary Pharmacology & Therapeutics.

Increasing Age and Comorbidities in a Population-based Study of Chronic Hepatitis B (CHB) Patients from 2007 to 2016 in Korea
Jun, D. W., Oh, H., Ahn, H. J., Kim, B. O., & Nguyen, M. H. (2018). Increasing Age and Comorbidities in a Population-based Study of Chronic Hepatitis B (CHB) Patients from 2007 to 2016 in Korea. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 33, 135.

Changing Landscape of Liver Cancer in California: A Glimpse Into the Future of Liver Cancer in the United States.
Han, S. S., Kelly, S. P., Li, Y., Yang, B., Nguyen, M., So, S., … Hsing, A. W. (2018). Changing Landscape of Liver Cancer in California: A Glimpse Into the Future of Liver Cancer in the United States. Journal of the National Cancer Institute.

High prevalence of significant histologic disease in patients with chronic hepatitis B (CHB) and normal ALT
Nguyen, M. H., Trinh, H. N., Garcia, R. T., Phan, J., Nguyen, G. H., Weiss, G., … Keeffe, E. B. (2007). High prevalence of significant histologic disease in patients with chronic hepatitis B (CHB) and normal ALT. HEPATOLOGY. JOHN WILEY & SONS INC.

Very high prevalence of precore (preC) and/or basal core promoter (BCP) mutations (MUT) in HBeAg-positive (eAg plus ) and negative (eAg-) chronic hepatitis B (CHB) especially among older patients
Nguyen, M. H., Trinh, H. N., Garcia, R. T., Phan, J., Nguyen, G. H., Nguyen, K., … Keeffe, E. B. (2007). Very high prevalence of precore (preC) and/or basal core promoter (BCP) mutations (MUT) in HBeAg-positive (eAg plus ) and negative (eAg-) chronic hepatitis B (CHB) especially among older patients. HEPATOLOGY. JOHN WILEY & SONS INC.

Life-threatening hepatic failure associated with entecavir resistance mutations 1269I/T and T184L two years after discontinuation of lamivudine
Morgan, M. E., Ayoub, W., Ahmed, A., Keeffe, E. B., & Nguyen, M. H. (2007). Life-threatening hepatic failure associated with entecavir resistance mutations 1269I/T and T184L two years after discontinuation of lamivudine. AMERICAN JOURNAL OF GASTROENTEROLOGY, 102, S322–S323.

Sensitivity and specificity of alpha-fetoprotein (AFP) in US patients with hepatitis C virus-related hepatocellular carcinoma (HCV/HCC).
Nguyen, M. H., Keeffe, E. B., & Wright, T. L. (2001). Sensitivity and specificity of alpha-fetoprotein (AFP) in US patients with hepatitis C virus-related hepatocellular carcinoma (HCV/HCC). HEPATOLOGY, 34(4), 663A.

Hip fracture risk in patients with cirrhosis: does diabetes mellitus matter?
Nguyen, M. H. (2019). Hip fracture risk in patients with cirrhosis: does diabetes mellitus matter? Hepatology (Baltimore, Md.).

Antiviral therapy and the development of osteopenia/osteoporosis among Asians with chronic hepatitis B.
Wei, M. T., Le, A. K., Chang, M. S., Hsu, H., Nguyen, P., Zhang, J. Q., … Nguyen, M. H. (2019). Antiviral therapy and the development of osteopenia/osteoporosis among Asians with chronic hepatitis B. Journal of Medical Virology.

Pathologic Response to Pretransplant Locoregional Therapy is Predictive of Patient Outcome After Liver Transplantation for Hepatocellular Carcinoma: Analysis From the US Multicenter HCC Transplant Consortium.
DiNorcia, J., Florman, S. S., Haydel, B., Tabrizian, P., Ruiz, R. M., Klintmalm, G. B., … Agopian, V. G. (2019). Pathologic Response to Pretransplant Locoregional Therapy is Predictive of Patient Outcome After Liver Transplantation for Hepatocellular Carcinoma: Analysis From the US Multicenter HCC Transplant Consortium. Annals of Surgery.

Correction to: Hospital Cirrhosis Volume and Readmission in Patients with Cirrhosis in California.
Wei, M., Ford, J., Li, Q., Jeong, D., Kwong, A. J., Nguyen, M. H., & Chang, M. S. (2019). Correction to: Hospital Cirrhosis Volume and Readmission in Patients with Cirrhosis in California. Digestive Diseases and Sciences.

Real-world rates of hepatitis B surface antigen seroclearance in patients with chronic hepatitis B: a systematic review, conventional aggregated data meta-analysis and individual patient data meta-analysis
Yeo, Y. H., Ho, H. J., Yang, H.-I., Tseng, T.-C., Kwak, M.-S., Park, Y. M., … Nguyen, M. (2018). Real-world rates of hepatitis B surface antigen seroclearance in patients with chronic hepatitis B: a systematic review, conventional aggregated data meta-analysis and individual patient data meta-analysis. JOURNAL OF HEPATOLOGY, 68, S478–S479.

Effective hepatitis B vaccination by serologic results in the United States: a population-based study from 1999-2016
Le, M. H., Lee, D. H., Lee, M.-H., Gane, E., So, S., & Nguyen, M. (2018). Effective hepatitis B vaccination by serologic results in the United States: a population-based study from 1999-2016. JOURNAL OF HEPATOLOGY, 68, S480.

Suboptimal rates of effective hepatitis B vaccination in adults at high risk of infection in the United States from 1999-2014
Le, M. H., Lee, D. H., Lee, M.-H., Gane, E., So, S., & Nguyen, M. (2018). Suboptimal rates of effective hepatitis B vaccination in adults at high risk of infection in the United States from 1999-2014. JOURNAL OF HEPATOLOGY, 68, S480–S481.

A risk score combining quantitative hepatitis B surface antigen and core-related antigen levels to predict off-therapy relapse after cessation of nucleos(t)ide analogues in patients with chronic hepatitis B
Hsu, Y.-C., Tanaka, Y., Nguyen, M., Chang, C.-Y., Tai, C.-M., Tseng, C.-H., … Lin, J.-T. (2018). A risk score combining quantitative hepatitis B surface antigen and core-related antigen levels to predict off-therapy relapse after cessation of nucleos(t)ide analogues in patients with chronic hepatitis B. JOURNAL OF HEPATOLOGY, 68, S498.

Changes in serum levels of the novel mac-2 binding protein glycosylation isomer and risk of hepatocellular carcinoma among chronic hepatitis B patients treated with nucleos(t)ide analogues
Hsu, Y.-C., Jun, T., Yeh, M.-L., Huang, Y.-T., Yu, M.-L., Nguyen, M., & Tanaka, Y. (2018). Changes in serum levels of the novel mac-2 binding protein glycosylation isomer and risk of hepatocellular carcinoma among chronic hepatitis B patients treated with nucleos(t)ide analogues. JOURNAL OF HEPATOLOGY, 68, S496–S498.

Men have higher mortality in cirrhosis: outcomes by gender and etiology in a large, diverse cohort
Yeluru, A., Le, M. H., Zhao, C., Nguyen, P., Trinh, S., Le, H., … Nguyen, M. (2018). Men have higher mortality in cirrhosis: outcomes by gender and etiology in a large, diverse cohort. JOURNAL OF HEPATOLOGY, 68, S709–S710.

The time trend of proportion and mortality rate of admissions associated with acute respiratory illness in cirrhotic patients with diverse ethnicityand socioeconomic status: an analysis on the US National Inpatient Sample
Zou, B., Yeo, Y. H., Jeong, D., Sheen, E., Park, H., Lee, D. H., … Nguyen, M. (2018). The time trend of proportion and mortality rate of admissions associated with acute respiratory illness in cirrhotic patients with diverse ethnicityand socioeconomic status: an analysis on the US National Inpatient Sample. JOURNAL OF HEPATOLOGY, 68, S146.

Sustained virologic response (SVR) to direct-acting antiviral (DAA) therapy in patients with chronic hepatitis C virus (HCV) infection and hepatocellular carcinoma (HCC): a systematic review and meta-analysis
Ji, F., Wei, M. T., Yeo, Y. H., Wei, B., Ogawa, E., Lee, D. H., … Nguyen, M. (2018). Sustained virologic response (SVR) to direct-acting antiviral (DAA) therapy in patients with chronic hepatitis C virus (HCV) infection and hepatocellular carcinoma (HCC): a systematic review and meta-analysis. JOURNAL OF HEPATOLOGY, 68, S259–S260.

Treatment of chronic hepatitis B and renal impairment in patients with and without cirrhosis
Vu, V., Trinh, S., Le, A., Johnson, T., Hoang, J., Jeong, D., … Nguyen, M. (2018). Treatment of chronic hepatitis B and renal impairment in patients with and without cirrhosis. JOURNAL OF HEPATOLOGY, 68, S511–S512.

Sustained virologic response rates (SVR-12) for chronic hepatitis C genotype 6 patients treated with Ledipasvir/Sofosbuvir or Sofosbuvir/Velpatasvir
Nguyen, E., Trinh, S., Trinh, H., Nguyen, H., Nguyen, K., Levitt, B., … Nguyen, M. (2018). Sustained virologic response rates (SVR-12) for chronic hepatitis C genotype 6 patients treated with Ledipasvir/Sofosbuvir or Sofosbuvir/Velpatasvir. JOURNAL OF HEPATOLOGY, 68, S284–S285.

The time trend of hospital admissions, inpatient mortality rate, and hospital cost of hospitalizations associated with cirrhosis in the United States: an analysis on the National Inpatient Sample
Zou, B., Yeo, Y. H., Jeong, D., Sheen, E., Park, H., Lee, D. H., … Nguyen, M. (2018). The time trend of hospital admissions, inpatient mortality rate, and hospital cost of hospitalizations associated with cirrhosis in the United States: an analysis on the National Inpatient Sample. JOURNAL OF HEPATOLOGY, 68, S733.

Clinical presentation and survival of Asian and non-Asian patients with HBV-related hepatocellular carcinoma (HBV-HCC): Results of 767 United States patients with long-term follow-up
Hoang, J., Nguyen, P., Leong, J., Yang, J., Le, A., Roberts, L., … Nguyen, M. (2018). Clinical presentation and survival of Asian and non-Asian patients with HBV-related hepatocellular carcinoma (HBV-HCC): Results of 767 United States patients with long-term follow-up. JOURNAL OF HEPATOLOGY, 68, S443.

Performance of Wisteria floribunda agglutinin-positive Mac2-binding protein as an HCC biomarker in an ethnically diverse cohort of patients with chronic HBV and HCV
Jun, T., Yu, M.-L., Hsu, Y.-C., Tanaka, Y., & Nguyen, M. (2018). Performance of Wisteria floribunda agglutinin-positive Mac2-binding protein as an HCC biomarker in an ethnically diverse cohort of patients with chronic HBV and HCV. JOURNAL OF HEPATOLOGY, 68, S439.

Estimated the number of undiagnosed patients and antiviral treatment rate of chronic hepatitis B in the US based on the Truven Health MarketScan Database
Ogawa, E., Jeong, D., Yeo, Y. H., & Nguyen, M. (2018). Estimated the number of undiagnosed patients and antiviral treatment rate of chronic hepatitis B in the US based on the Truven Health MarketScan Database. JOURNAL OF HEPATOLOGY, 68, S481–S482.

Ethnic differences in HCV-related HCC outcomes: Report from the Real-world Evidence by the Asia Pacific Rim Liver Consortium for HCC (REAL-HCC)
Prasad, D., Nguyen, P., Guy, J., Yeh, M.-L., Leong, J., Yang, J., … Nguyen, M. (2018). Ethnic differences in HCV-related HCC outcomes: Report from the Real-world Evidence by the Asia Pacific Rim Liver Consortium for HCC (REAL-HCC). JOURNAL OF HEPATOLOGY, 68, S304–S305.

Adherence to AASLD treatment guidelines on treatment initiation among treatment-eligible patients with chronic hepatitis B: Experiences from primary care and referral practices
Nguyen, V. H., Le, A., Chung, M., Johnson, T., Levitt, B., Nguyen, H., … Nguyen, M. (2018). Adherence to AASLD treatment guidelines on treatment initiation among treatment-eligible patients with chronic hepatitis B: Experiences from primary care and referral practices. JOURNAL OF HEPATOLOGY, 68, S505–S506.

Renal outcomes in chronic hepatitis b patients treated with tenofovir disoproxil fumarate or entecavir: a propensity score matched study
Trinh, S., Le, A., Hoang, J., Jeong, D., Chung, M., Lee, M.-H., … Nguyen, M. (2018). Renal outcomes in chronic hepatitis b patients treated with tenofovir disoproxil fumarate or entecavir: a propensity score matched study. JOURNAL OF HEPATOLOGY, 68, S519–S520.

Soluble cytotoxic T-lymphocyte-associated antigen-4 and soluble programmed cell death protein-1 are predictive immune checkpoint seromarkers for spontaneous functional cure of chronic hepatitis B with opposite effects
Yang, H.-I., Hu, H.-H., Pan, M.-H., Luo, W.-S., Jeng, R. W.-J., Su, C.-Y., … Chen, C.-J. (2018). Soluble cytotoxic T-lymphocyte-associated antigen-4 and soluble programmed cell death protein-1 are predictive immune checkpoint seromarkers for spontaneous functional cure of chronic hepatitis B with opposite effects. JOURNAL OF HEPATOLOGY, 68, S476.

Validation of a clinical scoring system to predict risk of hepatocellular carcinoma in an ethnically diverse cohort of patients with chronic hepatitis C virus infection
Wei, M. T., Le, M. H., Le, A., Trinh, H. N., Wong, G., Landis, C., … Nguyen, M. (2018). Validation of a clinical scoring system to predict risk of hepatocellular carcinoma in an ethnically diverse cohort of patients with chronic hepatitis C virus infection. JOURNAL OF HEPATOLOGY, 68, S305–S306.

Validation of AASLD treatment guideline eligibility based on disease outcomes of large community and clinical cohorts of chronic hepatitis B patients
Lee, D. H., Le, A., Chung, M., Nguyen, V. H., Johnson, T., Ji, F., … Nguyen, M. (2018). Validation of AASLD treatment guideline eligibility based on disease outcomes of large community and clinical cohorts of chronic hepatitis B patients. JOURNAL OF HEPATOLOGY, 68, S503.

Using Wisteria floribunda agglutinin-positive Mac2-binding protein in combination with the FIB-4 index to predict significant liver fibrosis
Jun, T., Tanaka, Y., Hsu, Y.-C., Nguyen, M., & Yu, M.-L. (2018). Using Wisteria floribunda agglutinin-positive Mac2-binding protein in combination with the FIB-4 index to predict significant liver fibrosis. JOURNAL OF HEPATOLOGY, 68, S650–S651.

Higher in-hospital and post-discharge mortality and hospital charges in cirrhotic patients with acute respiratory illness in the United States
Zou, B., Yeo, Y. H., Jeong, D., Sheen, E., Park, H., Nguyen, P., … Nguyen, M. (2018). Higher in-hospital and post-discharge mortality and hospital charges in cirrhotic patients with acute respiratory illness in the United States. JOURNAL OF HEPATOLOGY, 68, S704–S705.

Is renal impairment associated with chronic hepatitis B - a propensity score matched study of healthy non-hepatitis B patients compared to patients with untreated chronic hepatitis B
Vu, V., Trinh, S., Le, A., Johnson, T., Hoang, J., Jeong, D., … Nguyen, M. (2018). Is renal impairment associated with chronic hepatitis B - a propensity score matched study of healthy non-hepatitis B patients compared to patients with untreated chronic hepatitis B. JOURNAL OF HEPATOLOGY, 68, S512–S513.

Mac-2 Binding Protein Glycosylation Isomer as a Hepatocellular Carcinoma Marker in Patients With Chronic Hepatitis B or C Infection
Jun, T., Hsu, Y.-C., Ogawa, S., Huang, Y.-T., Yeh, M.-L., Tseng, C.-H., … Nguyen, M. H. (2019). Mac-2 Binding Protein Glycosylation Isomer as a Hepatocellular Carcinoma Marker in Patients With Chronic Hepatitis B or C Infection. HEPATOLOGY COMMUNICATIONS, 3(4), 493–503.

Entecavir safety and effectiveness in a national cohort of treatment-naïve chronic hepatitis B patients in the US - the ENUMERATE study.
Ahn, J., Lee, H. M., Lim, J. K., Pan, C. Q., Nguyen, M. H., Ray Kim, W., … Lok, A. S. (2016). Entecavir safety and effectiveness in a national cohort of treatment-naïve chronic hepatitis B patients in the US - the ENUMERATE study. Alimentary Pharmacology & Therapeutics, 43(1), 134–44.

Racial/ethnic- and county-specific prevalence of chronic hepatitis B and its burden in California.
Toy, M., Wei, B., Virdi, T. S., Le, A., Trinh, H., Li, J., … Nguyen, M. H. (2018). Racial/ethnic- and county-specific prevalence of chronic hepatitis B and its burden in California. Hepatology, Medicine and Policy, 3, 6.

Mac-2 Binding Protein Glycosylation Isomer as a Hepatocellular Carcinoma Marker in Patients With Chronic Hepatitis B or C Infection.
Jun, T., Hsu, Y.-C. C., Ogawa, S., Huang, Y.-T. T., Yeh, M.-L. L., Tseng, C.-H. H., … Nguyen, M. H. (2019). Mac-2 Binding Protein Glycosylation Isomer as a Hepatocellular Carcinoma Marker in Patients With Chronic Hepatitis B or C Infection. Hepatology Communications, 3(4), 493–503.

Treatment Outcomes With First-line Therapies With Entecavir and Tenofovir in Treatment-Naive Chronic Hepatitis B Patients in a Routine Clinical Practice.
Ha, N. B., Trinh, H. N., Rosenblatt, L., Nghiem, D., & Nguyen, M. H. (2016). Treatment Outcomes With First-line Therapies With Entecavir and Tenofovir in Treatment-Naive Chronic Hepatitis B Patients in a Routine Clinical Practice. Journal of Clinical Gastroenterology, 50(2), 169–74.

Reduced Hepatocellular Carcinoma Risk vs Bleeding Risk Associated With Aspirin.
Chien, N., Yeo, Y. H., & Nguyen, M. H. (2019). Reduced Hepatocellular Carcinoma Risk vs Bleeding Risk Associated With Aspirin. JAMA Oncology.

Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis
Li, J., Zou, B., Yeo, Y. H., Feng, Y., Xie, X., Lee, D. H., … Nguyen, M. H. (2019). Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis. LANCET GASTROENTEROLOGY & HEPATOLOGY, 4(5), 389–98.

Red blood cell distribution width to albumin ratio as a novel prognostic indicator for patients with chronic hepatitis B-related liver cirrhosis
Huang, R., Wang, J., Henry, L., Zhang, Z., Zhu, C., Nguyen, M., & Wu, C. (2019). Red blood cell distribution width to albumin ratio as a novel prognostic indicator for patients with chronic hepatitis B-related liver cirrhosis. JOURNAL OF HEPATOLOGY, 70, E694–E695.

Tenofovir disoproxil fumarate treatment in chronic hepatitis B patients with cirrhosis reduces hepatic decompensation, hepatocellular carcinoma and death
Liu, K., Choi, J., Le, A., Wong, V. W.-S., Chan, S. L., Nguyen, M., … Wong, G. L.-H. (2019). Tenofovir disoproxil fumarate treatment in chronic hepatitis B patients with cirrhosis reduces hepatic decompensation, hepatocellular carcinoma and death. JOURNAL OF HEPATOLOGY, 70, E475.

Long-term renal and bone safety of tenofovir disoproxil fumarate in chronic hepatitis B patients with cirrhosis
Liu, K., Choi, J., Le, A., Wong, V. W.-S., Chan, S. L., Nguyen, M., … Wong, G. L.-H. (2019). Long-term renal and bone safety of tenofovir disoproxil fumarate in chronic hepatitis B patients with cirrhosis. JOURNAL OF HEPATOLOGY, 70, E475–E476.

Prognostic value of various liver scoring systems in cirrhotic chronic hepatitis B patients with and without tenofovir disoproxil fumarate treatment
Choi, J., Liu, K., Le, A., Wong, V. W.-S., Chan, S. L., Nguyen, M., … Wong, G. L.-H. (2019). Prognostic value of various liver scoring systems in cirrhotic chronic hepatitis B patients with and without tenofovir disoproxil fumarate treatment. JOURNAL OF HEPATOLOGY, 70, E461.

Hepatitis B and renal function: A matched study comparing non-hepatitis B, untreated, treated and cirrhotic hepatitis patients
Vinh Vu, Trinh, S., An Le, Johnson, T., Hoang, J., Jeong, D., … Nguyen, M. H. (2019). Hepatitis B and renal function: A matched study comparing non-hepatitis B, untreated, treated and cirrhotic hepatitis patients. LIVER INTERNATIONAL, 39(4), 655–66.

Clinical Features Associated with Survival Outcome in African-American Patients with Hepatocellular Carcinoma
Estevez, J., Yang, J. D., Leong, J., Nguyen, P., Giama, N. H., Zhang, N., … Nguyen, M. H. (2019). Clinical Features Associated with Survival Outcome in African-American Patients with Hepatocellular Carcinoma. AMERICAN JOURNAL OF GASTROENTEROLOGY, 114(1), 80–88.

GALAD Score for Hepatocellular Carcinoma Detection in Comparison with Liver Ultrasound and Proposal of GALADUS Score
Yang, J. D., Addissie, B. D., Mara, K. C., Harmsen, W. S., Dai, J., Zhang, N., … Roberts, L. R. (2019). GALAD Score for Hepatocellular Carcinoma Detection in Comparison with Liver Ultrasound and Proposal of GALADUS Score. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 28(3), 531–38.

Rationale and design of the Hepatocellular carcinoma Early Detection Strategy study: A multi-center longitudinal initiative of the National Cancer Institute's Early Detection Research Network
Borges, K. A., Dai, J., Parikh, N. D., Schwartz, M., Nguyen, M. H., Roberts, L. R., … Reddy, K. R. (2019). Rationale and design of the Hepatocellular carcinoma Early Detection Strategy study: A multi-center longitudinal initiative of the National Cancer Institute's Early Detection Research Network. CONTEMPORARY CLINICAL TRIALS, 76, 49–54.

Prevalence of Undetectable Vaccine-Induced Immunity Against Hepatitis B Virus in US Adults at High Risk for Infection
Yeo, Y. H., Le, M. H., Chang, E. T., Henry, L., & Nguyen, M. H. (2019). Prevalence of Undetectable Vaccine-Induced Immunity Against Hepatitis B Virus in US Adults at High Risk for Infection. HEPATOLOGY, 69(4), 1385–97.

Hospital Cirrhosis Volume and Readmission in Patients with Cirrhosis in California (vol 63, pg 2267, 2018)
Wei, M., Ford, J., Li, Q., Jeong, D., Kwong, A. J., Nguyen, M. H., & Chang, M. S. (2019). Hospital Cirrhosis Volume and Readmission in Patients with Cirrhosis in California (vol 63, pg 2267, 2018). DIGESTIVE DISEASES AND SCIENCES, 64(5), 1392–94.

Healthcare resource utilization and costs by disease severity in an insured national sample of US patients with chronic hepatitis B
Nguyen, M. H., Ozbay, A. B., Liou, I., Meyer, N., Gordon, S. C., Dusheiko, G., & Lim, J. K. (2019). Healthcare resource utilization and costs by disease severity in an insured national sample of US patients with chronic hepatitis B. JOURNAL OF HEPATOLOGY, 70(1), 24–32.

A Comparison Between Community and Academic Practices in the USA in the Management of Chronic Hepatitis B Patients Receiving Entecavir: Results of the ENUMERATE Study
Lee, H. M., Ahn, J., Kim, W. R., Lim, J. K., Nguyen, M., Pan, C. Q., … Lok, A. S. (2019). A Comparison Between Community and Academic Practices in the USA in the Management of Chronic Hepatitis B Patients Receiving Entecavir: Results of the ENUMERATE Study. DIGESTIVE DISEASES AND SCIENCES, 64(2), 358–66.

Reply.
Yeo, Y. H., & Nguyen, M. H. (2019). Reply. Gastroenterology.

Reply to LTE 19-00352.
Yeo, Y. H., & Nguyen, M. H. (2019). Reply to LTE 19-00352. Gastroenterology.

Patient-Reported Outcomes in Patients Chronic Viral Hepatitis without Cirrhosis: The Impact of Hepatitis B and C Viral Replication.
Younossi, Z. M., Stepanova, M., Younossi, I., Papatheodoridis, G., Janssen, H. L., Agarwal, K., … Nader, F. (2019). Patient-Reported Outcomes in Patients Chronic Viral Hepatitis without Cirrhosis: The Impact of Hepatitis B and C Viral Replication. Liver International : Official Journal of the International Association for the Study of the Liver.

Genetic analysis reveals functions of atypical polyubiquitin chains
Gutierrez, F. M., Simsek, D., Mizrak, A., Deutschbauer, A., Braberg, H., Johnson, J., … Toczyski, D. P. (2018). Genetic analysis reveals functions of atypical polyubiquitin chains. ELIFE, 7.

Multiplexed precision genome editing with trackable genomic barcodes in yeast
Roy, K. R., Smith, J. D., Vonesch, S. C., Lin, G., Tu, C. S., Lederer, A. R., … Steinmetz, L. M. (2018). Multiplexed precision genome editing with trackable genomic barcodes in yeast. NATURE BIOTECHNOLOGY, 36(6), 512-+.

Temporal Trends in Disease Presentation and Survival of Patients With Hepatocellular Carcinoma: A Real-World Experience From 1998 to 2015
Kim, N. G., Nguyen, P. P., Dang, H., Kumari, R., Garcia, G., Esquivel, C. O., & Nguyen, M. H. (2018). Temporal Trends in Disease Presentation and Survival of Patients With Hepatocellular Carcinoma: A Real-World Experience From 1998 to 2015. CANCER, 124(12), 2588–98.

Deferred treatment with a fixed-dose combination of sofosbuvir-velpatasvir for chronic hepatitis C virus genotype 1, 2, 4, and 6 infection.
Asselah, T., Shafran, S. D., Bourgeois, S., Lai, C.-L., Mathurin, P., Willems, B., … Tran, T. T. (2019). Deferred treatment with a fixed-dose combination of sofosbuvir-velpatasvir for chronic hepatitis C virus genotype 1, 2, 4, and 6 infection. Journal of Viral Hepatitis.

Chronic hepatitis B prevalence among foreign-born and US-born adults in the United States, 1999-2016.
Le, M. H., Yeo, Y. H., Cheung, R., Henry, L., Lok, A. S., & Nguyen, M. H. (2019). Chronic hepatitis B prevalence among foreign-born and US-born adults in the United States, 1999-2016. Hepatology (Baltimore, Md.).

Comparison of renal safety of tenofovir and entecavir in patients with chronic hepatitis B: Systematic review with meta-analysis.
Lee, H.-Y. Y., Oh, H., Park, C.-H. H., Yeo, Y.-H. H., Nguyen, M. H., & Jun, D.-W. W. (2019). Comparison of renal safety of tenofovir and entecavir in patients with chronic hepatitis B: Systematic review with meta-analysis. World Journal of Gastroenterology, 25(23), 2961–72.

Antiviral therapy and the development of osteopenia/osteoporosis among Asians with chronic hepatitis Bn
Wei, M. T., Le, A. K., Chang, M. S., Hsu, H., Nguyen, P., Zhang, J. Q., … Nguyen, M. H. (2019). Antiviral therapy and the development of osteopenia/osteoporosis among Asians with chronic hepatitis Bn. JOURNAL OF MEDICAL VIROLOGY, 91(7), 1288–94.

Poor Adherence to Guidelines for Treatment of Chronic Hepatitis B Virus Infection at Primary Care and Referral Practices
Nguyen, V. H., Le, A. K., Trinh, H. N., Chung, M., Johnson, T., Wong, C., … Nguyen, M. H. (2019). Poor Adherence to Guidelines for Treatment of Chronic Hepatitis B Virus Infection at Primary Care and Referral Practices. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 17(5), 957-+.

Sustained virologic response rates in patients with chronic hepatitis C genotype 6 treated with ledipasvir plus sofosbuvir or sofosbuvir plus velpatasvir
Nguyen, E., Trinh, S., Huy Trinh, Huy Nguyen, Khanh Nguyen, Do, A., … Nguyen, M. H. (2019). Sustained virologic response rates in patients with chronic hepatitis C genotype 6 treated with ledipasvir plus sofosbuvir or sofosbuvir plus velpatasvir. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 49(1), 99–106.

Changing Landscape of Liver Cancer in California: A Glimpse Into the Future of Liver Cancer in the United States
Han, S. S., Kelly, S. P., Li, Y., Yang, B., Nguyen, M., So, S., … Hsing, A. W. (2019). Changing Landscape of Liver Cancer in California: A Glimpse Into the Future of Liver Cancer in the United States. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 111(6), 550–56.

Reduced Hepatocellular Carcinoma Risk vs Bleeding Risk Associated With Aspirin
Chien, N., Yeo, Y. H., & Nguyen, M. H. (2019). Reduced Hepatocellular Carcinoma Risk vs Bleeding Risk Associated With Aspirin. JAMA ONCOLOGY, 5(6), 911.

Rising Inpatient Encounters and Economic Burden for Patients with Nonalcoholic Fatty Liver Disease in the USA
Nguyen, A. L., Park, H., Nguyen, P., Sheen, E., Kim, Y. A., & Nguyen, M. H. (2019). Rising Inpatient Encounters and Economic Burden for Patients with Nonalcoholic Fatty Liver Disease in the USA. DIGESTIVE DISEASES AND SCIENCES, 64(3), 698–707.

Higher mortality and hospital charges in patients with cirrhosis and acute respiratory illness: a population-based study
Zou, B., Yeo, Y. H., Jeong, D., Sheen, E., Park, H., Nguyen, P., … Nguyen, M. H. (2018). Higher mortality and hospital charges in patients with cirrhosis and acute respiratory illness: a population-based study. SCIENTIFIC REPORTS, 8.

More advanced disease and worse survival in cryptogenic compared to viral hepatocellular carcinoma
Jun, T. W., Yeh, M.-L., Yang, J. D., Chen, V. L., Nguyen, P., Giama, N. H., … Nguyen, M. H. (2018). More advanced disease and worse survival in cryptogenic compared to viral hepatocellular carcinoma. LIVER INTERNATIONAL, 38(5), 895–902.

Factors Associated With Rates of HBsAg Seroclearance in Adults With Chronic HBV Infection: A Systematic Review and Meta-analysis
Yeo, Y. H., Ho, H. J., Yang, H.-I., Tseng, T.-C., Hosaka, T., Trinh, H. N., … Nguyen, M. H. (2019). Factors Associated With Rates of HBsAg Seroclearance in Adults With Chronic HBV Infection: A Systematic Review and Meta-analysis. GASTROENTEROLOGY, 156(3), 635-+.

Nonalcoholic fatty liver disease increases risk of incident advanced chronic kidney disease: A propensity-matched cohort study.
Park, H., Dawwas, G. K., Liu, X., & Nguyen, M. H. (2019). Nonalcoholic fatty liver disease increases risk of incident advanced chronic kidney disease: A propensity-matched cohort study. Journal of Internal Medicine.

Advancing Age and Comorbidity in a US Insured Population-Based Cohort of Patients With Chronic Hepatitis B
Nguyen, M. H., Lim, J. K., Ozbay, A. B., Fraysse, J., Liou, I., Meyer, N., … Gordon, S. C. (2019). Advancing Age and Comorbidity in a US Insured Population-Based Cohort of Patients With Chronic Hepatitis B. HEPATOLOGY, 69(3), 959–73.

Combining hepatitis B core-related and surface antigens at end of nucleos(t)ide analogue treatment to predict off-therapy relapse risk
Hsu, Y.-C., Nguyen, M. H., Mo, L.-R., Wu, M.-S., Yang, T.-H., Chen, C.-C., … Chang, C.-Y. (2019). Combining hepatitis B core-related and surface antigens at end of nucleos(t)ide analogue treatment to predict off-therapy relapse risk. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 49(1), 107–15.

Individual surveillance using model-based hepatocellular carcinoma risk estimates in chronic hepatitis C patients after antiviral treatment
Ji, F., Yeo, Y. H., He, C., Li, J., Gao, X., Li, Z., … Nguyen, M. H. (2019). Individual surveillance using model-based hepatocellular carcinoma risk estimates in chronic hepatitis C patients after antiviral treatment. JOURNAL OF HEPATOLOGY, 70(1), 209–11.

Serum M2BPGi level and risk of hepatocellular carcinoma after oral anti-viral therapy in patients with chronic hepatitis B
Hsu, Y.-C., Jun, T., Huang, Y.-T., Yeh, M.-L., Lee, C.-L., Ogawa, S., … Tanaka, Y. (2018). Serum M2BPGi level and risk of hepatocellular carcinoma after oral anti-viral therapy in patients with chronic hepatitis B. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 48(10), 1128–37.

Systematic review and meta-analysis: real-world effectiveness of direct-acting antiviral therapies in chronic hepatitis C genotype 3 in Asia
Wei, B., Ji, F., Yeo, Y. H., Ogawa, E., Stave, C. D., Dang, S., … Nguyen, M. H. (2018). Systematic review and meta-analysis: real-world effectiveness of direct-acting antiviral therapies in chronic hepatitis C genotype 3 in Asia. BMJ OPEN GASTROENTEROLOGY, 5(1).

Hospital Cirrhosis Volume and Readmission in Patients with Cirrhosis in California
Wei, M., Ford, J., Li, Q., Jeong, D., Kwong, A. J., Nguyen, M. H., & Chang, M. S. (2018). Hospital Cirrhosis Volume and Readmission in Patients with Cirrhosis in California. DIGESTIVE DISEASES AND SCIENCES, 63(9), 2267–74.

Changes in Renal Function in Patients With Chronic HBV Infection Treated With Tenofovir Disoproxil Fumarate vs Entecavir
Trinh, S., Le, A. K., Chang, E. T., Hoang, J., Jeong, D., Chung, M., … Nguyen, M. H. (2019). Changes in Renal Function in Patients With Chronic HBV Infection Treated With Tenofovir Disoproxil Fumarate vs Entecavir. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 17(5), 948-+.

Disparities in hepatocellular carcinoma incidence by race/ethnicity and geographic area in California: Implications for prevention
Yang, B., Liu, J. B., So, S. K., Han, S. S., Wang, S. S., Hertz, A., … Hsing, A. W. (2018). Disparities in hepatocellular carcinoma incidence by race/ethnicity and geographic area in California: Implications for prevention. CANCER, 124(17), 3551–59.

Barriers to care for chronic hepatitis C in the direct-acting antiviral era: a single-centre experience
Peter Nguyen, Vutien, P., Hoang, J., Trinh, S., Le, A., Yasukawa, L. A., … Nguyen, M. H. (2017). Barriers to care for chronic hepatitis C in the direct-acting antiviral era: a single-centre experience. BMJ OPEN GASTROENTEROLOGY, 4(1).

Real-world effectiveness of sofosbuvir plus ribavirin for chronic hepatitis C genotype 2 in Asia: a systematic review and meta-analysis
Wei, B., Ji, F., Yeo, Y. H., Ogawa, E., Zou, B., Stave, C. D., … Nguyen, M. H. (2018). Real-world effectiveness of sofosbuvir plus ribavirin for chronic hepatitis C genotype 2 in Asia: a systematic review and meta-analysis. BMJ OPEN GASTROENTEROLOGY, 5(1).

Reduced Incidence of Hepatocellular Carcinoma in Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis B Treated With Tenofovir-A Propensity Score-Matched Study
Nguyen, M. H., Yang, H.-I., Le, A., Henry, L., Nguyen, N., Lee, M.-H., … Huy Trinh. (2019). Reduced Incidence of Hepatocellular Carcinoma in Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis B Treated With Tenofovir-A Propensity Score-Matched Study. JOURNAL OF INFECTIOUS DISEASES, 219(1), 10–18.

Editorial: the durability of seroconversion of hepatitis B e antigen in the treatment of chronic hepatitis B with PEG-interferon alfa-2a
Wei, M. T., & Nguyen, M. H. (2018). Editorial: the durability of seroconversion of hepatitis B e antigen in the treatment of chronic hepatitis B with PEG-interferon alfa-2a. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 47(11), 1556–57.

Author response to "Cryptogenic hepatocellular carcinoma (HCC) had worse overall survival of disease than viral HCC patients"
Jun, T. W., Nguyen, M. H., & Yu, M.-L. (2018). Author response to "Cryptogenic hepatocellular carcinoma (HCC) had worse overall survival of disease than viral HCC patients". LIVER INTERNATIONAL, 38(6), 1141.

Autoantibodies in chronic hepatitis C virus infection: impact on clinical outcomes and extrahepatic manifestations
Gilman, A. J., Le, A. K., Zhao, C., Hoang, J., Yasukawa, L. A., Weber, S. C., … Nguyen, M. H. (2018). Autoantibodies in chronic hepatitis C virus infection: impact on clinical outcomes and extrahepatic manifestations. BMJ OPEN GASTROENTEROLOGY, 5(1).

Ezetimibe decreased nonalcoholic fatty liver disease activity score but not hepatic steatosis
Lee, H. Y., Jun, D. W., Kim, H. J., Oh, H., Saeed, W. K., Ahn, H., … Nguyen, M. H. (2019). Ezetimibe decreased nonalcoholic fatty liver disease activity score but not hepatic steatosis. KOREAN JOURNAL OF INTERNAL MEDICINE, 34(2), 296-+.

Prevalence of NAFLD in China: What Did We Learn From the Recent Meta-Analysis?
Wu, Y., Yeo, Y. H., Nguyen, M. H., & Cheung, R. C. (2019). Prevalence of NAFLD in China: What Did We Learn From the Recent Meta-Analysis? Hepatology (Baltimore, Md.).

Associations Between Body Fat, Muscle Mass, and Nonalcoholic Fatty Liver Disease: A Population-Based Study.
Hsing, J. C., Nguyen, M. H., Yang, B., Min, Y., Han, S. S., Pung, E., … Wang, C. J. (2019). Associations Between Body Fat, Muscle Mass, and Nonalcoholic Fatty Liver Disease: A Population-Based Study. Hepatology Communications, 3(8), 1061–72.

Changing incidence of reported viral hepatitis in China from 2004 to 2016: an observational study.
Zhang, M., Wu, R., Xu, H., Uhanova, J., Gish, R., Wen, X., … Niu, J. (2019). Changing incidence of reported viral hepatitis in China from 2004 to 2016: an observational study. BMJ Open, 9(8), e028248.

Direct-acting antivirals in East Asian hepatitis C patients: real-world experience from the REAL-C Consortium.
Huang, C.-F. F., Iio, E., Jun, D. W., Ogawa, E., Toyoda, H., Hsu, Y.-C. C., … Nguyen, M. H. (2019). Direct-acting antivirals in East Asian hepatitis C patients: real-world experience from the REAL-C Consortium. Hepatology International.

Sustained virologic response to direct-acting antiviral therapy in patients with chronic hepatitis C and hepatocellular carcinoma: A systematic review and meta-analysis
Ji, F., Yeo, Y. H., Wei, M. T., Ogawa, E., Enomoto, M., Lee, D. H., … Nguyen, M. H. (2019). Sustained virologic response to direct-acting antiviral therapy in patients with chronic hepatitis C and hepatocellular carcinoma: A systematic review and meta-analysis. JOURNAL OF HEPATOLOGY, 71(3), 473–85.

Only one-third of hepatocellular carcinoma cases are diagnosed via screening or surveillance: a systematic review and meta-analysis.
Zhao, C., Xing, F., Yeo, Y. H., Jin, M., Le, R., Le, M., … Nguyen, M. H. (2019). Only one-third of hepatocellular carcinoma cases are diagnosed via screening or surveillance: a systematic review and meta-analysis. European Journal of Gastroenterology & Hepatology.

Low Alanine Aminotransferase Cut-Off for Predicting Liver Outcomes; A Nationwide Population-Based Longitudinal Cohort Study.
Park, J. H., Choi, J., Jun, D. W., Han, S. W., Yeo, Y. H., & Nguyen, M. H. (2019). Low Alanine Aminotransferase Cut-Off for Predicting Liver Outcomes; A Nationwide Population-Based Longitudinal Cohort Study. Journal of Clinical Medicine, 8(9).

Tenofovir disoproxil fumarate reduces hepatocellular carcinoma, decompensation and death in chronic hepatitis B patients with cirrhosis.
Liu, K., Choi, J., Le, A., Yip, T. C.-F., Wong, V. W.-S., Chan, S. L., … Wong, G. L.-H. (2019). Tenofovir disoproxil fumarate reduces hepatocellular carcinoma, decompensation and death in chronic hepatitis B patients with cirrhosis. Alimentary Pharmacology & Therapeutics.

Commentary: tenofovir is superior to entecavir in HBeAg-positive chronic hepatitis B patients - authors' reply
Yaghoobi, M., Yuan, Y., & Hunt, R. H. (2014). Commentary: tenofovir is superior to entecavir in HBeAg-positive chronic hepatitis B patients - authors' reply. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 39(9), 993.

REAL-B (Real-world Effectiveness from the Asia Pacific Rim Liver Consortium for HBV) Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated with Oral Antiviral Therapy.
Yang, H.-I. I., Yeh, M.-L. L., Wong, G. L., Peng, C.-Y. Y., Chen, C.-H. H., Trinh, H. N., … Nguyen, M. H. (2019). REAL-B (Real-world Effectiveness from the Asia Pacific Rim Liver Consortium for HBV) Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated with Oral Antiviral Therapy. The Journal of Infectious Diseases.

Prevalence of viremic HCV infection by age, race/ethnicity, birthplace and disease awareness among viremic persons in the U.S., 1999-2016.
Zou, B., Yeo, Y. H., Le, M. H., Henry, L., Chang, E. T., Lok, A. S., … Nguyen, M. H. (2019). Prevalence of viremic HCV infection by age, race/ethnicity, birthplace and disease awareness among viremic persons in the U.S., 1999-2016. The Journal of Infectious Diseases.

Chronic hepatitis B and NASH: Is "fat" all bad?
Li, J., Cheung, R. C., & Nguyen, M. H. (2019). Chronic hepatitis B and NASH: Is "fat" all bad? Hepatology (Baltimore, Md.).

Nonalcoholic Fatty Liver Disease and Renal Function Impairment: A Cross-Sectional Population-Based Study on Its Relationship From 1999 to 2016.
Le, M. H., Yeo, Y. H., Henry, L., & Nguyen, M. H. (2019). Nonalcoholic Fatty Liver Disease and Renal Function Impairment: A Cross-Sectional Population-Based Study on Its Relationship From 1999 to 2016. Hepatology Communications, 3(10), 1334–46.

A Nationwide Study of Inpatient Admissions, Mortality, and Costs for Patients with Cirrhosis from 2005 to 2015 in the USA.
Zou, B., Yeo, Y. H., Jeong, D., Park, H., Sheen, E., Lee, D. H., … Nguyen, M. H. (2019). A Nationwide Study of Inpatient Admissions, Mortality, and Costs for Patients with Cirrhosis from 2005 to 2015 in the USA. Digestive Diseases and Sciences.

Cure with Interferon Free DAA is Associated with Increased Survival in Patients with HCV related HCC from both East and West.
Dang, H., Yeo, Y. H., Yasuda, S., Huang, C.-F. F., Iio, E., Landis, C., … Nguyen, M. H. (2019). Cure with Interferon Free DAA is Associated with Increased Survival in Patients with HCV related HCC from both East and West. Hepatology (Baltimore, Md.).

Tenofovir Versus Entecavir for Hepatocellular Carcinoma Prevention in an International Consortium of Chronic Hepatitis B.
Hsu, Y.-C. C., Wong, G. L.-H., Chen, C.-H. H., Peng, C.-Y. Y., Yeh, M.-L. L., Cheung, K.-S. S., … Nguyen, M. H. (2019). Tenofovir Versus Entecavir for Hepatocellular Carcinoma Prevention in an International Consortium of Chronic Hepatitis B. The American Journal of Gastroenterology.

Nonliver Comorbidities in Patients With Chronic Hepatitis B.
Wei, M. T., Henry, L., & Nguyen, M. H. (2019). Nonliver Comorbidities in Patients With Chronic Hepatitis B. Clinical Liver Disease, 14(3), 126–30.

SUBSTANTIAL GAP IN ASSESSMENT AND TREATMENT OF CHRONIC HEPATITIS B (CHB) PATIENTS IN THE UNITED STATES: A NATIONWIDE STUDY OF 7,124 PATIENTS
Ye, Q., Yeo, Y. H., Dang, N., Kam, L., Cheung, R., & Nguyen, M. H. (2019). SUBSTANTIAL GAP IN ASSESSMENT AND TREATMENT OF CHRONIC HEPATITIS B (CHB) PATIENTS IN THE UNITED STATES: A NATIONWIDE STUDY OF 7,124 PATIENTS. HEPATOLOGY, 70, 566A.

INCREASING PREVALENCE AND ASSOCIATION BETWEEN SEVERITY OF RENAL INSUFFICIENCY WITH MORTALITY IN PERSONS WITH NAFLD, A UNITED STATES POPULATION-BASED STUDY
Le, M., Yeo, Y. H., Henry, L., Cheung, R., & Nguyen, M. H. (2019). INCREASING PREVALENCE AND ASSOCIATION BETWEEN SEVERITY OF RENAL INSUFFICIENCY WITH MORTALITY IN PERSONS WITH NAFLD, A UNITED STATES POPULATION-BASED STUDY. HEPATOLOGY, 70, 155A–156A.

REDEFINING THE UPPER LIMIT OR NORMAL (ULN) OF ALANINE TRANSAMINASE (ALT) LEVELS FOR ASIANS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF 60 STUDIES AND 335,163 INDIVIDUALS
Huang, D., Yeo, Y. H., Tan, X. X. E., Kam, L., Fung, J., Lee, T. Y., … Nguyen, M. H. (2019). REDEFINING THE UPPER LIMIT OR NORMAL (ULN) OF ALANINE TRANSAMINASE (ALT) LEVELS FOR ASIANS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF 60 STUDIES AND 335,163 INDIVIDUALS. HEPATOLOGY. WILEY.

IMPACT OF SVR ON LONG-TERM LIVER-RELATED OUTCOMES: RESULTS OF THE REAL-C REGISTRY AT 23 CENTERS FROM HONG KONG, KOREA, JAPAN AND TAIWAN
Tanaka, Y., Toyoda, H., Jun, D. W., Enomoto, M., Huang, C.-F., Ogawa, E., … Yoon, E. (2019). IMPACT OF SVR ON LONG-TERM LIVER-RELATED OUTCOMES: RESULTS OF THE REAL-C REGISTRY AT 23 CENTERS FROM HONG KONG, KOREA, JAPAN AND TAIWAN. HEPATOLOGY. WILEY.

THE IMPACT OF COEXISTING HEPATIC STEATOSIS (HS) ON DEVELOPMENT OF CIRRHOSIS,HEPATOCELLULAR CARCINOMA (HCC) DEVELOPMENT AND HBsAg SEROCLEARANCE IN PATIENTS WITH CHRONIC HEPATITIS B (CHB)
Li, J., Yang, H.-I., Le, A., Henry, L., Hoang, J., Cheung, R., … Nguyen, M. H. (2019). THE IMPACT OF COEXISTING HEPATIC STEATOSIS (HS) ON DEVELOPMENT OF CIRRHOSIS,HEPATOCELLULAR CARCINOMA (HCC) DEVELOPMENT AND HBsAg SEROCLEARANCE IN PATIENTS WITH CHRONIC HEPATITIS B (CHB). HEPATOLOGY, 70, 1347A–1348A.

SYSTEMATIC REVIEW AND META-ANALYSIS: A NATURAL HISTORY STUDY TO INCLUDE NAFLD INCIDENCE, DISEASE TRANSITION AND OUTCOMES
Wu, Y., Yeo, Y. H., Zou, B., Li, X., Zheng, Q., Li, J., … Nguyen, M. H. (2019). SYSTEMATIC REVIEW AND META-ANALYSIS: A NATURAL HISTORY STUDY TO INCLUDE NAFLD INCIDENCE, DISEASE TRANSITION AND OUTCOMES. HEPATOLOGY, 70, 743A.

DISTRIBUTION OF BMI, SERUM ALT, HEPATIC STEATOSIS AND LIVER FIBROSIS IN ASIANS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD): A SYSTEMATIC REVIEW AND META-ANALYSIS OF 108 STUDIES WITH 2,260,207 INDIVIDUALS
Kam, L., Yeo, Y. H., Huang, D., Fung, J., Lee, T. Y., Yasuda, S., … Nguyen, M. H. (2019). DISTRIBUTION OF BMI, SERUM ALT, HEPATIC STEATOSIS AND LIVER FIBROSIS IN ASIANS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD): A SYSTEMATIC REVIEW AND META-ANALYSIS OF 108 STUDIES WITH 2,260,207 INDIVIDUALS. HEPATOLOGY. WILEY.

INCREASING PREVALENCE AND FACTORS ASSOCIATED WITH NAFLD IN MAINLAND CHINA: A META-ANALYSIS OF 124 STUDIES AND 1,232,281 PARTICIPANTS
Wu, Y., Zheng, Q., Zou, B., Yeo, Y. H., Li, X., Li, J., … Nguyen, M. H. (2019). INCREASING PREVALENCE AND FACTORS ASSOCIATED WITH NAFLD IN MAINLAND CHINA: A META-ANALYSIS OF 124 STUDIES AND 1,232,281 PARTICIPANTS. HEPATOLOGY, 70, 742A–743A.

PREVALENCE AND FACTORS ASSOCIATED WITH HEPATIC STEATOSIS (HS) AND HEPATIC FIBROSIS IN CHRONIC HEPATITIS B (CHB) ASSOCIATED WITH HS: A SYSTEMATIC REVIEW AND META-ANALYTIC ASSESSMENT OF 57 STUDIES AND 268,151 PARTICIPANTS
Zheng, Q., Wu, Y., Zou, B., Yeo, Y. H., Wu, H., Stave, C. D., … Nguyen, M. H. (2019). PREVALENCE AND FACTORS ASSOCIATED WITH HEPATIC STEATOSIS (HS) AND HEPATIC FIBROSIS IN CHRONIC HEPATITIS B (CHB) ASSOCIATED WITH HS: A SYSTEMATIC REVIEW AND META-ANALYTIC ASSESSMENT OF 57 STUDIES AND 268,151 PARTICIPANTS. HEPATOLOGY, 70, 570A–571A.

ASSOCIATIONS BETWEEN WEIGHT PERCEPTION AND THE INTENTION TO LOSE WEIGHT AND BETWEEN THE INTENTION TO DIET/EXERCISE AND REPORTED MET/CALORIE COUNT IN PERSONS WITH NAFLD: A US POPULATION-BASED STUDY OF 11,713 PARTICIPANTS, 2001-2014
Nguyen Hoang Vy, Yeo, Y. H., Zou, B., Le, M., Cheung, R., & Nguyen, M. H. (2019). ASSOCIATIONS BETWEEN WEIGHT PERCEPTION AND THE INTENTION TO LOSE WEIGHT AND BETWEEN THE INTENTION TO DIET/EXERCISE AND REPORTED MET/CALORIE COUNT IN PERSONS WITH NAFLD: A US POPULATION-BASED STUDY OF 11,713 PARTICIPANTS, 2001-2014. HEPATOLOGY, 70, 753A–754A.

HCV CURE BY ALL ORAL DAA IMPROVES 5-YEAR OVERALL AND LIVER-RELATED SURVIVAL IN HCV-RELATED HCC PATIENTS: A REAL-WORLD, PROPENSITY SCORE-MATCHED STUDY FROM BOTH EAST AND WEST
Dang, H., Yeo, Y. H., Yasuda, S., Huang, C.-F., Iio, E., Landis, C. S., … Nguyen, M. H. (2019). HCV CURE BY ALL ORAL DAA IMPROVES 5-YEAR OVERALL AND LIVER-RELATED SURVIVAL IN HCV-RELATED HCC PATIENTS: A REAL-WORLD, PROPENSITY SCORE-MATCHED STUDY FROM BOTH EAST AND WEST. HEPATOLOGY. WILEY.

RACE DOES NOT AFFECT THE PERFORMANCE OF ROUTINELY AVAILABLE NONINVASIVE TESTS FOR THE DISCRIMINATION OF ADVANCED FIBROSIS DUE TO NONALCOHOLIC STEATOHEPATITIS (NASH) IN THE PHASE 3 STELLAR TRIALS OF SELONSERTIB
Wong, V. W.-S., Tak, W. Y., Goh, G. B. B., Cheng, P.-N., Lawitz, E. J., Younossi, Z. M., … Okanoue, T. (2019). RACE DOES NOT AFFECT THE PERFORMANCE OF ROUTINELY AVAILABLE NONINVASIVE TESTS FOR THE DISCRIMINATION OF ADVANCED FIBROSIS DUE TO NONALCOHOLIC STEATOHEPATITIS (NASH) IN THE PHASE 3 STELLAR TRIALS OF SELONSERTIB. HEPATOLOGY, 70, 1029A–1030A.

IMPROVEMENT IN VIROLOGIC, BIOCHEMICAL AND RENAL OUTCOMES IN CHRONIC HEPATITIS B (CHB) PATIENTS SWITCHED TO TENOFOVIR ALAFENAMIDE (TAF) IN ROUTINE CLINICAL PRACTICE
Yeh, M.-L., Trinh, S., Huang, C.-F., Hsieh, M.-Y., Huang, C.-I., Liang, P.-C., … Yu, M.-L. (2019). IMPROVEMENT IN VIROLOGIC, BIOCHEMICAL AND RENAL OUTCOMES IN CHRONIC HEPATITIS B (CHB) PATIENTS SWITCHED TO TENOFOVIR ALAFENAMIDE (TAF) IN ROUTINE CLINICAL PRACTICE. HEPATOLOGY, 70, 295A–296A.

COMORBIDITY PREVALENCE AND HEALTH CARE UTILIZATION IN A POPULATION-BASED STUDY OF CHRONIC HEPATITIS B PATIENTS FROM 2007 TO 2016 IN SOUTH KOREA
Oh, H., Wong, G., Lee, E., Ahn, H. J., Kim, B. O., Jung, S., … Nguyen, M. H. (2019). COMORBIDITY PREVALENCE AND HEALTH CARE UTILIZATION IN A POPULATION-BASED STUDY OF CHRONIC HEPATITIS B PATIENTS FROM 2007 TO 2016 IN SOUTH KOREA. HEPATOLOGY, 70, 582A.

INCREASING AGE AND NON-LIVER COMORBIDITIES IN PATIENTS WITH CHRONIC HEPATITIS B IN TAIWAN: A NATIONWIDE POPULATION-BASED ANALYSIS
Tseng, C.-H., Hsu, Y.-C., Ho, H. J., Nguyen, M. H., & Wu, C.-Y. (2019). INCREASING AGE AND NON-LIVER COMORBIDITIES IN PATIENTS WITH CHRONIC HEPATITIS B IN TAIWAN: A NATIONWIDE POPULATION-BASED ANALYSIS. HEPATOLOGY, 70, 596A–597A.

TENOFOVIR VERSUS ENTECAVIR FOR HEPATOCELLULAR CARCINOMA PREVENTION IN AN INTERNATIONAL CONSORTIUM OF CHRONIC HEPATITIS B
Hsu, Y.-C., Wong, G. L.-H., Chen, C. H., Peng, C.-Y., Yeh, M.-L., Cheung, K.-S., … Nguyen, M. H. (2019). TENOFOVIR VERSUS ENTECAVIR FOR HEPATOCELLULAR CARCINOMA PREVENTION IN AN INTERNATIONAL CONSORTIUM OF CHRONIC HEPATITIS B. HEPATOLOGY. WILEY.

An Automated, Quantitative, and Multiplexed Assay Suitable for Point-of-Care Hepatitis B Virus Diagnostics.
Gani, A. W., Wei, W., Shi, R.-Z. Z., Ng, E., Nguyen, M., Chua, M.-S. S., … Wang, S. X. (2019). An Automated, Quantitative, and Multiplexed Assay Suitable for Point-of-Care Hepatitis B Virus Diagnostics. Scientific Reports, 9(1), 15615.

The Phosphatidylethanolamine Biosynthesis Pathway Provides a New Target for Cancer Chemotherapy.
Guan, Y., Chen, X., Wu, M., Zhu, W., Arslan, A., Takeda, S., … Peltz, G. (2019). The Phosphatidylethanolamine Biosynthesis Pathway Provides a New Target for Cancer Chemotherapy. Journal of Hepatology.

HCV Cure Rates are Reduced in Patients with Active but not Inactive Hepatocellular Carcinoma- A Practice Implication.
Ogawa, E., Toyoda, H., Iio, E., Jun, D. W., Huang, C.-F. F., Enomoto, M., … Yoon, E. L. (2019). HCV Cure Rates are Reduced in Patients with Active but not Inactive Hepatocellular Carcinoma- A Practice Implication. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America.

Inhibitory Effect of Nucleos(t)ide Analogs on Telomerase Activity and Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B.
Hsu, Y.-C. C., & Nguyen, M. H. (2020). Inhibitory Effect of Nucleos(t)ide Analogs on Telomerase Activity and Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B. The American Journal of Gastroenterology.

Prevalence of significant hepatic fibrosis using magnetic resonance elastography in a health check-up clinic population.
Kang, K. A., Jun, D. W., Kim, M. S., Kwon, H.-J. J., & Nguyen, M. H. (2020). Prevalence of significant hepatic fibrosis using magnetic resonance elastography in a health check-up clinic population. Alimentary Pharmacology & Therapeutics, 51(3), 388–96.

Fatty liver is not independently associated with rates of complete response to oral antiviral therapy in chronic hepatitis B patients.
Li, J., Le, A. K., Chaung, K. T., Henry, L., Hoang, J. K., Cheung, R., & Nguyen, M. H. (2020). Fatty liver is not independently associated with rates of complete response to oral antiviral therapy in chronic hepatitis B patients. Liver International : Official Journal of the International Association for the Study of the Liver.

Sustained Decline of Noninvasive Fibrosis Index Values in Patients With Chronic Hepatitis C (CHC) With Sustained Virologic Response (SVR) After Receiving Direct-Acting Antiviral Agents (DAAs)
Prabhakar, V., Lutchman, G., Ahmed, A., Nguyen, M. H., Daugherty, T., & Kwo, P. (2019). Sustained Decline of Noninvasive Fibrosis Index Values in Patients With Chronic Hepatitis C (CHC) With Sustained Virologic Response (SVR) After Receiving Direct-Acting Antiviral Agents (DAAs). AMERICAN JOURNAL OF GASTROENTEROLOGY, 114, S553–S554.

What to Do When Fecal Immunochemical Test (FIT) Is Positive Following Normal Colonoscopy? Comparison of Adenoma Detection Rate (ADR) of Standard FIT-Colonoscopy and Relook Colonoscopy
Wei, M., Dao, A. T., Le, A., Nguyen, T., Tran, B., Trinh, L. L., … Trinh, H. (2019). What to Do When Fecal Immunochemical Test (FIT) Is Positive Following Normal Colonoscopy? Comparison of Adenoma Detection Rate (ADR) of Standard FIT-Colonoscopy and Relook Colonoscopy. AMERICAN JOURNAL OF GASTROENTEROLOGY. LIPPINCOTT WILLIAMS & WILKINS.

Editorial: choosing an appropriate risk stratification tool for nonalcoholic fatty liver disease-one size does not fit all. Authors' reply.
Jun, D. W., & Nguyen, M. H. (2020). Editorial: choosing an appropriate risk stratification tool for nonalcoholic fatty liver disease-one size does not fit all. Authors' reply. Alimentary Pharmacology & Therapeutics, 51(6), 662–63.

Letter: a stepwise approach towards the screening of hepatic fibrosis in the general population-authors' reply.
Kang, K. A., Jun, D. W., & Nguyen, M. H. (2020). Letter: a stepwise approach towards the screening of hepatic fibrosis in the general population-authors' reply. Alimentary Pharmacology & Therapeutics, 51(6), 670–71.

Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy.
Nguyen, M. H., Wong, G., Gane, E., Kao, J.-H. H., & Dusheiko, G. (2020). Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy. Clinical Microbiology Reviews, 33(2).

Liver Transplantation Outcomes in a U.S. Multicenter Cohort of 789 Patients with Hepatocellular Carcinoma Presenting Beyond Milan Criteria.
Kardashian, A., Florman, S. S., Haydel, B., Ruiz, R. M., Klintmalm, G. B., Lee, D. D., … Agopian, V. G. (2020). Liver Transplantation Outcomes in a U.S. Multicenter Cohort of 789 Patients with Hepatocellular Carcinoma Presenting Beyond Milan Criteria. Hepatology (Baltimore, Md.).

Ethnic influence on nonalcoholic fatty liver disease prevalence and lack of disease awareness in the United States, 2011-2016.
Le, M. H., Yeo, Y. H., Cheung, R., Wong, V. W.-S., & Nguyen, M. H. (2020). Ethnic influence on nonalcoholic fatty liver disease prevalence and lack of disease awareness in the United States, 2011-2016. Journal of Internal Medicine.

Antiviral therapy and hepatocellular carcinoma risk in hepatitis B patients with cirrhosis.
Gao, X., Yang, H.-I. I., Trinh, H., Jeong, D., Li, J., Zhang, J., … Nguyen, M. H. (2019). Antiviral therapy and hepatocellular carcinoma risk in hepatitis B patients with cirrhosis. European Journal of Gastroenterology & Hepatology.

The epidemiology of NAFLD in Mainland China with analysis by adjusted gross regional domestic product: a meta-analysis.
Wu, Y., Zheng, Q., Zou, B., Yeo, Y. H., Li, X., Li, J., … Nguyen, M. H. (2020). The epidemiology of NAFLD in Mainland China with analysis by adjusted gross regional domestic product: a meta-analysis. Hepatology International.

Proton pump inhibitors and risk of liver cancer and mortality in patients with chronic liver disease: a systematic review and meta-analysis.
Song, H. J., Jiang, X., Henry, L., Nguyen, M. H., & Park, H. (2020). Proton pump inhibitors and risk of liver cancer and mortality in patients with chronic liver disease: a systematic review and meta-analysis. European Journal of Clinical Pharmacology.

Diagnosis Rates of Chronic Hepatitis B in Privately Insured Patients in the United States.
Ogawa, E., Yeo, Y. H., Dang, N., Le, M. H., Jeong, D., Tran, S., … Nguyen, M. H. (2020). Diagnosis Rates of Chronic Hepatitis B in Privately Insured Patients in the United States. JAMA Network Open, 3(4), e201844.

Prevalence, characteristics and mortality outcomes of obese, nonobese and lean NAFLD in the United States, 1999-2016.
Zou, B., Yeo, Y. H., Nguyen, V. H., Cheung, R., Ingelsson, E., & Nguyen, M. H. (2020). Prevalence, characteristics and mortality outcomes of obese, nonobese and lean NAFLD in the United States, 1999-2016. Journal of Internal Medicine.

Hepatitis B Virus Reactivation Potentiated by Biologics.
Ogawa, E., Wei, M. T., & Nguyen, M. H. (2020). Hepatitis B Virus Reactivation Potentiated by Biologics. Infectious Disease Clinics of North America.

Baseline Mac-2 Binding Protein Glycosylation Isomer Level Stratifies Risks of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Oral Antiviral Therapy.
Tseng, T.-C. C., Peng, C.-Y. Y., Hsu, Y.-C. C., Su, T.-H. H., Wang, C.-C. C., Liu, C.-J. J., … Kao, J.-H. H. (2020). Baseline Mac-2 Binding Protein Glycosylation Isomer Level Stratifies Risks of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Oral Antiviral Therapy. Liver Cancer, 9(2), 207–20.

Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis.
Ye, Q., Zou, B., Yeo, Y. H., Li, J., Huang, D. Q., Wu, Y., … Nguyen, M. H. (2020). Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis. The Lancet. Gastroenterology & Hepatology.

Prevalence of Chronic Hepatitis B Virus Infection in the United States.
Lim, J. K., Nguyen, M. H., Kim, W. R., Gish, R., Perumalswami, P., & Jacobson, I. M. (2020). Prevalence of Chronic Hepatitis B Virus Infection in the United States. The American Journal of Gastroenterology.

Development and validation of a risk score for liver cirrhosis prediction in untreated and treated chronic hepatitis B.
Le, A. K., Yang, H.-I. I., Yeh, M.-L. L., Jin, M., Trinh, H. N., Henry, L., … Nguyen, M. H. (2020). Development and validation of a risk score for liver cirrhosis prediction in untreated and treated chronic hepatitis B. The Journal of Infectious Diseases.

Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (= 5 cm) after initial curative resection.
Feng, Y., Wu, H., Huang, D. Q., Xu, C., Zheng, H., Maeda, M., … Zhu, Q. (2020). Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (= 5 cm) after initial curative resection. European Radiology.

Increasing comorbidities in a South Korea insured population-based cohort of patients with chronic hepatitis B.
Oh, H., Jun, D. W., Lee, I.-H. H., Ahn, H. J., Kim, B. O., Jung, S., & Nguyen, M. H. (2020). Increasing comorbidities in a South Korea insured population-based cohort of patients with chronic hepatitis B. Alimentary Pharmacology & Therapeutics.

Pathologic Response to Pretransplant Locoregional Therapy is Predictive of Patient Outcome After Liver Transplantation for Hepatocellular Carcinoma Analysis From the US Multicenter HCC Transplant Consortium
DiNorcia, J., Florman, S. S., Haydel, B., Tabrizian, P., Ruiz, R. M., Klintmalm, G. B., … Agopian, V. G. (2020). Pathologic Response to Pretransplant Locoregional Therapy is Predictive of Patient Outcome After Liver Transplantation for Hepatocellular Carcinoma Analysis From the US Multicenter HCC Transplant Consortium. ANNALS OF SURGERY, 271(4), 616–24.

Epidemiology of COVID-19: A Systematic Review and Meta-analysis of Clinical Characteristics, Risk factors and Outcomes.
Li, J., Huang, D. Q., Zou, B., Yang, H., Hui, W. Z., Rui, F., … Nguyen, M. H. (2020). Epidemiology of COVID-19: A Systematic Review and Meta-analysis of Clinical Characteristics, Risk factors and Outcomes. Journal of Medical Virology.

Is tenofovir more effective than entecavir to prevent hepatocellular carcinoma? The controversy goes on.
Tseng, C.-H. H., Nguyen, M. H., & Hsu, Y.-C. C. (2020). Is tenofovir more effective than entecavir to prevent hepatocellular carcinoma? The controversy goes on. Hepatology International.

Racial and Socioeconomic Disparities in Hospitalization of Pediatrics with Liver Disease from 2005 to 2015.
Martin, M., Zou, B., Hoang, J., Jeong, D., Bensen, R., & Nguyen, M. H. (2020). Racial and Socioeconomic Disparities in Hospitalization of Pediatrics with Liver Disease from 2005 to 2015. Digestive Diseases and Sciences.

High hepatitis C virus cure rates with approved interferon-free direct-acting antivirals among diverse mainland Chinese patients including genotypes 3a and 3b
Ji, F., Li, J., Liu, L., Liang, J., Wang, X., Liu, J., … Nguyen, M. H. (2020). High hepatitis C virus cure rates with approved interferon-free direct-acting antivirals among diverse mainland Chinese patients including genotypes 3a and 3b. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY.

Validity of International Classification of Diseases, 10th Revision, Codes for Cirrhosis.
Ramrakhiani, N. S., Le, M., Yeo, Y. H., Le, A., Maeda, M., & Nguyen, M. H. (2020). Validity of International Classification of Diseases, 10th Revision, Codes for Cirrhosis. Digestive Diseases (Basel, Switzerland).

Liver Care and Surveillance: The Global Impact of the COVID-19 Pandemic
Toyoda, H., Huang, D. Q., Le, M. H., & Nguyen, M. H. (2020). Liver Care and Surveillance: The Global Impact of the COVID-19 Pandemic. HEPATOLOGY COMMUNICATIONS.

Liver Care and Surveillance: The Global Impact of the COVID-19 Pandemic.
Toyoda, H., Huang, D. Q., Le, M. H., & Nguyen, M. H. (2020). Liver Care and Surveillance: The Global Impact of the COVID-19 Pandemic. Hepatology Communications.

Editorial: comorbidities in patients with chronic hepatitis B-authors' reply.
Yoon, E. L., Oh, H., Jun, D. W., & Nguyen, M. H. (2020). Editorial: comorbidities in patients with chronic hepatitis B-authors' reply. Alimentary Pharmacology & Therapeutics, 52(5), 893–94.

High hepatitis C virus cure rates with approved interferon-free direct-acting antivirals among diverse mainland Chinese patients including genotypes 3a and 3b.
Ji, F., Li, J., Liu, L., Liang, J., Wang, X., Liu, J., … Nguyen, M. H. (2020). High hepatitis C virus cure rates with approved interferon-free direct-acting antivirals among diverse mainland Chinese patients including genotypes 3a and 3b. Journal of Gastroenterology and Hepatology.

Non-alcoholic fatty liver disease (NAFLD) in Asia - More efforts are needed.
Li, J., & Nguyen, M. H. (2020). Non-alcoholic fatty liver disease (NAFLD) in Asia - More efforts are needed. Liver International : Official Journal of the International Association for the Study of the Liver.

Early multiplexed detection of cirrhosis by giant magnetoresistive biosensors with protein biomarkers.
Ng, E., Le, A. K., Nguyen, M. H., & Wang, S. X. (2020). Early multiplexed detection of cirrhosis by giant magnetoresistive biosensors with protein biomarkers. ACS Sensors.

Increasing age and non-liver comorbidities in patients with chronic hepatitis B in Taiwan: A nationwide population-based analysis.
Tseng, C.-H. H., Hsu, Y.-C. C., Ho, H. J., Nguyen, M. H., & Wu, C.-Y. Y. (2020). Increasing age and non-liver comorbidities in patients with chronic hepatitis B in Taiwan: A nationwide population-based analysis. Digestive Diseases (Basel, Switzerland).

ALT Levels for Asians With Metabolic Diseases: A Meta-analysis of 86 Studies With Individual Patient Data Validation
Huang, D. Q., Yeo, Y. H., Tan, E., Takahashi, H., Yasuda, S., Saruwatari, J., … Nguyen, M. H. (2020). ALT Levels for Asians With Metabolic Diseases: A Meta-analysis of 86 Studies With Individual Patient Data Validation. HEPATOLOGY COMMUNICATIONS.

Hepatocellular carcinoma incidence with tenofovir versus entecavir in chronic hepatitis B: a systematic review and meta-analysis.
Tseng, C.-H. H., Hsu, Y.-C. C., Chen, T.-H. H., Ji, F., Chen, I.-S. S., Tsai, Y.-N. N., … Nguyen, M. H. (2020). Hepatocellular carcinoma incidence with tenofovir versus entecavir in chronic hepatitis B: a systematic review and meta-analysis. The Lancet. Gastroenterology & Hepatology.

Effects of Cirrhosis and Diagnosis Scenario in Metabolic-Associated Fatty Liver Disease-Related Hepatocellular Carcinoma
Chen, V. L., Yeh, M.-L., Yang, J. D., Leong, J., Huang, D. Q., Toyoda, H., … Nguyen, M. H. (2020). Effects of Cirrhosis and Diagnosis Scenario in Metabolic-Associated Fatty Liver Disease-Related Hepatocellular Carcinoma. HEPATOLOGY COMMUNICATIONS.

Incidence, Factors, and Patient-Level Data for Spontaneous HBsAg Seroclearance: A Cohort Study of 11,264 Patients
Yeo, Y. H., Tseng, T.-C., Hosaka, T., Cunningham, C., Fung, J. Y. Y., Ho, H. J., … Nguyen, M. H. (2020). Incidence, Factors, and Patient-Level Data for Spontaneous HBsAg Seroclearance: A Cohort Study of 11,264 Patients. CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 11(9).

Letter: substantial under-diagnosis of NAFLD - more efforts are needed globally.
Emhmed Ali, S., & Nguyen, M. H. (2020). Letter: substantial under-diagnosis of NAFLD - more efforts are needed globally. Alimentary Pharmacology & Therapeutics, 52(10), 1624.

Delayed Diagnosis and Disparity in Hepatitis C Virus-Infected Immigrants in North America: A Call for Action.
Emhmed Ali, S., & Nguyen, M. H. (2020). Delayed Diagnosis and Disparity in Hepatitis C Virus-Infected Immigrants in North America: A Call for Action. Liver International : Official Journal of the International Association for the Study of the Liver.

Incidence, Factors, and Patient-Level Data for Spontaneous HBsAg Seroclearance: A Cohort Study of 11,264 Patients.
Yeo, Y. H., Tseng, T.-C. C., Hosaka, T., Cunningham, C., Fung, J. Y., Ho, H. J., … Nguyen, M. H. (2020). Incidence, Factors, and Patient-Level Data for Spontaneous HBsAg Seroclearance: A Cohort Study of 11,264 Patients. Clinical and Translational Gastroenterology, 11(9), e00196.

Genomic analysis of Vascular Invasion in Hepatocellular Carcinoma (HCC) Reveals Molecular Drivers and Predictive Biomarkers.
Krishnan, M. S., Rajan Kd, A., Park, J., Arjunan, V., Garcia Marques, F. J., Bermudez, A., … Dhanasekaran, R. (2020). Genomic analysis of Vascular Invasion in Hepatocellular Carcinoma (HCC) Reveals Molecular Drivers and Predictive Biomarkers. Hepatology (Baltimore, Md.).

HIGH HCV CURE RATES WITH APPROVED INTERFERON-FREE DIRECT ACTING ANTIVIRALS AMONG DIVERSE MAINLAND CHINESE PATIENTS INCLUDING GENOTYPES 3a AND 3b
Ji, F., Li, J., Liu, L., Jing, L., Wang, X. Z., Liu, J., … Nguyen, M. H. (2020). HIGH HCV CURE RATES WITH APPROVED INTERFERON-FREE DIRECT ACTING ANTIVIRALS AMONG DIVERSE MAINLAND CHINESE PATIENTS INCLUDING GENOTYPES 3a AND 3b. HEPATOLOGY. WILEY.

THE INCIDENCE OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B VIRUS INFECTION SUBJECTS NOT MEETING CRITERIA FOR ANTIVIRAL THERAPY
Alshuwaykh, O., Goel, A., Daugherty, T., Cheung, A., Kim, W. R., Kwong, A. J., … Kwo, P. Y. (2020). THE INCIDENCE OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B VIRUS INFECTION SUBJECTS NOT MEETING CRITERIA FOR ANTIVIRAL THERAPY. HEPATOLOGY. WILEY.

LONGITUDINAL REAL-WORLD STUDY ON ESTIMATED GLOMERULAR FILTRATION RATE (EGFR) CHANGES IN ENTECAVIR (ETV) VERSUS TENOFOVIR DISOPROXIL FUMARATE (TDF)-TREATED CHRONIC HEPATITIS B (CHB) PATIENTS: A REAL-B STUDY
Mak, L. Y., Hoang, J., Jun, D. W., Chen, C. H., Peng, C.-Y., Yet, M.-L., … Nguyen, M. H. (2020). LONGITUDINAL REAL-WORLD STUDY ON ESTIMATED GLOMERULAR FILTRATION RATE (EGFR) CHANGES IN ENTECAVIR (ETV) VERSUS TENOFOVIR DISOPROXIL FUMARATE (TDF)-TREATED CHRONIC HEPATITIS B (CHB) PATIENTS: A REAL-B STUDY. HEPATOLOGY. WILEY.

INCIDENCE AND FACTORS ASSOCIATED WITH FUNCTIONAL CURE (HBsAg SEROCLEARANCE) DURING ETV OR TDF THERAPY FOR CHRONIC HEPATITIS B (CHB): AN INTERNATIONAL REAL-WORLD STUDY WITH LONG-TERM FOLLOW-UP
Hsu, Y.-C., Yeh, M.-L., Wong, G. L.-H., Chen, C. H., Peng, C.-Y., Ferrets, M. A. B., … Nguyen, M. H. (2020). INCIDENCE AND FACTORS ASSOCIATED WITH FUNCTIONAL CURE (HBsAg SEROCLEARANCE) DURING ETV OR TDF THERAPY FOR CHRONIC HEPATITIS B (CHB): AN INTERNATIONAL REAL-WORLD STUDY WITH LONG-TERM FOLLOW-UP. HEPATOLOGY, 72, 463A–464A.

SEQUENTIAL THERAPY WITH TENOFOVIR ALAFENAMIDE (TAF) IN PATIENTS WITH CHRONIC HEPATITIS B (CHB): AN INTERIM ANALYSIS OF AN ONGOING MULTINATIONAL PROSPECTIVE STUDY
Ogawa, E., Toyoda, H., Jun, D. W., Hsu, Y.-C., Yoon, E., Ahn, S. B., … Nguyen, M. H. (2020). SEQUENTIAL THERAPY WITH TENOFOVIR ALAFENAMIDE (TAF) IN PATIENTS WITH CHRONIC HEPATITIS B (CHB): AN INTERIM ANALYSIS OF AN ONGOING MULTINATIONAL PROSPECTIVE STUDY. HEPATOLOGY. WILEY.

ELASTOGRAPHY AND LIVER BIOPSY DATA FOR NASH AND FIBROSIS PREVALENCE AMONG SOUTH KOREAN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD): A META-ANALYSIS OF 61 STUDIES AND 27,496 PARTICIPANTS
Park, J., Lee, E. Y., Lee, D. H., Li, J., Zou, B., Jun, M. J., … Nguyen, M. H. (2020). ELASTOGRAPHY AND LIVER BIOPSY DATA FOR NASH AND FIBROSIS PREVALENCE AMONG SOUTH KOREAN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD): A META-ANALYSIS OF 61 STUDIES AND 27,496 PARTICIPANTS. HEPATOLOGY, 72, 964–65.

INCREASED VIRAL SUPPRESSION RATE IN REAL-WORLD CHRONIC HEPATITIS B (CHB) PATIENTS AFTER SWITCH FROM LONG-TERN ENTECAVIR (ETV) THERAPY TO TENOFOVIR ALAFENAMIDE (TAF): A MULTICENTER STUDY
Nguyen, M. H., Atsukawa, M., Ishikawa, T., Yasuda, S., Trinh, H. N., Yokohama, K., … Toyoda, H. (2020). INCREASED VIRAL SUPPRESSION RATE IN REAL-WORLD CHRONIC HEPATITIS B (CHB) PATIENTS AFTER SWITCH FROM LONG-TERN ENTECAVIR (ETV) THERAPY TO TENOFOVIR ALAFENAMIDE (TAF): A MULTICENTER STUDY. HEPATOLOGY, 72, 486A–487A.

HEPATOCELLULAR CARCINOMA INCIDENCE WITH TENOFOVIR VS ENTECAVIR IN CHRONIC HEPATITIS B: A SYSTEMATIC REVIEW AND META-ANALYSIS
Tseng, C.-H., Hsu, Y.-C., Chen, T.-H., Ji, F., Chen, I.-S., Tsai, Y.-N., … Nguyen, M. H. (2020). HEPATOCELLULAR CARCINOMA INCIDENCE WITH TENOFOVIR VS ENTECAVIR IN CHRONIC HEPATITIS B: A SYSTEMATIC REVIEW AND META-ANALYSIS. HEPATOLOGY, 72, 642A.

THE EPIDEMIOLOGY OF NAFLD AND LEAN NAFLD IN JAPAN: A SYSTEMATIC REVIEW AND META-ANALYSIS WITH INDIVIDUAL PATIENT LEVEL DATA AND FORECASTING, 1995-2040
Ito, T., Ishigami, M., Zou, B., Tanaka, T., Takahashi, H., Kurosaki, M., … Nguyen, M. H. (2020). THE EPIDEMIOLOGY OF NAFLD AND LEAN NAFLD IN JAPAN: A SYSTEMATIC REVIEW AND META-ANALYSIS WITH INDIVIDUAL PATIENT LEVEL DATA AND FORECASTING, 1995-2040. HEPATOLOGY, 72, 999.

DIFFERENTIAL CHARACTERISTICS AND OUTCOMES OF ASIAN AND NON-ASIAN PATIENTS WITH HBV-RELATED HEPATOCELLULAR CARCINOMA
Huang, D., Hoang, J., Leong, J., Barciela, R., Maeda, M., Vargas-Accarino, E., … Nguyen, M. H. (2020). DIFFERENTIAL CHARACTERISTICS AND OUTCOMES OF ASIAN AND NON-ASIAN PATIENTS WITH HBV-RELATED HEPATOCELLULAR CARCINOMA. HEPATOLOGY. WILEY.

VIROLOGIC, BIOCHEMICAL, AND RENAL OUTCOMES OF TREATMENT-NAIVE PATIENTS WITH SEQUENTIAL THERAPY FROM TENOFOVIR DISOPROXIL FUMARATE (TDF) TO TENOFOVIR ALAFENAMIDE (TAF) IN ROUTINE PRACTICE
Toyoda, H., Trinh, H. N., Leong, J., Atsukawa, M., Watanabe, T., Chuma, M., … Nguyen, M. H. (2020). VIROLOGIC, BIOCHEMICAL, AND RENAL OUTCOMES OF TREATMENT-NAIVE PATIENTS WITH SEQUENTIAL THERAPY FROM TENOFOVIR DISOPROXIL FUMARATE (TDF) TO TENOFOVIR ALAFENAMIDE (TAF) IN ROUTINE PRACTICE. HEPATOLOGY, 72, 498A–499A.

HCC RISK POST-SVR WITH DAAS IN EAST ASIANS: FINDINGS FROM THE REAL-C COHORT
Tanaka, Y., Ogawa, E., Huang, C.-F., Toyoda, H., Jun, D. W., Tseng, C.-H., … Yang, H.-I. (2020). HCC RISK POST-SVR WITH DAAS IN EAST ASIANS: FINDINGS FROM THE REAL-C COHORT. HEPATOLOGY. WILEY.

INCIDENCE AND PREDICTIVE FACTORS OF HEPATOCELLULAR CARCINOMA (HCC) IN A PROSPECTIVELY FOLLOWED US COHORT OF PATIENTS AT RISK: HEPATOCELLULAR CARCINOMA EARLY DETECTION STRATEGY (HEDS) STUDY
Reddy, K. R., Parikh, N. D., Roberts, L. R., Schwartz, M. E., Nguyen, M. H., Befelee, A., … Marrero, J. A. (2020). INCIDENCE AND PREDICTIVE FACTORS OF HEPATOCELLULAR CARCINOMA (HCC) IN A PROSPECTIVELY FOLLOWED US COHORT OF PATIENTS AT RISK: HEPATOCELLULAR CARCINOMA EARLY DETECTION STRATEGY (HEDS) STUDY. HEPATOLOGY, 72, 643A.

PRECISE MEDICINE USING A NEW SUBCLASSIFICATION AND CLINICAL MANAGEMENT FOR BARCELONA CLINIC LIVER CANCER STAGE C HEPATOCELLULAR CARCINOMA: A MULTICENTRE STUDY
Lin, C. W., Chen, Y.-S., Lo, G.-H., Wu, T.-C., Yeh, J.-H., Wang, Y.-C., … Yu, M.-L. (2020). PRECISE MEDICINE USING A NEW SUBCLASSIFICATION AND CLINICAL MANAGEMENT FOR BARCELONA CLINIC LIVER CANCER STAGE C HEPATOCELLULAR CARCINOMA: A MULTICENTRE STUDY. HEPATOLOGY, 72, 96A–97A.

Prevalence of Hepatitis B Vaccination Coverage and Serologic Evidence of Immunity Among US-Born Children and Adolescents From 1999 to 2016.
Le, M. H., Yeo, Y. H., So, S., Gane, E., Cheung, R. C., & Nguyen, M. H. (2020). Prevalence of Hepatitis B Vaccination Coverage and Serologic Evidence of Immunity Among US-Born Children and Adolescents From 1999 to 2016. JAMA Network Open, 3(11), e2022388.

ALT Levels for Asians With Metabolic Diseases: A Meta-analysis of 86 Studies With Individual Patient Data Validation.
Huang, D. Q., Yeo, Y. H., Tan, E., Takahashi, H., Yasuda, S., Saruwatari, J., … Nguyen, M. H. (2020). ALT Levels for Asians With Metabolic Diseases: A Meta-analysis of 86 Studies With Individual Patient Data Validation. Hepatology Communications, 4(11), 1624–1636.

Review article: current gaps and opportunities in HBV prevention, testing and linkage to care in the United States-a call for action.
Yeo, Y. H., & Nguyen, M. H. (2020). Review article: current gaps and opportunities in HBV prevention, testing and linkage to care in the United States-a call for action. Alimentary Pharmacology & Therapeutics.

Provider Perspectives on HCC Surveillance in Patients With Cirrhosis: Community Provider Perspectives Matter.
Wei, M. T., & Nguyen, M. H. (2020). Provider Perspectives on HCC Surveillance in Patients With Cirrhosis: Community Provider Perspectives Matter. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

Association between fatty liver and cirrhosis, hepatocellular carcinoma, and HBsAg seroclearance in chronic hepatitis B.
Li, J., Yang, H.-I. I., Yeh, M.-L. L., Le, M. H., Le, A. K., Yeo, Y. H., … Nguyen, M. H. (2020). Association between fatty liver and cirrhosis, hepatocellular carcinoma, and HBsAg seroclearance in chronic hepatitis B. The Journal of Infectious Diseases.

Noninvasive diagnosis methods are needed in paediatric non-alcoholic fatty liver disease (NAFLD).
Li, J., & Nguyen, M. H. (2020). Noninvasive diagnosis methods are needed in paediatric non-alcoholic fatty liver disease (NAFLD). Liver International : Official Journal of the International Association for the Study of the Liver.

HCC risk post-SVR with DAAs in East Asians: findings from the REAL-C cohort.
Tanaka, Y., Ogawa, E., Huang, C.-F. F., Toyoda, H., Jun, D. W., Tseng, C.-H. H., … Nguyen, M. H. (2020). HCC risk post-SVR with DAAs in East Asians: findings from the REAL-C cohort. Hepatology International.

Post-Transplant Outcomes in Older Patients with Hepatocellular Carcinoma (HCC) are Driven by non-HCC Factors.
Adeniji, N., Arjunan, V., Prabhakar, V., Mannalithara, A., Ghaziani, T., Ahmed, A., … Dhanasekaran, R. (2020). Post-Transplant Outcomes in Older Patients with Hepatocellular Carcinoma (HCC) are Driven by non-HCC Factors. Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Discrepancies between actual weight, weight perception and weight loss intention amongst persons with NAFLD.
Nguyen, V. H., Yeo, Y. H., Zou, B., Le, M. H., Henry, L., Cheung, R. C., & Nguyen, M. H. (2020). Discrepancies between actual weight, weight perception and weight loss intention amongst persons with NAFLD. Journal of Internal Medicine.

Transition rates to cirrhosis and liver cancer by age, gender, disease and treatment status in Asian chronic hepatitis B patients.
Liu, M., Tseng, T.-C. C., Jun, D. W., Yeh, M.-L. L., Trinh, H., Wong, G. L., … Nguyen, M. H. (2021). Transition rates to cirrhosis and liver cancer by age, gender, disease and treatment status in Asian chronic hepatitis B patients. Hepatology International.

Predictors of Outcomes of Patients Referred to a Transplant Center for Urgent Liver Transplantation Evaluation
Alshuwaykh, O., Kwong, A., Goel, A., Cheung, A., Dhanasekaran, R., Ahmed, A., … Kwo, P. Y. (2020). Predictors of Outcomes of Patients Referred to a Transplant Center for Urgent Liver Transplantation Evaluation. HEPATOLOGY COMMUNICATIONS.

Effects of Cirrhosis and Diagnosis Scenario in Metabolic-Associated Fatty Liver Disease-Related Hepatocellular Carcinoma.
Chen, V. L., Yeh, M.-L. L., Yang, J. D., Leong, J., Huang, D. Q., Toyoda, H., … Nguyen, M. H. (2021). Effects of Cirrhosis and Diagnosis Scenario in Metabolic-Associated Fatty Liver Disease-Related Hepatocellular Carcinoma. Hepatology Communications, 5(1), 122–132.

Risk of hepatocellular carcinoma with tenofovir versus entecavir in chronic hepatitis B - Authors' reply.
Tseng, C.-H. H., Hsu, Y.-C. C., & Nguyen, M. H. (2021). Risk of hepatocellular carcinoma with tenofovir versus entecavir in chronic hepatitis B - Authors' reply. The Lancet. Gastroenterology & Hepatology, 6(2), 87–88.

Natural History and Hepatocellular Carcinoma Risk in Untreated Chronic Hepatitis B Patients with Indeterminate Phase (117/120).
Huang, D. Q., Li, X., Le, M. H., Le, A. K., Yeo, Y. H., Trinh, H. N., … Nguyen, M. H. (2021). Natural History and Hepatocellular Carcinoma Risk in Untreated Chronic Hepatitis B Patients with Indeterminate Phase (117/120). Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

Improved survival and high sustained virologic response with DAA therapy in patients with HCV-related HCC: A call for expanded use.
Ji, F., Li, T., & Nguyen, M. H. (2021). Improved survival and high sustained virologic response with DAA therapy in patients with HCV-related HCC: A call for expanded use. Journal of Gastroenterology and Hepatology.

NASH/liver fibrosis prevalence and incidence of non-liver comorbidities among people with NAFLD and incidence of NAFLD by metabolic comorbidites: Lessons from South Korea.
Park, J., Lee, E. Y., Li, J., Jun, M. J., Yoon, E., Ahn, S. B., … Nguyen, M. H. (2021). NASH/liver fibrosis prevalence and incidence of non-liver comorbidities among people with NAFLD and incidence of NAFLD by metabolic comorbidites: Lessons from South Korea. Digestive Diseases (Basel, Switzerland).

Twelve-month post-treatment parameters are superior in predicting hepatocellular carcinoma in patients with chronic hepatitis B.
Ahn, S. B., Choi, J., Jun, D. W., Oh, H., Yoon, E. L., Kim, H. S., … Nguyen, M. H. (2021). Twelve-month post-treatment parameters are superior in predicting hepatocellular carcinoma in patients with chronic hepatitis B. Liver International : Official Journal of the International Association for the Study of the Liver.

One-year Fibrosis-4 index helps identify minimal HCC risk in non-cirrhotic chronic hepatitis B patients with antiviral treatment.
Tseng, T.-C. C., Choi, J., Nguyen, M. H., Peng, C.-Y. Y., Siakavellas, S., Papatheodoridis, G., … Kao, J.-H. H. (2021). One-year Fibrosis-4 index helps identify minimal HCC risk in non-cirrhotic chronic hepatitis B patients with antiviral treatment. Hepatology International.

Clinical Response to Treatment for Acute Kidney Injury (AKI) in Patients With Cirrhosis
John, N., Alshuwaykh, O., Goel, A., Ahmed, A., Cheung, A., Dronamraju, D., … Kwo, P. Y. (2020). Clinical Response to Treatment for Acute Kidney Injury (AKI) in Patients With Cirrhosis. AMERICAN JOURNAL OF GASTROENTEROLOGY. LIPPINCOTT WILLIAMS & WILKINS.

Sarcopenic Obesity in Non-Alcoholic Fatty Liver Disease-The Union of Two Culprits.
Emhmed Ali, S., & Nguyen, M. H. (2021). Sarcopenic Obesity in Non-Alcoholic Fatty Liver Disease-The Union of Two Culprits. Life (Basel, Switzerland), 11(2).

Risk of hepatocellular carcinoma with tenofovir versus entecavir in chronic hepatitis B Reply
Tseng, C.-H., Hsu, Y.-C., & Nguyen, M. H. (2021). Risk of hepatocellular carcinoma with tenofovir versus entecavir in chronic hepatitis B Reply. LANCET GASTROENTEROLOGY & HEPATOLOGY, 6(2), 87–88.

The epidemiology of NAFLD and lean NAFLD in Japan: a meta-analysis with individual and forecasting analysis, 1995-2040.
Ito, T., Ishigami, M., Zou, B., Tanaka, T., Takahashi, H., Kurosaki, M., … Nguyen, M. H. (2021). The epidemiology of NAFLD and lean NAFLD in Japan: a meta-analysis with individual and forecasting analysis, 1995-2040. Hepatology International.

Treatment eligibility in hepatitis B: a call for better linkage to optimal care.
Huang, D. Q., & Nguyen, M. H. (2021). Treatment eligibility in hepatitis B: a call for better linkage to optimal care. The Lancet. Gastroenterology & Hepatology, 6(3), 160.

Chronic hepatitis, osteoporosis, and men: under-recognised and underdiagnosed.
Prasad, D., & Nguyen, M. H. (2021). Chronic hepatitis, osteoporosis, and men: under-recognised and underdiagnosed. The Lancet. Diabetes & Endocrinology, 9(3), 141.

Letter to the Editor: HCC surveillance in cirrhosis patients: Is the real-world situation even worse than reported?
Huang, D. Q., Yeo, Y. H., & Nguyen, M. H. (2021). Letter to the Editor: HCC surveillance in cirrhosis patients: Is the real-world situation even worse than reported? Hepatology (Baltimore, Md.).

Defining age related thresholds for ALT and the risk of confounders.
Huang, D. Q., & Nguyen, M. H. (2021). Defining age related thresholds for ALT and the risk of confounders. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

Epidemiology, pathogenesis, diagnosis, surveillance, and management of hepatocellular carcinoma associated with vascular liver disease.
Prasad, D., & Nguyen, M. H. (2021). Epidemiology, pathogenesis, diagnosis, surveillance, and management of hepatocellular carcinoma associated with vascular liver disease. The Kaohsiung Journal of Medical Sciences.

Predictors of Outcomes of Patients Referred to a Transplant Center for Urgent Liver Transplantation Evaluation.
Alshuwaykh, O., Kwong, A., Goel, A., Cheung, A., Dhanasekaran, R., Ahmed, A., … Kwo, P. Y. (2021). Predictors of Outcomes of Patients Referred to a Transplant Center for Urgent Liver Transplantation Evaluation. Hepatology Communications, 5(3), 516–525.

Treatment and renal outcomes up to 96 weeks after tenofovir alafenamide switch from tenofovir disoproxil fumarate in routine practice.
Toyoda, H., Leong, J., Landis, C., Atsukawa, M., Watanabe, T., Huang, D. Q., … Nguyen, M. H. (2021). Treatment and renal outcomes up to 96 weeks after tenofovir alafenamide switch from tenofovir disoproxil fumarate in routine practice. Hepatology (Baltimore, Md.).

Differential Characteristics and Outcomes of Asian and non-Asian Patients with HBV-related Hepatocellular Carcinoma.
Huang, D. Q., Hoang, J. K., Leong, J., Riveiro-Barciela, M., Maeda, M., Yang, J. D., … Nguyen, M. H. (2021). Differential Characteristics and Outcomes of Asian and non-Asian Patients with HBV-related Hepatocellular Carcinoma. Liver International : Official Journal of the International Association for the Study of the Liver.

Characteristics and healthcare costs in the aging hepatitis B population of Japan: A nationwide real-world analysis.
Yotsuyanagi, H., Kurosaki, M., Yatsuhashi, H., Lee, I.-H. H., Ng, A., Brooks-Rooney, C., & Nguyen, M. H. (2021). Characteristics and healthcare costs in the aging hepatitis B population of Japan: A nationwide real-world analysis. Digestive Diseases (Basel, Switzerland).

Fatty Liver Index and Development of Cardiovascular Disease: Findings from the UK Biobank.
Zou, B., Yeo, Y. H., Cheung, R., Ingelsson, E., & Nguyen, M. H. (2021). Fatty Liver Index and Development of Cardiovascular Disease: Findings from the UK Biobank. Digestive Diseases and Sciences.

Chronic hepatitis, osteoporosis, and men: under-recognised and underdiagnosed
Prasad, D., & Nguyen, M. H. (2021). Chronic hepatitis, osteoporosis, and men: under-recognised and underdiagnosed. LANCET DIABETES & ENDOCRINOLOGY, 9(3), 141.

A population-based US study of hepatitis C diagnosis rate.
Yeo, Y. H., Kam, L. Y., Le, M. H., Jeong, D., Dang, N., Henry, L., … Nguyen, M. H. (2021). A population-based US study of hepatitis C diagnosis rate. European Journal of Gastroenterology & Hepatology.

Treatment eligibility in hepatitis B: a call for better linkage to optimal care
Huang, D. Q., & Nguyen, M. H. (2021). Treatment eligibility in hepatitis B: a call for better linkage to optimal care. LANCET GASTROENTEROLOGY & HEPATOLOGY, 6(3), 160.

Initial Evaluation, Long-Term Monitoring, and Hepatocellular Carcinoma Surveillance of Chronic Hepatitis B in Routine Practice: A Nationwide US Study.
Tran, S., Jeong, D., Henry, L., Cheung, R. C., & Nguyen, M. H. (2021). Initial Evaluation, Long-Term Monitoring, and Hepatocellular Carcinoma Surveillance of Chronic Hepatitis B in Routine Practice: A Nationwide US Study. The American Journal of Gastroenterology.

Antiviral kinetics of tenofovir alafenamide and tenofovir disoproxil fumarate over 24 weeks in women of childbearing potential with chronic HBV.
Pan, C. Q., Chang, T.-T. T., Bae, S. H., Brunetto, M., Seto, W.-K. K., Coffin, C. S., … Gane, E. J. (2021). Antiviral kinetics of tenofovir alafenamide and tenofovir disoproxil fumarate over 24 weeks in women of childbearing potential with chronic HBV. PloS One, 16(5), e0251552.

Incidences and Determinants of Functional Cure during Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis B.
Hsu, Y.-C. C., Yeh, M.-L. L., Wong, G. L.-H., Chen, C.-H. H., Peng, C.-Y. Y., Buti, M., … Nguyen, M. H. (2021). Incidences and Determinants of Functional Cure during Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis B. The Journal of Infectious Diseases.

Resubclassification and clinical management for Barcelona Clinic Liver Cancer Stage C hepatocellular carcinoma.
Lin, C.-W. W., Chen, Y.-S. S., Lo, G.-H. H., Wu, T.-C. C., Yeh, J.-H. H., Yeh, M.-L. L., … Yu, M.-L. L. (2021). Resubclassification and clinical management for Barcelona Clinic Liver Cancer Stage C hepatocellular carcinoma. Hepatology International.

Differential clinical characteristics and mortality outcomes in persons with NAFLD and/or MAFLD.
Nguyen, V. H., Le, M. H., Cheung, R. C., & Nguyen, M. H. (2021). Differential clinical characteristics and mortality outcomes in persons with NAFLD and/or MAFLD. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

Outcomes of Sequential Therapy With Tenofovir Alafenamide After Long-term Entecavir.
Nguyen, M. H., Atsukawa, M., Ishikawa, T., Yasuda, S., Yokohama, K., Trinh, H. N., … Toyoda, H. (2021). Outcomes of Sequential Therapy With Tenofovir Alafenamide After Long-term Entecavir. The American Journal of Gastroenterology, 116(6), 1264–1273.

Progression Rates by Age, Sex, Treatment, and Disease Activity by AASLD and EASL Criteria: Data for Precision Medicine.
Park, J., Le, A. K., Tseng, T.-C. C., Yeh, M.-L. L., Jun, D. W., Trinh, H., … Nguyen, M. H. (2021). Progression Rates by Age, Sex, Treatment, and Disease Activity by AASLD and EASL Criteria: Data for Precision Medicine. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

Evaluation of ethnic influence in the application of a hepatocellular carcinoma predictive model for chronic hepatitis C.
Wei, M. T., Le, M. H., Landis, C., Trinh, H., Wong, G., Le, A., … Nguyen, M. H. (2021). Evaluation of ethnic influence in the application of a hepatocellular carcinoma predictive model for chronic hepatitis C. Journal of Medical Virology.

Incorporating fatty liver disease in multidisciplinary care and novel clinical trial designs for patients with metabolic diseases.
Eslam, M., Ahmed, A., Després, J.-P. P., Jha, V., Halford, J. C., Wei Chieh, J. T., … George, J. (2021). Incorporating fatty liver disease in multidisciplinary care and novel clinical trial designs for patients with metabolic diseases. The Lancet. Gastroenterology & Hepatology.

Characteristics and Survival Outcomes of Hepatocellular Carcinoma Developed after HCV SVR.
Yeh, M.-L., Liang, P.-C., Tsai, P.-C., Wang, S.-C., Leong, J., Ogawa, E., … Yu, M.-L. (2021). Characteristics and Survival Outcomes of Hepatocellular Carcinoma Developed after HCV SVR. Cancers, 13(14).

HBV-related Hepatocellular Carcinoma: A Call to Improve Surveillance and Linkage to Care.
Huang, D. Q., Hoang, J. K., & Nguyen, M. H. (2021). HBV-related Hepatocellular Carcinoma: A Call to Improve Surveillance and Linkage to Care. Liver International : Official Journal of the International Association for the Study of the Liver.

Incidence of hepatic outcomes in patients with cirrhosis due to primary biliary cholangitis: A population-based epidemiology study
Titievsky, L., Ness, E., Law, A., Goldman, E., Wheeler, D., Bertoia, M., … Bassanelli, C. (2021). Incidence of hepatic outcomes in patients with cirrhosis due to primary biliary cholangitis: A population-based epidemiology study. JOURNAL OF HEPATOLOGY. ELSEVIER.

Incidence rates of hepatobiliary outcomes among patients with non-alcoholic steatohepatitis based on fibrosis-4 score severity at baseline
Titievsky, L., Jamal-Allial, A., Gallagher, K., Capozza, T., Dodge, S., Du, S., … Esposito, D. (2021). Incidence rates of hepatobiliary outcomes among patients with non-alcoholic steatohepatitis based on fibrosis-4 score severity at baseline. JOURNAL OF HEPATOLOGY. ELSEVIER.

Characteristics and Survival Outcomes of Hepatocellular Carcinoma Developed After HCV SVR
Yeh, M.-L., Liang, P.-C., Tsai, P.-C., Wang, S.-C., Leong, J., Ogawa, E., … Yu, M.-L. (2021). Characteristics and Survival Outcomes of Hepatocellular Carcinoma Developed After HCV SVR. JOURNAL OF HEPATOLOGY. ELSEVIER.

Proportion, characteristics, and outcome of chronic hepatitis B who are 'linked to care' in Korea: A nationwide retrospective longitudinal study
Ju, Y. C., Jun, D. W., Yoon, E., Ahn, S. B., Kim, Y. J., & Nguyen, M. (2021). Proportion, characteristics, and outcome of chronic hepatitis B who are 'linked to care' in Korea: A nationwide retrospective longitudinal study. JOURNAL OF HEPATOLOGY. ELSEVIER.

Comorbidity and healthcare utilization burden of patients diagnosed with non-alcoholic steatohepatitis based on fibrosis-4 score severity
Titievsky, L., Jamal-Allial, A., Gallagher, K., Capozza, T., Dodge, S., Du, S., … Esposito, D. (2021). Comorbidity and healthcare utilization burden of patients diagnosed with non-alcoholic steatohepatitis based on fibrosis-4 score severity. JOURNAL OF HEPATOLOGY. ELSEVIER.

The Changing Epidemiology of Liver Disease Among US Children and Adolescents From 1999 to 2016.
Li, J., Le, M. H., Barakat, M. T., Cheung, R. C., & Nguyen, M. H. (2021). The Changing Epidemiology of Liver Disease Among US Children and Adolescents From 1999 to 2016. The American Journal of Gastroenterology.

Treatment Algorithm for Managing Chronic Hepatitis B Virus Infection in the United States: 2021 Update.
Martin, P., Nguyen, M. H., Dieterich, D. T., Lau, D. T.-Y., Janssen, H. L., Peters, M. G., & Jacobson, I. (2021). Treatment Algorithm for Managing Chronic Hepatitis B Virus Infection in the United States: 2021 Update. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

ALT levels in Treatment-Naïve, Chronic Hepatitis B Patients with Concurrent Fatty Liver Disease: A U.S. Nationwide Study.
Chang, C. Y., Kam, L., Dang, N., Cheung, R., & Nguyen, M. H. (2021). ALT levels in Treatment-Naïve, Chronic Hepatitis B Patients with Concurrent Fatty Liver Disease: A U.S. Nationwide Study. Digestive Diseases (Basel, Switzerland).

Severe Acute Exacerbation after Cessation of Nucleos(t)ide Analog for Chronic Hepatitis B: a Real-world Study of Routine Practice.
Hsu, Y.-C. C., Wu, J.-L. L., Tseng, C.-H. H., Nguyen, M. H., Lin, C.-W. W., & Hung, C.-L. L. (2021). Severe Acute Exacerbation after Cessation of Nucleos(t)ide Analog for Chronic Hepatitis B: a Real-world Study of Routine Practice. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

Prevalence of hepatic steatosis, fibrosis and associated factors in chronic hepatitis B.
Zheng, Q., Zou, B., Wu, Y., Yeo, Y., Wu, H., Stave, C. D., … Nguyen, M. H. (2021). Prevalence of hepatic steatosis, fibrosis and associated factors in chronic hepatitis B. Alimentary Pharmacology & Therapeutics.

Impact of non-alcoholic steatohepatitis (NASH) case definition on population characteristics identified in a US claims database
Gallagher, K., Esposito, D., Jamal-Allial, A. A., Du, S., Patel, Y., Nguyen, M., … Titievsky, L. (2021). Impact of non-alcoholic steatohepatitis (NASH) case definition on population characteristics identified in a US claims database. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. WILEY.

The incidence rates of hepatobiliary diseases among non-alcoholic steatohepatitis patients stratified by fibrosis-4 (FIB-4) index for liver fibrosis
Jamal-Allial, A. A., Gallagher, K., Capozza, T., Du, S., Ness, E., Nguyen, M., … Titievsky, L. (2021). The incidence rates of hepatobiliary diseases among non-alcoholic steatohepatitis patients stratified by fibrosis-4 (FIB-4) index for liver fibrosis. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. WILEY.

Substantial gaps in evaluation and treatment of patients with hepatitis B in the US.
Ye, Q., Kam, L. Y., Yeo, Y. H., Dang, N., Huang, D. Q., Cheung, R., & Nguyen, M. H. (2021). Substantial gaps in evaluation and treatment of patients with hepatitis B in the US. Journal of Hepatology.

Characteristics and Survival Outcomes of Hepatocellular Carcinoma Developed After HCV SVR
Yeh, M.-L., Leong, J., Ogawa, E., Jun, D. W., Tseng, C.-H., Landis, C., … Yu, M.-L. (2021). Characteristics and Survival Outcomes of Hepatocellular Carcinoma Developed After HCV SVR. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY.

Optimizing Hepatitis B Virus Screening in the United States Using a Simple Demographics-Based Model.
Ramrakhiani, N. S., Chen, V. L., Le, M., Yeo, Y. H., Barnett, S. D., Waljee, A. K., … Nguyen, M. H. (2021). Optimizing Hepatitis B Virus Screening in the United States Using a Simple Demographics-Based Model. Hepatology (Baltimore, Md.).

Optimal Timing of Administration of Direct-acting Antivirals for Patients With Hepatitis C-associated Hepatocellular Carcinoma Undergoing Liver Transplantation.
Turgeon, M. K., Shah, S. A., Delman, A. M., Tran, B. V., Agopian, V. G., Wedd, J. P., … Maithel, S. K. (2021). Optimal Timing of Administration of Direct-acting Antivirals for Patients With Hepatitis C-associated Hepatocellular Carcinoma Undergoing Liver Transplantation. Annals of Surgery, 274(4), 613–620.

Provider Perspectives on HCC Surveillance in Patients With Cirrhosis: Community Provider Perspectives Matter
Provider Perspectives on HCC Surveillance in Patients With Cirrhosis: Community Provider Perspectives Matter. (2021). CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 19(9), 1991.

Letter: hepatocellular carcinoma risk in patients with non-selective beta blockers.
Huang, D. Q., & Nguyen, M. H. (2021). Letter: hepatocellular carcinoma risk in patients with non-selective beta blockers. Alimentary Pharmacology & Therapeutics, 54(8), 1093–1094.

Quantify the Risk of Severe Hepatitis B Flare in a Real World Where Cessation of Nucleos(t)ide Analog is Routinely Practiced.
Hsu, Y.-C. C., Wu, J.-L. L., & Nguyen, M. H. (2021). Quantify the Risk of Severe Hepatitis B Flare in a Real World Where Cessation of Nucleos(t)ide Analog is Routinely Practiced. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

Cost-effectiveness of HCC Surveillance among HCV patients after Sustained Virological Response with Direct-acting Antivirals.
Huang, D. Q., & Nguyen, M. H. (2021). Cost-effectiveness of HCC Surveillance among HCV patients after Sustained Virological Response with Direct-acting Antivirals. Liver International : Official Journal of the International Association for the Study of the Liver.

Body weight changes in treated hepatitis B patients switching to tenofovir alafenamide?.
Yeh, M.-L. L., Liang, P.-C. C., Trinh, S., Huang, C.-I. I., Huang, C.-F. F., Hsieh, M.-Y. Y., … Yu, M.-L. L. (2021). Body weight changes in treated hepatitis B patients switching to tenofovir alafenamide?. Journal of the Formosan Medical Association = Taiwan Yi Zhi.

Pooling data to assess risks and benefits of discontinuing nucleos(t)ide analogs in patients with chronic hepatitis B: challenges and opportunities.
Hsu, Y.-C. C., Tseng, C.-H. H., Su, T.-H. H., Kao, J.-H. H., & Nguyen, M. H. (2021). Pooling data to assess risks and benefits of discontinuing nucleos(t)ide analogs in patients with chronic hepatitis B: challenges and opportunities. Gut.

Nationwide Data on the Characteristics of Linked-to-Care Chronic Hepatitis B in Korea.
Ju, Y. C., Jun, D. W., Yoon, E. L., Ahn, S. B., Kim, Y. J., & Nguyen, M. H. (2021). Nationwide Data on the Characteristics of Linked-to-Care Chronic Hepatitis B in Korea. Journal of Clinical Medicine, 10(20).

On-treatment gamma-glutamyl transferase predicts the development of hepatocellular carcinoma in chronic hepatitis B patients.
Huang, C.-F., Tyng-Yuan, J., Jun, D. W., Ahn, S. B., An, J., Enomoto, M., … Yu, M.-L. (2021). On-treatment gamma-glutamyl transferase predicts the development of hepatocellular carcinoma in chronic hepatitis B patients. Liver International : Official Journal of the International Association for the Study of the Liver.

Lurking in acute hepatitis B flares following treatment cessation were inescapable uncertainty and potential irreversibility.
Hsu, Y.-C., Tseng, C.-H., & Nguyen, M. H. (2021). Lurking in acute hepatitis B flares following treatment cessation were inescapable uncertainty and potential irreversibility. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

Effect of sarcopenia on survival in patients with cirrhosis: A systematic review and meta-analysis.
Tantai, X., Liu, Y., Yeo, Y. H., Praktiknjo, M., Mauro, E., Hamaguchi, Y., … Nguyen, M. H. (2021). Effect of sarcopenia on survival in patients with cirrhosis: A systematic review and meta-analysis. Journal of Hepatology.

Longitudinal renal changes in chronic hepatitis B patients treated with entecavir versus TDF: a REAL-B study.
Mak, L.-Y. Y., Hoang, J., Jun, D. W., Chen, C.-H. H., Peng, C.-Y. Y., Yeh, M.-L. L., … Nguyen, M. H. (2021). Longitudinal renal changes in chronic hepatitis B patients treated with entecavir versus TDF: a REAL-B study. Hepatology International.

META-ANALYSIS: REGIONAL DIFFERENCES IN OUTCOMES OF SURGICAL RESECTION FOR HEPATOCELLULAR CARCINOMA
Teng, M., Reveron-Thornton, R., Lee, E. Y., Tran, A. K., Vajanaphanich, S., Tan, X. X. E., … Huang, D. (2021). META-ANALYSIS: REGIONAL DIFFERENCES IN OUTCOMES OF SURGICAL RESECTION FOR HEPATOCELLULAR CARCINOMA. HEPATOLOGY. WILEY.

OVERALL (OS) AND RECURRENCE-FREE SURVIVAL (RFS) FOLLOWING SURGICAL RESECTION FOR HEPATOCELLULAR CARCINOMA (HCC) WITH MACROVASCULAR INVASION (MVI): A META-ANALYSIS OF 40 STUDIES AND 8,218 PATIENTS
Huang, D., Tran, A. K., Tan, X. X. E., Quek, S., Nerurkar, S., Teh, R., … Nguyen, M. H. (2021). OVERALL (OS) AND RECURRENCE-FREE SURVIVAL (RFS) FOLLOWING SURGICAL RESECTION FOR HEPATOCELLULAR CARCINOMA (HCC) WITH MACROVASCULAR INVASION (MVI): A META-ANALYSIS OF 40 STUDIES AND 8,218 PATIENTS. HEPATOLOGY. WILEY.

UTILIZATION AND OUTCOMES OF HEPATITIS B-POSITIVE GRAFTS IN ORTHOTOPIC LIVER TRANSPLANTATION (OLT) IN THE UNITED STATES, 1987-2020
Ali, S. E., Vutien, P., Bonham, C. A., Landis, C., Kwo, P. Y., Esquivel, C. O., & Nguyen, M. H. (2021). UTILIZATION AND OUTCOMES OF HEPATITIS B-POSITIVE GRAFTS IN ORTHOTOPIC LIVER TRANSPLANTATION (OLT) IN THE UNITED STATES, 1987-2020. HEPATOLOGY. WILEY.

LONG-TERM OVERALL AND RECURRENCE-FREE SURVIVAL FOLLOWING CURATIVE SURGICAL RESECTION FOR HEPATOCELLULAR CARCINOMA IN THE RECENT DECADE: A META-ANALYSIS OF 110 STUDIES AND 82,392 PATIENTS
Reveron-Thornton, R., Teng, M. L. P., Lee, E. Y., Tran, A. K., Vajanaphanich, S., Tan, X. X. E., … Huang, D. (2021). LONG-TERM OVERALL AND RECURRENCE-FREE SURVIVAL FOLLOWING CURATIVE SURGICAL RESECTION FOR HEPATOCELLULAR CARCINOMA IN THE RECENT DECADE: A META-ANALYSIS OF 110 STUDIES AND 82,392 PATIENTS. HEPATOLOGY. WILEY.

DISPARITIES IN CIRRHOSIS-RELATED MORTALITY AMONG URBAN AND RURAL AREAS IN THE UNITED STATES: A POPULATION-BASED STUDY FROM 1999-2019
Ha, A., Le, M., Cheung, R. C., & Nguyen, M. H. (2021). DISPARITIES IN CIRRHOSIS-RELATED MORTALITY AMONG URBAN AND RURAL AREAS IN THE UNITED STATES: A POPULATION-BASED STUDY FROM 1999-2019. HEPATOLOGY. WILEY.

COMPARATIVE DIAGNOSTIC PERFORMANCE OF NONINVASIVE TESTS FOR NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND ADVANCED FIBROSIS: A UNITED STATES POPULATION-BASED STUDY IN 2017-2018
Le, M., Yeo, Y. H., Cheung, R. C., & Nguyen, M. H. (2021). COMPARATIVE DIAGNOSTIC PERFORMANCE OF NONINVASIVE TESTS FOR NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND ADVANCED FIBROSIS: A UNITED STATES POPULATION-BASED STUDY IN 2017-2018. HEPATOLOGY. WILEY.

TREATMENT EVALUATION, TREATMENT ELIGIBILITY, AND ANTIVIRAL THERAPY AMONG ASIAN AND NON-ASIAN PATIENTS WITH CHRONIC HEPATITIS B (CHB)
Huang, D., Nguyen, V. H., Trinh, H. N., Ogawa, E., Enomoto, M., Kozuka, R., … Nguyen, M. H. (2021). TREATMENT EVALUATION, TREATMENT ELIGIBILITY, AND ANTIVIRAL THERAPY AMONG ASIAN AND NON-ASIAN PATIENTS WITH CHRONIC HEPATITIS B (CHB). HEPATOLOGY. WILEY.

ALT LEVELS IN HEPATITIS B PATIENTS WITH CONCURRENT FATTY LIVER DISEASE: A US NATIONWIDE STUDY
Chang, C., Kam, L., Dang, N., Cheung, R. C., & Nguyen, M. H. (2021). ALT LEVELS IN HEPATITIS B PATIENTS WITH CONCURRENT FATTY LIVER DISEASE: A US NATIONWIDE STUDY. HEPATOLOGY. WILEY.

CHANGE OF PREDICTIVE ABILITY IN NON-INVASIVE FIBROSIS MARKERS AMONG ASIAN NON-ALCOHOLIC FATTY LIVER DISEASE BY AGE, OBESITY, AND A PRESENCE OF TYPE 2 DIABETES
Ito, T., Nguyen, V. H., Tanaka, T., Park, H., Yeh, M.-L., Kawanaka, M., … Cheung, R. C. (2021). CHANGE OF PREDICTIVE ABILITY IN NON-INVASIVE FIBROSIS MARKERS AMONG ASIAN NON-ALCOHOLIC FATTY LIVER DISEASE BY AGE, OBESITY, AND A PRESENCE OF TYPE 2 DIABETES. HEPATOLOGY. WILEY.

DECLINING HBV IMMUNITY FOLLOWING HBV VACCINATION DURING CHILDHOOD/ADOLESCENCE AND AMNESTIC RESPONSE RATES TO BOOSTER: A SYSTEMATIC REVIEW AND META-ANALYSIS.
Le, D. M., Le, M., Yeo, Y. H., Lee, E. Y., Cheung, R. C., & Nguyen, M. H. (2021). DECLINING HBV IMMUNITY FOLLOWING HBV VACCINATION DURING CHILDHOOD/ADOLESCENCE AND AMNESTIC RESPONSE RATES TO BOOSTER: A SYSTEMATIC REVIEW AND META-ANALYSIS. HEPATOLOGY. WILEY.

ENTECAVIR VERSUS TENOFOVIR DISOPROXIL FUMARATE FOR SEROCLEARANCE OF HEPATITIS B SURFACE ANTIGEN IN AN INTERNATIONAL REAL-WORLD COHORT
Hsu, Y.-C., Jun, D. W., Peng, C.-Y., Yeh, M.-L., Trinh, H. N., Wong, G. L. H., … Nguyen, M. H. (2021). ENTECAVIR VERSUS TENOFOVIR DISOPROXIL FUMARATE FOR SEROCLEARANCE OF HEPATITIS B SURFACE ANTIGEN IN AN INTERNATIONAL REAL-WORLD COHORT. HEPATOLOGY. WILEY.

GLOBAL NAFLD PREVALENCE NOW AND IN THE FUTURE- A META-ANALYSIS WITH TREND AND FORECASTING
Le, M., Yeo, Y. H., Li, X., Li, J., Zou, B., Wu, Y., … Nguyen, M. H. (2021). GLOBAL NAFLD PREVALENCE NOW AND IN THE FUTURE- A META-ANALYSIS WITH TREND AND FORECASTING. HEPATOLOGY. WILEY.

REAL-WORLD EFFECTIVENESS AND SAFETY OF INTERFERON-FREE DAAS FOR 14,676 HEPATITIS C (CHC) PATIENTS WITH GENOTYPES 1, 2, 3, 4 AND 6: A MULTINATIONAL STUDY
Ji, F., Ogawa, E., Huang, C.-F., Toyoda, H., Wong, Y. J., Iio, E., … Nguyen, M. H. (2021). REAL-WORLD EFFECTIVENESS AND SAFETY OF INTERFERON-FREE DAAS FOR 14,676 HEPATITIS C (CHC) PATIENTS WITH GENOTYPES 1, 2, 3, 4 AND 6: A MULTINATIONAL STUDY. HEPATOLOGY. WILEY.

CHANGES IN SERUM LEVEL OF RHEUMATOID FACTOR FOLLOWING ERADICATION OF HEPATITIS C VIRUS INFECTION BY INTERFERON-BASED OR INTERFERON-FREE REGIMENS
Lo, C., Tsai, Y.-N., Tseng, C.-H., Hsieh, S.-C., Nguyen, M. H., & Hsu, Y.-C. (2021). CHANGES IN SERUM LEVEL OF RHEUMATOID FACTOR FOLLOWING ERADICATION OF HEPATITIS C VIRUS INFECTION BY INTERFERON-BASED OR INTERFERON-FREE REGIMENS. HEPATOLOGY. WILEY.

SEVERE ACUTE EXACERBATION AFTER CESSATION OF NUCLEOS(T)IDE ANALOGS FOR CHRONIC HEPATITIS B: A REAL-WORLD STUDY OF ROUTINE PRACTICE
Wu, J.-L., Tseng, C.-H., Nguyen, M. H., Chen, T.-H., Tsai, Y.-N., Lin, C. W., … Hsu, Y.-C. (2021). SEVERE ACUTE EXACERBATION AFTER CESSATION OF NUCLEOS(T)IDE ANALOGS FOR CHRONIC HEPATITIS B: A REAL-WORLD STUDY OF ROUTINE PRACTICE. HEPATOLOGY. WILEY.

GALAD SCORE IMPROVES EARLY DETECTION OF HCC PRIOR TO THE DIAGNOSIS OF HCC: A PHASE 3 BIOMARKER VALIDATION STUDY
Marrero, J. A., Marsh, T. L., Parikh, N. D., Roberts, L. R., Schwartz, M. E., Nguyen, M. H., … Reddy, K. R. (2021). GALAD SCORE IMPROVES EARLY DETECTION OF HCC PRIOR TO THE DIAGNOSIS OF HCC: A PHASE 3 BIOMARKER VALIDATION STUDY. HEPATOLOGY. WILEY.

GLOBAL PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN CHILDREN AND ADOLESCENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS
Li, J., Ha, A., Rui, F., Yang, H., Xue, Q., Hu, X., … Nguyen, M. H. (2021). GLOBAL PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN CHILDREN AND ADOLESCENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS. HEPATOLOGY. WILEY.

ANTIVIRAL TREATMENT WITH TENOFOVIR DISOPROXIL FUMARATE DECREASES SERUM LEVELS OF HEPATITIS B CORE-RELATED ANTIGEN AND VIRAL RNA IN CHRONIC HEPATITIS B PATIENTS
Wu, Y.-L., Tseng, T.-C., Tsai, Y.-N., Tseng, C.-H., Chen, C.-Y., Lin, J.-T., … Hsu, Y.-C. (2021). ANTIVIRAL TREATMENT WITH TENOFOVIR DISOPROXIL FUMARATE DECREASES SERUM LEVELS OF HEPATITIS B CORE-RELATED ANTIGEN AND VIRAL RNA IN CHRONIC HEPATITIS B PATIENTS. HEPATOLOGY. WILEY.

REDUCED HEPATOCELLULAR CARCINOMA RISK IN STATIN USERS WITH NON-ALCOHOLIC FATTY LIVER DISEASE: A NATIONWIDE US STUDY
Zou, B., Odden, M. C., & Nguyen, M. H. (2021). REDUCED HEPATOCELLULAR CARCINOMA RISK IN STATIN USERS WITH NON-ALCOHOLIC FATTY LIVER DISEASE: A NATIONWIDE US STUDY. HEPATOLOGY. WILEY.

SEVERE HEPATITIS FLARE AND RELATED MORTALITY AFTER DISCONTINUATION OF ORAL ANTIVIRAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS B: A POPULATION-BASED STUDY
Hsu, Y.-C., Lin, Y.-H., Lee, T.-Y., Nguyen, M. H., Ho, H. J., Kao, F.-Y., … Wu, C.-Y. (2021). SEVERE HEPATITIS FLARE AND RELATED MORTALITY AFTER DISCONTINUATION OF ORAL ANTIVIRAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS B: A POPULATION-BASED STUDY. HEPATOLOGY. WILEY.

THE INCIDENCE OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B VIRUS INFECTION SUBJECTS WITH CIRRHOSIS NOT MEETING CURRENT TREATMENT GUIDANCE
Alshuwaykh, O., Goel, A., Ghaziani, T. T., Daugherty, T., Dhanasekaran, R., Ahmed, A., … Kwo, P. Y. (2021). THE INCIDENCE OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B VIRUS INFECTION SUBJECTS WITH CIRRHOSIS NOT MEETING CURRENT TREATMENT GUIDANCE. HEPATOLOGY. WILEY.

RENAL OUTCOMES IN POST-LIVER TRANSPLANT RECIPIENTS TREATED WITH TENOFOVIR ALAFENAMIDE COMPARED WITH TENOFOVIR DISOPROXIL FUMARATE AND ENTECAVIR
Liu, J., Vutien, P., Huang, D., Ishigami, M., Daniel, P. C. Y. N., Ito, T., … Nguyen, M. H. (2021). RENAL OUTCOMES IN POST-LIVER TRANSPLANT RECIPIENTS TREATED WITH TENOFOVIR ALAFENAMIDE COMPARED WITH TENOFOVIR DISOPROXIL FUMARATE AND ENTECAVIR. HEPATOLOGY. WILEY.

ON-TREATMENT GAMMA-GLUTAMYL TRANSFERASE PREDICTS THE DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B PATIENTS
Huang, C.-F., Jang, T.-Y., & Yu, M.-L. (2021). ON-TREATMENT GAMMA-GLUTAMYL TRANSFERASE PREDICTS THE DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B PATIENTS. HEPATOLOGY. WILEY.

OPTIMIZING HEPATITIS B VIRUS SCREENING IN THE UNITED STATES USING A SIMPLE DEMOGRAPHICS-BASED MODEL
Ramrakhiani, N., Chen, V., Le, M., Yeo, Y. H., Barnett, S. D., Waljee, A., … Nguyen, M. H. (2021). OPTIMIZING HEPATITIS B VIRUS SCREENING IN THE UNITED STATES USING A SIMPLE DEMOGRAPHICS-BASED MODEL. HEPATOLOGY. WILEY.

Genetic susceptibility to hepatocellular carcinoma in chromosome 22q13.31, findings of a genome-wide association study
Wang, Z., Budhu, A. S., Shen, Y., Wong, L. L., Hernandez, B. Y., Tiirikainen, M., … Yu, H. (2021). Genetic susceptibility to hepatocellular carcinoma in chromosome 22q13.31, findings of a genome-wide association study. JGH OPEN.

2019 global NAFLD prevalence - A systematic review and meta-analysis.
Le, M. H., Yeo, Y. H., Li, X., Li, J., Zou, B., Wu, Y., … Nguyen, M. H. (2021). 2019 global NAFLD prevalence - A systematic review and meta-analysis. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

Letter: hepatic steatosis in chronic hepatitis B-viral, metabolic or treatment-related? Authors' reply.
Zheng, Q., & Nguyen, M. H. (2022). Letter: hepatic steatosis in chronic hepatitis B-viral, metabolic or treatment-related? Authors' reply. Alimentary Pharmacology & Therapeutics, 55(1), 149.

Letter: hepatic steatosis and fibrosis in chronic hepatitis B-the chicken-and-egg conundrum. Authors' reply.
Zheng, Q., & Nguyen, M. H. (2022). Letter: hepatic steatosis and fibrosis in chronic hepatitis B-the chicken-and-egg conundrum. Authors' reply. Alimentary Pharmacology & Therapeutics, 55(1), 145–146.

A MULTI-ANALYTE BLOOD TEST FOR ACCURATE AND EARLY DETECTION OF HEPATOCELLULAR CARCINOMA
Lin, N., Lin, Y., Xu, J., Li, M., Liu, D., Gallant, M. A., … Li, W. (2021). A MULTI-ANALYTE BLOOD TEST FOR ACCURATE AND EARLY DETECTION OF HEPATOCELLULAR CARCINOMA. HEPATOLOGY. WILEY.

Hepatitis B screening-Universal or simplified semi-targeted but not the status quo.
Chen, V. L., Ramrakhiani, N. S., & Nguyen, M. H. (1800). Hepatitis B screening-Universal or simplified semi-targeted but not the status quo. Hepatology (Baltimore, Md.).

Clinical profiles of Asians with NAFLD: A systematic review and meta-analysis.
Kam, L., Huang, D. Q., Teng, M. L., Takahashi, H., Tanaka, K., Yasuda, S., … Nguyen, M. H. (2021). Clinical profiles of Asians with NAFLD: A systematic review and meta-analysis. Digestive Diseases (Basel, Switzerland).

Genetic susceptibility to hepatocellular carcinoma in chromosome 22q13.31, findings of a genome-wide association study.
Wang, Z., Budhu, A. S., Shen, Y., Wong, L. L., Hernandez, B. Y., Tiirikainen, M., … Yu, H. (2021). Genetic susceptibility to hepatocellular carcinoma in chromosome 22q13.31, findings of a genome-wide association study. JGH Open : an Open Access Journal of Gastroenterology and Hepatology, 5(12), 1363–1372.

Increased risk of liver-related outcomes in chronic hepatitis B patients with metabolic syndrome: A systematic review and meta-analysis.
Thin, K. N., Tran, A., Li, J., Lee, E. Y., Yang, H., Rui, F., … Nguyen, M. H. (2022). Increased risk of liver-related outcomes in chronic hepatitis B patients with metabolic syndrome: A systematic review and meta-analysis. Digestive Diseases (Basel, Switzerland).

Inhibition of Viral Replication Reduces Transcriptionally Active Distinct Hepatitis B Virus Integrations with Implications on Host Gene Dysregulation.
Hsu, Y.-C. C., Suri, V., Nguyen, M. H., Huang, Y.-T. T., Chen, C.-Y. Y., Chang, I.-W. W., … Podlaha, O. (2022). Inhibition of Viral Replication Reduces Transcriptionally Active Distinct Hepatitis B Virus Integrations with Implications on Host Gene Dysregulation. Gastroenterology.

Serum soluble programmed cell death 1 levels predict spontaneous functional cure in inactive carriers with chronic hepatitis B.
Hu, H.-H. H., Jeng, W.-J. J., Pan, M.-H. H., Luo, W.-S. S., Chang, C.-L. L., Huang, Y.-T. T., … Yang, H.-I. I. (2022). Serum soluble programmed cell death 1 levels predict spontaneous functional cure in inactive carriers with chronic hepatitis B. Alimentary Pharmacology & Therapeutics.

MAFLD and pregnancy- What are the consequences?
Nakanishi, A., Henry, L., & Nguyen, M. H. (2022). MAFLD and pregnancy- What are the consequences? Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

Performance of noninvasive tests of fibrosis among Asians, Hispanic and non-Hispanic Whites in the STELLAR trials.
Wong, V. W.-S., Tak, W. Y., Goh, G. B., Cheng, P.-N. N., Lawitz, E. J., Younossi, Z. M., … Okanoue, T. (2022). Performance of noninvasive tests of fibrosis among Asians, Hispanic and non-Hispanic Whites in the STELLAR trials. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

Is it safe to treat chronic hepatitis C patients with decompensated cirrhosis with PI-based DAA?
Wong, Y. J., & Nguyen, M. H. (2022). Is it safe to treat chronic hepatitis C patients with decompensated cirrhosis with PI-based DAA? Journal of Hepatology.

County-Level Variation in Cirrhosis-Related Mortality in the US, 1999-2019.
Ha, A. Y., Le, M. H., Henry, L., Yeo, Y. H., Cheung, R. C., & Nguyen, M. H. (2022). County-Level Variation in Cirrhosis-Related Mortality in the US, 1999-2019. JAMA Network Open, 5(2), e2146427.

Chronic hepatitis B and fatty liver -weal or woe?
Li, J., Henry, L., & Nguyen, M. H. (2022). Chronic hepatitis B and fatty liver -weal or woe? The American Journal of Gastroenterology.

Renal outcomes with tenofovir alafenamide in liver transplant recipients.
Liu, J. K., Vutien, P., Huang, D. Q., Ishigami, M., Landis, C., Nguyen, M. H., … Leong, J. (2022). Renal outcomes with tenofovir alafenamide in liver transplant recipients. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

Statin Use and Reduced Hepatocellular Carcinoma Risk in Patients with Non-alcoholic Fatty Liver Disease.
Zou, B., Odden, M. C., & Nguyen, M. H. (2022). Statin Use and Reduced Hepatocellular Carcinoma Risk in Patients with Non-alcoholic Fatty Liver Disease. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

A multi-analyte cell-free DNA-based blood test for early detection of hepatocellular carcinoma.
Lin, N., Lin, Y., Xu, J., Liu, D., Li, D., Meng, H., … Li, W. (2022). A multi-analyte cell-free DNA-based blood test for early detection of hepatocellular carcinoma. Hepatology Communications.

Global and regional long-term survival following resection for HCC in the recent decade: A meta-analysis of 110 studies.
Reveron-Thornton, R. F., Teng, M. L., Lee, E. Y., Tran, A., Vajanaphanich, S., Tan, E. X., … Huang, D. Q. (2022). Global and regional long-term survival following resection for HCC in the recent decade: A meta-analysis of 110 studies. Hepatology Communications.

Defining Age-Related Thresholds for ALT and the Risk of Confounders
Huang, D. Q., & Nguyen, M. H. (2022). Defining Age-Related Thresholds for ALT and the Risk of Confounders. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 20(3), 715–716.

Global multi-stakeholder endorsement of the MAFLD definition.
Méndez-Sánchez, N., Bugianesi, E., Gish, R. G., Lammert, F., Tilg, H., Nguyen, M. H., … Eslam, M. (2022). Global multi-stakeholder endorsement of the MAFLD definition. The Lancet. Gastroenterology & Hepatology.

Response to "Does NAFLD prevalence data expire?"
Yeo, Y. H., Le, M. H., & Nguyen, M. H. (2022). Response to "Does NAFLD prevalence data expire?". Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

Multi-target blood test to improve the performance of hepatocellular carcinoma surveillance programs: A modeling-based virtual trial
Chhatwal, J., Samur, S., Yang, J. D., Roberts, L. R., Nguyen, M., Ozbay, A. B., … Singal, A. G. (2022). Multi-target blood test to improve the performance of hepatocellular carcinoma surveillance programs: A modeling-based virtual trial. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

Metabolic abnormalities play a crucial role in non-obese people suffering from non-alcoholic fatty liver disease (NAFLD).
Ye, Q., Ito, T., Henry, L., & Nguyen, M. H. (2022). Metabolic abnormalities play a crucial role in non-obese people suffering from non-alcoholic fatty liver disease (NAFLD). Hepatobiliary Surgery and Nutrition, 11(2), 333–334.

NAFLD versus MAFLD: Prevalence, Outcomes and Implications of a Change in Name.
Ng, C. H., Huang, D. Q., & Nguyen, M. H. (2022). NAFLD versus MAFLD: Prevalence, Outcomes and Implications of a Change in Name. Clinical and Molecular Hepatology.

Machine Learning Can Predict Recurrence Patterns After Liver Transplantation in Hepatocellular Carcinoma Patients: Analysis from the US Multicenter HCC Transplant Consortium
Narayan, R. R., Safarnejad, L., Tran, B., Nguyen, M., Ross, E., Agopian, V., & Melcher, M. (2022). Machine Learning Can Predict Recurrence Patterns After Liver Transplantation in Hepatocellular Carcinoma Patients: Analysis from the US Multicenter HCC Transplant Consortium. ANNALS OF SURGICAL ONCOLOGY. SPRINGER.

Poor diagnostic efficacy of noninvasive tests for advanced fibrosis in obese or younger than 60 diabetic NAFLD patients.
Ito, T., Nguyen, V. H., Tanaka, T., Park, H., Yeh, M.-L. L., Kawanaka, M., … Cheung, R. C. (2022). Poor diagnostic efficacy of noninvasive tests for advanced fibrosis in obese or younger than 60 diabetic NAFLD patients. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

Meta-analysis: global prevalence, trend and forecasting of non-alcoholic fatty liver disease in children and adolescents, 2000-2021.
Li, J., Ha, A., Rui, F., Zou, B., Yang, H., Xue, Q., … Nguyen, M. H. (2022). Meta-analysis: global prevalence, trend and forecasting of non-alcoholic fatty liver disease in children and adolescents, 2000-2021. Alimentary Pharmacology & Therapeutics.

Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir Treatment for Chronic Hepatitis B Virus: A Reconstructed Individual Patient Data Meta-analysis.
Tan, D. J., Ng, C. H., Tay, P. W., Syn, N., Muthiah, M. D., Lim, W. H., … Huang, D. Q. (2022). Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir Treatment for Chronic Hepatitis B Virus: A Reconstructed Individual Patient Data Meta-analysis. JAMA Network Open, 5(6), e2219407.

Cabozantinib plus atezolizumab in advanced hepatocellular carcinoma and the role of adjuvant antiviral therapy.
Ji, F., & Nguyen, M. H. (2022). Cabozantinib plus atezolizumab in advanced hepatocellular carcinoma and the role of adjuvant antiviral therapy. The Lancet. Oncology.

Utilization and outcomes of hepatitis B-positive grafts in orthotopic liver transplantation in the United States, 1999-2021.
Ali, S. E., Vutien, P., Bonham, C. A., Landis, C., Kwo, P., Esquivel, C., & Nguyen, M. H. (2022). Utilization and outcomes of hepatitis B-positive grafts in orthotopic liver transplantation in the United States, 1999-2021. Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Increased mortality of patients with alcohol-related liver diseases during the COVID-19 pandemic in the United States.
Yeo, Y. H., Zou, B., Cheung, R., & Nguyen, M. H. (2022). Increased mortality of patients with alcohol-related liver diseases during the COVID-19 pandemic in the United States. Journal of Internal Medicine.

Characteristics and outcomes of hepatocellular carcinoma patients with macrovascular invasion following surgical resection: a meta-analysis of 40 studies and 8,218 patients
Huang, D. Q., Tran, A., Tan, E. X., Nerurkar, S. N., Teh, R., Teng, M. L. P., … Nguyen, M. H. (2022). Characteristics and outcomes of hepatocellular carcinoma patients with macrovascular invasion following surgical resection: a meta-analysis of 40 studies and 8,218 patients. HEPATOBILIARY SURGERY AND NUTRITION.

Improved treatment response and bone density in patients with chronic hepatitis B (CHB) switched to tenofovir alafenamide (TAF) from other nucleos (t)ide analogue: 96-week results from a prospective multinational study
Ogawa, E., Jun, D. W., Toyoda, H., Hsu, Y.-C., Yoon, E., Ahn, S. B., … Nguyen, M. (2022). Improved treatment response and bone density in patients with chronic hepatitis B (CHB) switched to tenofovir alafenamide (TAF) from other nucleos (t)ide analogue: 96-week results from a prospective multinational study. JOURNAL OF HEPATOLOGY. ELSEVIER.

The effect of sarcopenia on survival of patients with cirrhosis: a systematic review and meta-analysis
Tantai, X., Liu, Y., Yeo, Y. H., Praktiknjo, M., Mauro, E., Hamaguchi, Y., … Nguyen, M. (2022). The effect of sarcopenia on survival of patients with cirrhosis: a systematic review and meta-analysis. JOURNAL OF HEPATOLOGY. ELSEVIER.

Could a multi-target blood test make hepatocellular carcinoma surveillance programs more effective? A modelling-based virtual trial
Chhatwal, J., Samur, S., Yang, J. D., Roberts, L., Nguyen, M., Ozbay, A. B., … Singal, A. (2022). Could a multi-target blood test make hepatocellular carcinoma surveillance programs more effective? A modelling-based virtual trial. JOURNAL OF HEPATOLOGY. ELSEVIER.

Transient Elastography and Serum-based Tests for Diagnosis of Fatty Liver and Advanced Fibrosis in a Community Cohort- a Cross Sectional Analysis.
Le, M. H., Henry, L., Cheung, R., & Nguyen, M. H. (2022). Transient Elastography and Serum-based Tests for Diagnosis of Fatty Liver and Advanced Fibrosis in a Community Cohort- a Cross Sectional Analysis. Digestive Diseases (Basel, Switzerland).

Impact of the COVID-19 pandemic on liver disease-related mortality rates in the United States.
Gao, X., Lv, F., He, X., Zhao, Y., Liu, Y., Zu, J., … Nguyen, M. H. (2022). Impact of the COVID-19 pandemic on liver disease-related mortality rates in the United States. Journal of Hepatology.

Incidence of hepatocellular carcinoma in chronic hepatitis B virus infection in those not meeting criteria for antiviral therapy.
Alshuwaykh, O., Daugherty, T., Cheung, A., Goel, A., Dhanasekaran, R., Ghaziani, T. T., … Kwo, P. Y. (2022). Incidence of hepatocellular carcinoma in chronic hepatitis B virus infection in those not meeting criteria for antiviral therapy. Hepatology Communications.

Letter to the editor: Screening for fatty liver disease and fibrosis in the elderly population: A call for action.
Li, J., & Nguyen, M. H. (2022). Letter to the editor: Screening for fatty liver disease and fibrosis in the elderly population: A call for action. Hepatology (Baltimore, Md.).

Clinical characteristics and outcomes in those with primary extrahepatic malignancy and malignant ascites.
Alshuwaykh, O., Cheung, A., Goel, A., Kwong, A., Dhanasekaran, R., Ghaziani, T. T., … Kwo, P. Y. (2022). Clinical characteristics and outcomes in those with primary extrahepatic malignancy and malignant ascites. BMC Gastroenterology, 22(1), 410.

Effectiveness of entecavir vs tenofovir disoproxil fumarate for functional cure of chronic hepatitis B in an international cohort.
Hsu, Y.-C. C., Jun, D. W., Peng, C.-Y. Y., Yeh, M.-L. L., Trinh, H., Wong, G. L.-H., … Nguyen, M. H. (2022). Effectiveness of entecavir vs tenofovir disoproxil fumarate for functional cure of chronic hepatitis B in an international cohort. Hepatology International.

Liver complications in untreated treatment-ineligible versus treated treatment-eligible patients with hepatitis B.
Huang, D. Q., Lee, D. H., Le, M. H., Le, A., Yeo, Y. H., Trinh, H. N., … Nguyen, M. H. (2022). Liver complications in untreated treatment-ineligible versus treated treatment-eligible patients with hepatitis B. Digestive Diseases (Basel, Switzerland).

Most excess years of potential life loss among individuals with cirrhosis during the pandemic were not related to COVID-19
Zhao, Y., Yeo, Y. H., Samaan, J., Lv, F., He, X., Gao, N., … Nguyen, M. H. (2022). Most excess years of potential life loss among individuals with cirrhosis during the pandemic were not related to COVID-19. GUT.

Gaps in hepatocellular carcinoma surveillance in a United States cohort of insured patients with cirrhosis.
Nguyen, M. H., Roberts, L. R., Engel-Nitz, N. M., Bancroft, T., Ozbay, A. B., & Singal, A. G. (2022). Gaps in hepatocellular carcinoma surveillance in a United States cohort of insured patients with cirrhosis. Current Medical Research and Opinion, 1–35.

Forecasted 2040 Global Prevalence of NAFLD using Hierarchical Bayesian Approach.
Le, M. H., Yeo, Y. H., Zou, B., Barnet, S., Henry, L., Cheung, R., & Nguyen, M. H. (2022). Forecasted 2040 Global Prevalence of NAFLD using Hierarchical Bayesian Approach. Clinical and Molecular Hepatology.

Bulevirtide and tenofovir combination therapy for hepatitis D virus infection: longer treatment and more diverse trial populations are needed.
Ito, T., & Nguyen, M. H. (2022). Bulevirtide and tenofovir combination therapy for hepatitis D virus infection: longer treatment and more diverse trial populations are needed. The Lancet. Infectious Diseases.

Gaps in hepatocellular carcinoma surveillance among insured patients with hepatitis B infection without cirrhosis in the United States.
Nguyen, M. H., Roberts, L. R., Engel-Nitz, N. M., Bancroft, T., Ozbay, A. B., & Singal, A. G. (2022). Gaps in hepatocellular carcinoma surveillance among insured patients with hepatitis B infection without cirrhosis in the United States. Hepatology Communications.

Impact of advanced practice providers on characteristics and quality of care of patients with chronic hepatitis B.
Kam, L. Y., Huang, D. Q., Tobias, A. F., Poon, K., Henry, L., Kwo, P., … Nguyen, M. H. (2022). Impact of advanced practice providers on characteristics and quality of care of patients with chronic hepatitis B. Alimentary Pharmacology & Therapeutics.

A Reappraisal of the Diagnostic Performance of B-Mode Ultrasonography for Mild Liver Steatosis.
Lee, C.-M. M., Yoon, E. L., Nakajima, A., Yoneda, M., Toyoda, H., Yasuda, S., … Sumida, Y. (2022). A Reappraisal of the Diagnostic Performance of B-Mode Ultrasonography for Mild Liver Steatosis. The American Journal of Gastroenterology.

Recognizing skin conditions in patients with cirrhosis: a narrative review.
Liu, Y., Zhao, Y., Gao, X., Liu, J., Ji, F., Hsu, Y.-C. C., … Nguyen, M. H. (2022). Recognizing skin conditions in patients with cirrhosis: a narrative review. Annals of Medicine, 54(1), 3017–3029.

Prevalence, characteristics, and mortality outcomes of obese and nonobese MAFLD in the United States.
Dao, A. D., Nguyen, V. H., Ito, T., Cheung, R., & Nguyen, M. H. (2022). Prevalence, characteristics, and mortality outcomes of obese and nonobese MAFLD in the United States. Hepatology International.

Trends of Cirrhosis-related Mortality in the USA during the COVID-19 Pandemic
Yeo, Y. H., He, X., Lv, F., Zhao, Y., Liu, Y., Yang, J. D., … Nguyen, M. H. (2022). Trends of Cirrhosis-related Mortality in the USA during the COVID-19 Pandemic. JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY.

Serious adverse events after cessation of nucleos(t)ide analogues in individuals with chronic hepatitis B: A systematic review and meta-analysis.
Tseng, C.-H. H., Chen, T.-H. H., Wu, J.-L. L., Lee, T.-Y. Y., Borghi, J. A., Lin, J.-T. T., … Hsu, Y.-C. C. (2023). Serious adverse events after cessation of nucleos(t)ide analogues in individuals with chronic hepatitis B: A systematic review and meta-analysis. JHEP Reports : Innovation in Hepatology, 5(1), 100617.

Characteristics and Treatment Rate of Patients With Hepatitis C Virus Infection in the Direct-Acting Antiviral Era and During the COVID-19 Pandemic in the United States.
Nguyen, V. H., Kam, L., Yeo, Y. H., Huang, D. Q., Henry, L., Cheung, R., & Nguyen, M. H. (2022). Characteristics and Treatment Rate of Patients With Hepatitis C Virus Infection in the Direct-Acting Antiviral Era and During the COVID-19 Pandemic in the United States. JAMA Network Open, 5(12), e2245424.

Association of Direct-Acting Antiviral Therapy With Liver and Nonliver Complications and Long-term Mortality in Patients With Chronic Hepatitis C.
Ogawa, E., Chien, N., Kam, L., Yeo, Y. H., Ji, F., Huang, D. Q., … Nguyen, M. H. (2022). Association of Direct-Acting Antiviral Therapy With Liver and Nonliver Complications and Long-term Mortality in Patients With Chronic Hepatitis C. JAMA Internal Medicine.

Curing chronic hepatitis B virus infection.
Hsu, Y.-C. C., & Nguyen, M. H. (2022). Curing chronic hepatitis B virus infection. The Lancet. Infectious Diseases.

ANTIVIRAL THERAPY IS SEVERELY UNDERUTILIZED IN HEPATITIS B-AND HEPATITIS C-ASSOCIATED HEPATOCELLULAR CARCINOMA AFTER LIVER RESECTION: A REAL-HCC STUDY
Huang, D., Kamal, R., Bonham, C., Tsai, P.-C., Toyoda, H., Yeh, M.-L., … Nguyen, M. H. (2022). ANTIVIRAL THERAPY IS SEVERELY UNDERUTILIZED IN HEPATITIS B-AND HEPATITIS C-ASSOCIATED HEPATOCELLULAR CARCINOMA AFTER LIVER RESECTION: A REAL-HCC STUDY. HEPATOLOGY. WILEY.

Characteristics and outcomes of hepatocellular carcinoma patients with macrovascular invasion following surgical resection: a meta-analysis of 40 studies and 8,218 patients.
Huang, D. Q., Tran, A., Tan, E. X., Nerurkar, S. N., Teh, R., Teng, M. L., … Nguyen, M. H. (2022). Characteristics and outcomes of hepatocellular carcinoma patients with macrovascular invasion following surgical resection: a meta-analysis of 40 studies and 8,218 patients. Hepatobiliary Surgery and Nutrition, 11(6), 848–860.

CHARACTERISTICS AND CARE OF CHRONIC HEPATITIS B PATIENTS WITH ADVANCED PRACTICE PROVIDERS
Kam, L., Huang, D., Tobias, A. F., Poon, K., Henry, L., Kwo, P. Y., … Nguyen, M. H. (2022). CHARACTERISTICS AND CARE OF CHRONIC HEPATITIS B PATIENTS WITH ADVANCED PRACTICE PROVIDERS. HEPATOLOGY. WILEY.

A NOVEL EDUCATIONAL PROGRAM TO ADDRESS MISUNDERSTANDINGS IN APPLYING AASLD HBV TREATMENT GUIDELINES
Ahn, J., Anderson, S., Dela Cruz, A. C. L., Kwo, P. Y., Nguyen, M. H., & Schwartz, Z. (2022). A NOVEL EDUCATIONAL PROGRAM TO ADDRESS MISUNDERSTANDINGS IN APPLYING AASLD HBV TREATMENT GUIDELINES. HEPATOLOGY. WILEY.

RACIAL AND ETHNIC DISPARITIES IN CHARACTERISTICS AND CARE PATTERNS OF CHRONIC HEPATITIS B (CHB) PATIENTS IN THE UNITED STATES (US): RESULTS OF A NATIONWIDE COHORT
Liu, J., Kam, L., Huang, D., Henry, L., Cheung, R., & Nguyen, M. H. (2022). RACIAL AND ETHNIC DISPARITIES IN CHARACTERISTICS AND CARE PATTERNS OF CHRONIC HEPATITIS B (CHB) PATIENTS IN THE UNITED STATES (US): RESULTS OF A NATIONWIDE COHORT. HEPATOLOGY. WILEY.

INCREASED TREATMENT RESPONSE AND BONE DENSITY IN PATIENTS WITH CHRONIC HEPATITIS B SWITCHED TO TENOFOVIR ALAFENAMIDE FROM OTHER NUCLEOS(T) IDE ANALOGUE: 96-WEEK RESULTS FROM A PROSPECTIVE MULTINATIONAL STUDY
Ogawa, E., Jun, D. W., Toyoda, H., Hsu, Y.-C., Yoon, E., Ahn, S. B., … Nguyen, M. H. (2022). INCREASED TREATMENT RESPONSE AND BONE DENSITY IN PATIENTS WITH CHRONIC HEPATITIS B SWITCHED TO TENOFOVIR ALAFENAMIDE FROM OTHER NUCLEOS(T) IDE ANALOGUE: 96-WEEK RESULTS FROM A PROSPECTIVE MULTINATIONAL STUDY. HEPATOLOGY. WILEY.

CHARACTERISTICS AND TREATMENT RATE OF PATIENTS WITH HEPATITIS C VIRUS INFECTION IN THE DAA AND COVID-19 ERAS IN THE UNITED STATES
Nguyen, V. H., Kam, L., Yeo, Y. H., Huang, D., Henry, L., Cheung, R., & Nguyen, M. H. (2022). CHARACTERISTICS AND TREATMENT RATE OF PATIENTS WITH HEPATITIS C VIRUS INFECTION IN THE DAA AND COVID-19 ERAS IN THE UNITED STATES. HEPATOLOGY. WILEY.

ANTIVIRAL THERAPY REDUCES HEPATOCELLULAR CARCINOMA RISK AMONG HBV PATIENTS IN THE INDETERMINATE PHASE
Huang, D., Tran, A. K., Yeh, M.-L., Tsai, P.-C., Chuang, W.-L., Huang, C.-F., … Nguyen, M. H. (2022). ANTIVIRAL THERAPY REDUCES HEPATOCELLULAR CARCINOMA RISK AMONG HBV PATIENTS IN THE INDETERMINATE PHASE. HEPATOLOGY. WILEY.

NATIONWIDE POPULATION-LEVEL REAL-WORLD EVIDENCE OF LONG-TERM MORTALITY, LIVER AND NON-LIVER BENEFITS OF DAA THERAPY IN PATIENTS WITH CHRONIC HEPATITIS (CHC) TREATED WITH DIRECT-ACTING ANTIVIRALS (DAA)
Ogawa, E., Chien, N., Kam, L., Tran, S., Huang, D., Yeo, Y. H., … Nguyen, M. H. (2022). NATIONWIDE POPULATION-LEVEL REAL-WORLD EVIDENCE OF LONG-TERM MORTALITY, LIVER AND NON-LIVER BENEFITS OF DAA THERAPY IN PATIENTS WITH CHRONIC HEPATITIS (CHC) TREATED WITH DIRECT-ACTING ANTIVIRALS (DAA). HEPATOLOGY. WILEY.

DIFFERENTIAL HEPATOCELLULAR CARCINOMA (HCC) INCIDENCE AND SURVIVAL RATES BY ETIOLOGY OF CHRONIC LIVER DISEASE (CLD) IN A NATIONWIDE REAL-WORLD COHORT OF UNITED STATES PATIENTS WITH CIRRHOSIS, 2003-2021
Tran, S., Zou, B., Kam, L., Huang, D., Henry, L., Cheung, R., & Nguyen, M. H. (2022). DIFFERENTIAL HEPATOCELLULAR CARCINOMA (HCC) INCIDENCE AND SURVIVAL RATES BY ETIOLOGY OF CHRONIC LIVER DISEASE (CLD) IN A NATIONWIDE REAL-WORLD COHORT OF UNITED STATES PATIENTS WITH CIRRHOSIS, 2003-2021. HEPATOLOGY. WILEY.

UTILIZATION OF ANTIVIRAL THERAPY AND ITS IMPACT ON SURVIVAL RATES IN PATIENTS WITH CHRONIC HEPATITIS B VIRUS-RELATED HEPATOCELLULAR CARCINOMA (HBV-HCC) IN THE UNITED STATES
Kudaravalli, S., Kam, L., Huang, D., Cheung, R., & Nguyen, M. H. (2022). UTILIZATION OF ANTIVIRAL THERAPY AND ITS IMPACT ON SURVIVAL RATES IN PATIENTS WITH CHRONIC HEPATITIS B VIRUS-RELATED HEPATOCELLULAR CARCINOMA (HBV-HCC) IN THE UNITED STATES. HEPATOLOGY. WILEY.

REAL-WORLD TREATMENT OUTCOME WITH PROTEASE INHIBITOR (PI) VERSUS NON-PI DIRECT ACTING ANTIVIRAL (DAA) IN DECOMPENSATED HEPATITIS C (HCV) CIRRHOSIS: A REAL-C STUDY WITH INVERSE PROBABILITY OF TREATMENT WEIGHTING (IPTW) ANALYSIS
Wong, Y. J., Tran, S., Huang, C.-F., Hsu, Y.-C., Preda, C., Toyoda, H., … Nguyen, M. H. (2022). REAL-WORLD TREATMENT OUTCOME WITH PROTEASE INHIBITOR (PI) VERSUS NON-PI DIRECT ACTING ANTIVIRAL (DAA) IN DECOMPENSATED HEPATITIS C (HCV) CIRRHOSIS: A REAL-C STUDY WITH INVERSE PROBABILITY OF TREATMENT WEIGHTING (IPTW) ANALYSIS. HEPATOLOGY. WILEY.

PREDICTING HEPATOCELLULAR CARCINOMA DEVELOPMENT IN NAFLD PATIENTS WITHOUT CIRRHOSIS
Huang, D., Lin, Y. L., Tran, S., Zou, B., Yeo, Y. H., Cheung, R., & Nguyen, M. H. (2022). PREDICTING HEPATOCELLULAR CARCINOMA DEVELOPMENT IN NAFLD PATIENTS WITHOUT CIRRHOSIS. HEPATOLOGY. WILEY.

DIFFERENTIAL CHARACTERISTICS AND SURVIVAL BY CHRONIC LIVER DISEASE (CLD) ETIOLOGY IN A NATIONWIDE REAL-WORLD COHORT OF PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC), 2003-2021
Tran, S., Zou, B., Kam, L., Huang, D., Henry, L., Hsing, A., … Nguyen, M. H. (2022). DIFFERENTIAL CHARACTERISTICS AND SURVIVAL BY CHRONIC LIVER DISEASE (CLD) ETIOLOGY IN A NATIONWIDE REAL-WORLD COHORT OF PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC), 2003-2021. HEPATOLOGY. WILEY.

SEX DIFFERENCES IN CLINICAL PRESENTATION AND SURVIVAL IN PATIENTS WITH CIRRHOSIS
Fong, A., Tran, A. K., Ha, A., Nguyen, V. H., Zhao, C., Jin, M., … Nguyen, M. H. (2022). SEX DIFFERENCES IN CLINICAL PRESENTATION AND SURVIVAL IN PATIENTS WITH CIRRHOSIS. HEPATOLOGY. WILEY.

HIGHER HEPATOCELLULAR CARCINOMA (HCC) INCIDENCE IN CHRONIC HEPATITIS C (CHC) PATIENTS AFTER HEPATITIS C VIRUS (HCV) CURE COMPARED TO TREATED CHRONIC HEPATITIS B (CHB): RESULTS FROM A MULTINATIONAL REAL-WORLD COHORT OF PATIENTS WITH CIRRHOSIS
Park, J., Tran, S., Ogawa, E., Huang, C.-F., Toyoda, H., Chen, C. H., … Nguyen, M. H. (2022). HIGHER HEPATOCELLULAR CARCINOMA (HCC) INCIDENCE IN CHRONIC HEPATITIS C (CHC) PATIENTS AFTER HEPATITIS C VIRUS (HCV) CURE COMPARED TO TREATED CHRONIC HEPATITIS B (CHB): RESULTS FROM A MULTINATIONAL REAL-WORLD COHORT OF PATIENTS WITH CIRRHOSIS. HEPATOLOGY. WILEY.

RACIAL AND ETHNIC DISPARITIES IN CLINICAL PRESENTATION, TREATMENT, AND OVERALL SURVIVAL IN PATIENTS WITH HEPATITIS C-RELATED HEPATOCELLULAR CARCINOMA (HCV-HCC): A REAL-WORLD EXPERIENCE FROM THE REAL-HCC REGISTRY
Park, J. E., Nguyen, V. H., Tsai, P.-C., Toyoda, H., Leong, J., Guy, J. E., … Nguyen, M. H. (2022). RACIAL AND ETHNIC DISPARITIES IN CLINICAL PRESENTATION, TREATMENT, AND OVERALL SURVIVAL IN PATIENTS WITH HEPATITIS C-RELATED HEPATOCELLULAR CARCINOMA (HCV-HCC): A REAL-WORLD EXPERIENCE FROM THE REAL-HCC REGISTRY. HEPATOLOGY. WILEY.

THE TREND OF YEARS OF POTENTIAL LIFE LOST ASSOCIATED WITH CIRRHOSIS BEFORE AND DURING THE COVID-19 PANDEMIC: A POPULATION-BASED STUDY
Zhao, Y., Yeo, Y. H., Samaan, J., Lv, F., He, X., Gao, N., … Nguyen, M. H. (2022). THE TREND OF YEARS OF POTENTIAL LIFE LOST ASSOCIATED WITH CIRRHOSIS BEFORE AND DURING THE COVID-19 PANDEMIC: A POPULATION-BASED STUDY. HEPATOLOGY. WILEY.

PREDICTION OF CLINICAL RELAPSE AFTER DISCONTINUATION OF NUCLEOS( T) IDE ANALOGS FOR CHRONIC HEPATITIS B USING DYNAMIC HBV CORE-RELATED ANTIGEN MEASUREMENTS
Tsai, Y.-N., Wu, J.-L., Tseng, C.-H., Chen, T.-H., Wu, Y.-L., Chen, C.-C., … Hsu, Y.-C. (2022). PREDICTION OF CLINICAL RELAPSE AFTER DISCONTINUATION OF NUCLEOS( T) IDE ANALOGS FOR CHRONIC HEPATITIS B USING DYNAMIC HBV CORE-RELATED ANTIGEN MEASUREMENTS. HEPATOLOGY. WILEY.

INCIDENCE AND PREDICTORS OF OFF-THERAPY RELAPSES AFTER CESSATION OF TENOFOVIR ALAFENAMIDE IN PATIENTS WITH CHRONIC HEPATITIS B
Tseng, C.-H., Chen, C.-Y., Huang, C.-F., Chen, P. Y., Jang, T.-Y., Yang, T.-H., … Hsu, Y.-C. (2022). INCIDENCE AND PREDICTORS OF OFF-THERAPY RELAPSES AFTER CESSATION OF TENOFOVIR ALAFENAMIDE IN PATIENTS WITH CHRONIC HEPATITIS B. HEPATOLOGY. WILEY.

EXCESS CIRRHOSIS-RELATED MORTALITY AND RELEVANT DISPARITIES DURING THE COVID-19 PANDEMIC
Yeo, Y. H., Zhao, Y., Samaan, J., Lv, F., He, X., Park, J., … Nguyen, M. H. (2022). EXCESS CIRRHOSIS-RELATED MORTALITY AND RELEVANT DISPARITIES DURING THE COVID-19 PANDEMIC. HEPATOLOGY. WILEY.

SERIOUS ADVERSE CLINICAL EVENTS AFTER CESSATION OF NUCLEOS(T) IDE ANALOGUES IN PATIENTS WITH CHRONIC HEPATITIS B: A SYSTEMATIC REVIEW AND META-ANALYSIS
Tseng, C.-H., Chen, T.-H., Wu, J.-L., Lee, T.-Y., Borghi, J. A., Lin, J.-T., … Hsu, Y.-C. (2022). SERIOUS ADVERSE CLINICAL EVENTS AFTER CESSATION OF NUCLEOS(T) IDE ANALOGUES IN PATIENTS WITH CHRONIC HEPATITIS B: A SYSTEMATIC REVIEW AND META-ANALYSIS. HEPATOLOGY. WILEY.

GLOBAL INCIDENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS
Le, M., Le, D. M., Baez, T., Wu, Y., Lee, E. Y., Ito, T., & Nguyen, M. H. (2022). GLOBAL INCIDENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS. HEPATOLOGY. WILEY.

RACIAL AND ETHNIC DISPARITIES IN CLINICAL PRESENTATION AND OUTCOMES AMONG PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE IN THE UNITED STATES: A REAL-WORLD STUDY OF 10,135 PATIENTS
Nguyen, V. H., Ha, A., Park, J. E., Rouillard, N., Le, R. H. X., Fong, A., … Nguyen, M. H. (2022). RACIAL AND ETHNIC DISPARITIES IN CLINICAL PRESENTATION AND OUTCOMES AMONG PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE IN THE UNITED STATES: A REAL-WORLD STUDY OF 10,135 PATIENTS. HEPATOLOGY. WILEY.

IMPACT OF THE COVID-19 PANDEMIC ON MORTALITY RATE OF LIVER DISEASE IN THE UNITED STATES: A POPULATION-BASED STUDY, 2010-2021
Gao, X., Lv, F., He, X., Zhao, Y., Liu, Y., Zu, J., … Nguyen, M. H. (2022). IMPACT OF THE COVID-19 PANDEMIC ON MORTALITY RATE OF LIVER DISEASE IN THE UNITED STATES: A POPULATION-BASED STUDY, 2010-2021. HEPATOLOGY. WILEY.

RACIAL AND ETHNIC DISPARITIES IN YEARS OF POTENTIAL LIFE LOST ASSOCIATED WITH CIRRHOSIS IN THE UNITED STATES BEFORE AND DURING THE COVID-19 PANDEMIC
Yeo, Y. H., Zhao, Y., Samaan, J., Lv, F., He, X., Liu, Y., … Nguyen, M. H. (2022). RACIAL AND ETHNIC DISPARITIES IN YEARS OF POTENTIAL LIFE LOST ASSOCIATED WITH CIRRHOSIS IN THE UNITED STATES BEFORE AND DURING THE COVID-19 PANDEMIC. HEPATOLOGY. WILEY.

CIRRHOSIS INCIDENCE AND LONG-TERM MORTALITY RATE AMONG LEAN, OVERWEIGHT, AND OBESE PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN THE UNITED STATES
Nguyen, V. H., Ha, A., Park, J. E., Rouillard, N., Le, R. H. X., Fong, A., … Nguyen, M. H. (2022). CIRRHOSIS INCIDENCE AND LONG-TERM MORTALITY RATE AMONG LEAN, OVERWEIGHT, AND OBESE PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN THE UNITED STATES. HEPATOLOGY. WILEY.

GLOBAL TREATMENT RATE AND BARRIERS TO DIRECT ACTING ANTIVIRAL (DAA) TREATMENT OF CHRONIC HEPATITIS C (CHC): A SYSTEMATIC REVIEW AND META-ANALYSIS OF 179 STUDIES AND 2,421,347 CHC PATIENTS
Nguyen, V. H., Tan, D. J. H., Jin, M., Lee, E. Y., Nerurkar, S. N., Huang, D., … Nguyen, M. H. (2022). GLOBAL TREATMENT RATE AND BARRIERS TO DIRECT ACTING ANTIVIRAL (DAA) TREATMENT OF CHRONIC HEPATITIS C (CHC): A SYSTEMATIC REVIEW AND META-ANALYSIS OF 179 STUDIES AND 2,421,347 CHC PATIENTS. HEPATOLOGY. WILEY.

Liver-Related Mortality in Hepatitis B Virus Core Antibody+/Hepatitis B Virus Surface Antigen- Patients: Occult Hepatitis B Virus, Hepatitis B Virus Reactivation, and Hepatocellular Carcinoma Development.
Jung, J., & Nguyen, M. H. (2023). Liver-Related Mortality in Hepatitis B Virus Core Antibody+/Hepatitis B Virus Surface Antigen- Patients: Occult Hepatitis B Virus, Hepatitis B Virus Reactivation, and Hepatocellular Carcinoma Development. The American Journal of Gastroenterology, 118(1), 24–25.

NAFLD and Non-Liver Comorbidities.
Manikat, R., & Nguyen, M. H. (2023). NAFLD and Non-Liver Comorbidities. Clinical and Molecular Hepatology.

Outcomes in liver transplant recipients with nonalcoholic fatty liver disease-related HCC: results from the US multicenter HCC transplant consortium.
Verna, E. C., Phipps, M. M., Halazun, K. J., Markovic, D., Florman, S. S., Haydel, B. M., … Agopian, V. (2023). Outcomes in liver transplant recipients with nonalcoholic fatty liver disease-related HCC: results from the US multicenter HCC transplant consortium. Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 29(1), 34–47.

Meta-analysis: Chemoprevention of hepatocellular carcinoma with statins, aspirin and metformin.
Zeng, R. W., Yong, J. N., Tan, D. J., Fu, C. E., Lim, W. H., Xiao, J., … Huang, D. Q. (2023). Meta-analysis: Chemoprevention of hepatocellular carcinoma with statins, aspirin and metformin. Alimentary Pharmacology & Therapeutics.

Letter: rising incidence and poor survival in patients with nonviral HCC-better HCC surveillance and treatment for alcohol-associated and non-alcohol fatty liver diseases are needed.
Manikat, R., & Nguyen, M. H. (2023). Letter: rising incidence and poor survival in patients with nonviral HCC-better HCC surveillance and treatment for alcohol-associated and non-alcohol fatty liver diseases are needed. Alimentary Pharmacology & Therapeutics, 57(3), 361–362.

Global treatment rate and barriers to DAA therapy: A systematic review and meta-analysis of 146 studies and 1,760,352 HCV patients.
Nguyen, V. H., Huang, D. Q., Le, M. H., Jin, M., Lee, E. Y., Henry, L., … Nguyen, M. H. (2023). Global treatment rate and barriers to DAA therapy: A systematic review and meta-analysis of 146 studies and 1,760,352 HCV patients. Liver International : Official Journal of the International Association for the Study of the Liver.

Effectiveness and tolerability of camrelizumab combined with molecular targeted therapy for patients with unresectable or advanced HCC.
Li, T., Guo, J., Liu, Y., Du, Z., Guo, Z., Fan, Y., … Ji, F. (2023). Effectiveness and tolerability of camrelizumab combined with molecular targeted therapy for patients with unresectable or advanced HCC. Cancer Immunology, Immunotherapy : CII.

Letter to the Editor: Risk Stratification for Sarcopenic Obesity in Nonalcoholic Fatty Liver Disease.
Lai, R., & Nguyen, M. H. (2023). Letter to the Editor: Risk Stratification for Sarcopenic Obesity in Nonalcoholic Fatty Liver Disease. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

Nonalcoholic fatty liver disease (NAFLD) detection and deep learning in a Chinese community-based population.
Yang, Y., Liu, J., Sun, C., Shi, Y., Hsing, J. C., Kamya, A., … Zhu, S. (2023). Nonalcoholic fatty liver disease (NAFLD) detection and deep learning in a Chinese community-based population. European Radiology.

Perspectives on the Underlying Etiology of HCC and Its Effects on Treatment Outcomes.
Ito, T., & Nguyen, M. H. (2023). Perspectives on the Underlying Etiology of HCC and Its Effects on Treatment Outcomes. Journal of Hepatocellular Carcinoma, 10, 413–428.

Trends of Cirrhosis-related Mortality in the USA during the COVID-19 Pandemic.
Yeo, Y. H., He, X., Lv, F., Zhao, Y., Liu, Y., Yang, J. D., … Nguyen, M. H. (2023). Trends of Cirrhosis-related Mortality in the USA during the COVID-19 Pandemic. Journal of Clinical and Translational Hepatology, 11(3), 751–756.

Development and validation of a REcurrent Liver cAncer Prediction ScorE (RELAPSE) following liver transplantation in patients with hepatocellular carcinoma: analysis of the us multicenter hcc transplant consortium.
Tran, B. V., Moris, D., Markovic, D., Zaribafzadeh, H., Henao, R., Lai, Q., … Agopian, V. G. (2023). Development and validation of a REcurrent Liver cAncer Prediction ScorE (RELAPSE) following liver transplantation in patients with hepatocellular carcinoma: analysis of the us multicenter hcc transplant consortium. Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Global burden of hepatitis B virus: current status, missed opportunities and a call for action.
Hsu, Y.-C. C., Huang, D. Q., & Nguyen, M. H. (2023). Global burden of hepatitis B virus: current status, missed opportunities and a call for action. Nature Reviews. Gastroenterology & Hepatology.

Global incidence of non-alcoholic fatty liver disease: a systematic review and meta-analysis of 63 studies and 1,201,807 persons.
Le, M. H., Le, D. M., Baez, T. C., Wu, Y., Ito, T., Lee, E. Y., … Nguyen, M. H. (2023). Global incidence of non-alcoholic fatty liver disease: a systematic review and meta-analysis of 63 studies and 1,201,807 persons. Journal of Hepatology.

Letter: grouping traditional biomarkers that are within reach has great utility - further validation is needed.
Lai, R., & Nguyen, M. H. (2023). Letter: grouping traditional biomarkers that are within reach has great utility - further validation is needed. Alimentary Pharmacology & Therapeutics, 57(9), 1050–1051.

Immortal Time and Selection Biases in Study of Direct-Acting Antiviral Treatment and Hepatitis C Outcomes-Reply.
Ogawa, E., Yeo, Y. H., & Nguyen, M. H. (2023). Immortal Time and Selection Biases in Study of Direct-Acting Antiviral Treatment and Hepatitis C Outcomes-Reply. JAMA Internal Medicine.

Sarcopenia in cirrhosis: epidemiology, diagnosis, management and prognosis.
Liu, Y., Ji, F., & Nguyen, M. H. (2023). Sarcopenia in cirrhosis: epidemiology, diagnosis, management and prognosis. Current Opinion in Gastroenterology, 39(3), 131–139.

Impact of fatty liver on long-term outcomes in chronic hepatitis B: a systematic review and matched analysis of individual patient data meta-analysis.
Wong, Y. J., Nguyen, V. H., Yang, H.-I. I., Li, J., Le, M. H., Wu, W.-J. J., … Nguyen, M. H. (2023). Impact of fatty liver on long-term outcomes in chronic hepatitis B: a systematic review and matched analysis of individual patient data meta-analysis. Clinical and Molecular Hepatology.

Antiviral therapy substantially reduces hepatocellular carcinoma risk in chronic Hepatitis B patients in the indeterminate phase.
Huang, D. Q., Tran, A., Yeh, M.-L., Yasuda, S., Tsai, P.-C., Huang, C.-F., … Nguyen, M. H. (2023). Antiviral therapy substantially reduces hepatocellular carcinoma risk in chronic Hepatitis B patients in the indeterminate phase. Hepatology (Baltimore, Md.).

An international multidisciplinary consensus statement on MAFLD and the risk of CVD.
Zhou, X.-D. D., Targher, G., Byrne, C. D., Somers, V., Kim, S. U., Chahal, C. A., … Zheng, M.-H. H. (2023). An international multidisciplinary consensus statement on MAFLD and the risk of CVD. Hepatology International.

Effectiveness of HCC surveillance programs using multitarget blood test: A modeling study.
Chhatwal, J., Samur, S., Yang, J. D., Roberts, L. R., Nguyen, M. H., Ozbay, A. B., … Singal, A. G. (2023). Effectiveness of HCC surveillance programs using multitarget blood test: A modeling study. Hepatology Communications, 7(6).

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Open Trials Closed Trials

Sustained Virological Response (SVR) to Antiviral Treatment of Liver Transplant Recipients With Recurrent Hepatitis C »

Safety, Tolerability, and Efficacy of 24 Weeks Simeprevir+Sofosbuvir for Chronic Hepatitis C Genotype 1 »

Safety and Efficacy of LDV/SOF Fixed-Dose Combination (FDC) ± Ribavirin in HCV Genotype 1 Subjects »

Safety and Efficacy Study in Subjects With Chronic HCV and Underlying Hemophilia »

Comparative Efficacy of Fixed-dose Combination Sofosbuvir + Ledipasvir, 8 vs. 12 Weeks in Chronic Hepatitis C Genotype 6 »

Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Treatment of Hepatitis B e Antigen-Negative Hepatitis B »

Epidemiologic Study of Hepatocellular Carcinoma in the US »

Case-Control Study of the Glycotest™ HCC Panel vs AFP for the Detection of Early-stage Hepatocellular Carcinoma »

Registry Study for Patients With Chronic HBV Receiving Nucleotide Therapy »

Samatasvir (IDX719) in Combinations With Simeprevir and/or TMC647055/Ritonavir With or Without Ribavirin for 12 Weeks in Participants With Chronic Hepatitis C Infection (MK-1894-005) »

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination (FDC) With and Without Ribavirin for the Treatment of HCV »

Gilead Sustained Virologic Response (SVR) Registry »

Evaluation of Stereotactic Radiosurgery For Liver Malignancies »

Transarterial Chemoembolization vs CyberKnife for Recurrent Hepatocellular Carcinoma »

Risk Factors and Molecular Genomics of U.S. Patients With Chronic Liver Disease and Hepatocellular Cancer »

Specializing In

Hepatitis
Hepatitis A
Hepatitis B
Hepatitis C
Hepatitis D
Hepatology (Liver Conditions)
Liver Transplant
Polycystic Liver Disease

Practice Locations

Liver Transplant Program in San Jose, O'Connor Drive San Jose, CA

San Jose, CA

Liver Transplant Program in San Jose, O'Connor Drive

231 O'Connor Drive

San Jose , CA 95128

(650) 725-1988

More Clinic Information »

Liver Transplant Program in San Jose, Jose Figueres Avenue San Jose, CA

San Jose, CA

Liver Transplant Program in San Jose, Jose Figueres Avenue

200 Jose Figueres Avenue, Suite 255

San Jose , CA 95116

(650) 725-1988

More Clinic Information »

Liver (Hepatology) Clinic in Redwood City Redwood City, CA

Redwood City, CA

Liver (Hepatology) Clinic in Redwood City

420 Broadway Street, Pavilion D, 2nd Floor

Redwood City , CA 94063

(650) 498-7999

More Clinic Information »

Digestive Health Center in Redwood City Redwood City, CA

Redwood City, CA

Digestive Health Center in Redwood City

420 Broadway Street, Pavilion D, 2nd Floor

Redwood City , CA 94063

(650) 736-5555

More Clinic Information »

Important Information about Our Organizations and Physician Affiliation

Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of Stanford Health Care, Stanford Health Care Tri- Valley, or Stanford Medicine Partners. Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.

Patient Ratings

(67 Ratings)

Overall Rating

4.8/5

View Ratings by Category

4.9/5

Friendliness

4.8/5

Explanations

4.8/5

Listens

4.8/5

Care provider's efforts to include you in decisions about your care

4.8/5

Recommended to others

0.0/5

Wait times

How Our Ratings Work

The Patients Ratings and comments are gathered from our Patient Satisfaction Survey and displayed in their entirety.

Patient Satisfaction Survey Disclaimer

Patient Reviews

(111 reviews)

Good Doctor

Mar 2023

•

Verified SHC Patient

Dr. Nguyen is a great help to me. I trust her to make the best decisions when treating me. She is very smart and articulate.

Mar 2023

•

Verified SHC Patient

Very good visit; I was concerned about my elevated fibrosis score but you quickly allay them when you shared your thoughts that the score might be elevated due the reasons you shared during the meeting and the score might be biased to the up side. Hopefully the some the diet changes I plan to incur will have an impact to lower my fibrosis score for my next appointment.

Mar 2023

•

Verified SHC Patient

She is a wonderful doctor. Very thorough..

Feb 2023

•

Verified SHC Patient

Sheâ€™s great and the associate working with her was excellent as well.

Feb 2023

•

Verified SHC Patient

Very nice video conference with Dr. Nguyen. Thanks

Dec 2022

•

Verified SHC Patient

Friendly and empathetic

Dec 2022

•

Verified SHC Patient

Would like Mindie Nguyá»…n to communicate with better clarity, reasons for each tests, the frequencies etc.

Nov 2022

•

Verified SHC Patient

I am very happy and feel she has my best interests at heart!

Nov 2022

•

Verified SHC Patient

Always the best health service I can expect from Stanford Healthcare.

Sep 2022

•

Verified SHC Patient

She is a cheerful and capable doctor who is very well acquainted with my illness and recommends careful monitoring and testing procedures to care for me. I'm very grateful.

Sep 2022

•

Verified SHC Patient

Dr. Nguyen has always been a very caring care giver to me. Its always a pleasure to converse with her

Aug 2022

•

Verified SHC Patient

Dr. Nguyá»…n was clear, direct, responsive, kind, wise and friendly. What more could anyone expect and wish for from any physician, no less, someone new to me. She even brought up subjects that are sometimes hard to hear in a caring manner that made that easier to receive. Three cheers!

Aug 2022

•

Verified SHC Patient

Very good Doctor

Aug 2022

•

Verified SHC Patient

Dr Nguyen is an excellent physician. Kind and knowledgeable. She communicates effectively.

Jul 2022

•

Verified SHC Patient

Dr. Mindie Nguyen is Awesome! She is really detailed in all of her explanationâ€™s and answers all questions in terms that are easily understood. I am blessed to have Dr. Nguyen on my care team.

Jun 2022

•

Verified SHC Patient

I am proud to have Dr. Mindie Nguyen and the Liver Clinic staff looking after my health. They all work well together and have nothing but compliments for the work they do to support my overall health

Jun 2022

•

Verified SHC Patient

Dr. Mindie Nguyen took good care about her patient's health issue. So glad to be under her care. Thank you Dr. Nguyen.

Jun 2022

•

Verified SHC Patient

Dr. Nguyen was very nice. She shared her personal experience which made me feel a bit better with my situation. She also asked if I would like another opinion from the Oncology department which I opted for. I think her assessment so far makes good sense and I agree with the plan so far. I do get a sense that towards the end of our 30-minute appointment, the conversation became a bit rushed. Perhaps she has another appointment to go to. Other than that, I think she was very reasonable and I appreciate the perspectives + additional x-ray and lab work to continue with my care. Also, I like Alfred very much. I really appreciate his patience and genuine care in helping me understand my current health situation. Thank you both!

Jun 2022

•

Verified SHC Patient

Dr Nguyen is an outstanding doctor and recommend her anyone without reservation!

May 2022

•

Verified SHC Patient

Very comprehensive advise . Highly recommend

May 2022

•

Verified SHC Patient

Dr. Nguyen was excellent and answered all my questions. She took her time and explained everything and what my future treatment would be. She genuinely cares for her patient.

May 2022

•

Verified SHC Patient

I've been working with Dr. Mindie Nguyen for a few years now and always appreciated she looked after me. Would recommend Dr. Nguyen to anyone wholeheartedly.

Mar 2022

•

Verified SHC Patient

Dr. Nguyen is an excellent doctor and I highly recommend her.

Mar 2022

•

Verified SHC Patient

She is very approachable, explains things clearly, and is sympathetic. Made me feel very comfortable.

Mar 2022

•

Verified SHC Patient

Ella es una excelente doctora no tengo q decir nada y muy linda con mi mamÃ¡ gracias, Gracias

Feb 2022

•

Verified SHC Patient

Very thorough and thoughtful, cheerful doctor. Glad to have her as my doctor.

Jan 2022

•

Verified SHC Patient

You doing great job

Jan 2022

•

Verified SHC Patient

Dr Nguyen was very friendly, and easy to talk with. She answered all questions.

Jan 2022

•

Verified SHC Patient

Dr. Nguyá»…n is outstanding!

Jan 2022

•

Verified SHC Patient

Dr. Nguyá»…n is outstanding!

Jan 2022

•

Verified SHC Patient

She is great!

Jan 2022

•

Verified SHC Patient

Dr.Nguyen takes good care of her patients. Sheâ€™s a responsible doctor with knowledge and make my condition better every visit.

Jan 2022

•

Verified SHC Patient

Dr. NguyÃªn is a great doctor.

Dec 2021

•

Verified SHC Patient

I live in Las Vegas. Youâ€™ve been treating my medical problems for over a decade.. That means Iâ€™m a â€œ happy patients.â€

Nov 2021

•

Verified SHC Patient

Dr. Mindie Nyguyen is an exceptional doctor - thorough and attentive to patient concerns. I would highly recommend her.

Nov 2021

•

Verified SHC Patient

Great

Nov 2021

•

Verified SHC Patient

Outstanding communicator and knowledgeable physician. I rate her as outstanding period

Nov 2021

•

Verified SHC Patient

I really enjoy working with Dr Nguyen,

Oct 2021

•

Verified SHC Patient

Highly recommend.

Sep 2021

•

Verified SHC Patient

Dr. Nguyen knows what she is doing well. I am better ever since I saw her. She is a good doctor!

Sep 2021

•

Verified SHC Patient

Dr Mindie was excellent as always during my visit.

Sep 2021

•

Verified SHC Patient

She is kind and competent provider for my health issues.

Aug 2021

•

Verified SHC Patient

Doctor Mindie Nguyen is a very professional and experienced Doctor. Sheâ€™s kind and cares for your situation.

Aug 2021

•

Verified SHC Patient

Great doctor. I have nothing but praise for her.

Jul 2021

•

Verified SHC Patient

I like her alot as my doctor.

Jun 2021

•

Verified SHC Patient

Dr. Mindie is an awesome doctor and very clear and organized. She ordered all the blood tests I needed and I could easily understand her advice. I am happy to be treated by her.

Jun 2021

•

Verified SHC Patient

Excellent doctor!

May 2021

•

Verified SHC Patient

Great.

May 2021

•

Verified SHC Patient

She us wonderful.

May 2021

•

Verified SHC Patient

She's the best. Very thorough, answers all my questions, I never feel rushed and she is an expert in her field.

Apr 2021

•

Verified SHC Patient

Dr. Nguyen is excellent in every way I hope a doctor to be. Five stars plus. She keeps me informed about my condition in detail, answers questions completely and with patience, and stays on top of ongoing procedures and tests, when they'll be scheduled, and how I will be notified of same. Her assistant, Alfred, was also excellent and much appreciated as well. I'm truly very grateful to have access to Dr. Nguyen's medical care. It feels like she actually cares about me, a definite plus that helps enhance a sense of well-being in her hands. So very much appreciated. :^)

Apr 2021

•

Verified SHC Patient

She is extending my quality of life.

Apr 2021

•

Verified SHC Patient

The doctor was very attentive & very kind.

Apr 2021

•

Verified SHC Patient

I adore her.

Apr 2021

•

Verified SHC Patient

Dr. Nguyen & her PA are excellent!

Mar 2020

•

Verified SHC Patient

my doctor very good.

Oct 2019

•

Verified SHC Patient

I really enjoyed this visit with Dr. Nguyen, who is hands down one of the best doctors I've ever seen.

Jun 2019

•

Verified SHC Patient

Dr. Mindie & staff are the best!

Mar 2019

•

Verified SHC Patient

Love Dr. Mindie Nguyen!!!

Apr 2018

•

Verified SHC Patient

Very good.

Apr 2018

•

Verified SHC Patient

good

Mar 2018

•

Verified SHC Patient

I would recommend Stanford to anyone who had serious medical problems.

Feb 2018

•

Verified SHC Patient

Dr. Mindie Nguyen is the best!

Feb 2018

•

Verified SHC Patient

One of the best care providers EVER!!

Jan 2018

•

Verified SHC Patient

Dr Nguyen is a great doctor and I have full confidence in her

Nov 2017

•

Verified SHC Patient

Dr. Mindie Nguyen is very kind, compassionate and thorough!

Aug 2017

•

Verified SHC Patient

Good.

Aug 2017

•

Verified SHC Patient

My visit the nurse prac. was very good.

Aug 2017

•

Verified SHC Patient

Good.

Aug 2017

•

Verified SHC Patient

Good.

Jul 2017

•

Verified SHC Patient

Provider knowledgeable; very thorough; asked many questions.

Apr 2017

•

Verified SHC Patient

Good.

Mar 2017

•

Verified SHC Patient

Great service.

Mar 2017

•

Verified SHC Patient

It would be nice if care provider took a little time to explain in detail my test results. "Everything is fine & the same as last test results" somehow doesn't make me feel reassured.

Mar 2017

•

Verified SHC Patient

Stanford is awesome. Dr. Mindie Nguyen is an angel in disguise!

Feb 2017

•

Verified SHC Patient

Dr.Mindie Nguyen is the best doctor

Feb 2017

•

Verified SHC Patient

I am honored by having this extraordinary doctor Nguyn care for my health through treatment and recovery. Stanford is fortunate to have such a wonderful asset.

Feb 2017

•

Verified SHC Patient

Good service.

Jan 2017

•

Verified SHC Patient

Dr. Mindie is my hero -

Jan 2017

•

Verified SHC Patient

Very good.

Dec 2016

•

Verified SHC Patient

good

Dec 2016

•

Verified SHC Patient

Friendliness. Very kind. Recommended to other.

Nov 2016

•

Verified SHC Patient

Good.

Oct 2016

•

Verified SHC Patient

Good.

Oct 2016

•

Verified SHC Patient

The doctor is excellent. the blood lab is understaffed.

Oct 2016

•

Verified SHC Patient

Good.

Oct 2016

•

Verified SHC Patient

very knowledgeable doctor. hope participate on future research work with her

Sep 2016

•

Verified SHC Patient

Good.

Sep 2016

•

Verified SHC Patient

Dr. Nyguen is awesome. As are her clinical coordinators.

Sep 2016

•

Verified SHC Patient

Good.

Sep 2016

•

Verified SHC Patient

She is a good listener, also she explain clearly the plan she will do with me.

Apr 2016

•

Verified SHC Patient

Dr. Nguyen was great!! Same caliber as Dr. Ayoub who is no longer with you.

Mar 2016

•

Verified SHC Patient

I fill very comfortable and confident

Mar 2016

•

Verified SHC Patient

Best experience.

Nov 2015

•

Verified SHC Patient

Dr. Mindie Nguyen is a SAINT!!

Nov 2015

•

Verified SHC Patient

Perhaps it is that my health condition is in excellent shape. Hence, my doctor does not really show much of concern on my Hep-B test results.

Oct 2015

•

Verified SHC Patient

Very Good

Aug 2015

•

Verified SHC Patient

Excellent

Jul 2015

•

Verified SHC Patient

Great, knowledgeable, compassionate doctor!

Jun 2015

•

Verified SHC Patient

our care provider that day is the absolute BEST!!! We have complete confidence in her.

Jun 2015

•

Verified SHC Patient

Excellent

May 2015

•

Verified SHC Patient

Dr. Nyugen is extremely knowledgeable and easy to converse with

May 2015

•

Verified SHC Patient

Very good!

Feb 2015

•

Verified SHC Patient

I have been a patient with Dr. Nguyen for a very long time. She has always made me feel that I was being cared for with the utmost ability. I would recommend her to anybody -

Sep 2014

•

Verified SHC Patient

Good.

Jul 2014

•

Verified SHC Patient

Mindy has been my doctor for a long time. She has been concerned in the best way possible about me in categories of my health.

Jun 2014

•

Verified SHC Patient

Dr. Nguyen is superb! Very social - Enjoy talking with her during visits.

May 2014

•

Verified SHC Patient

Good - doctor to have, to keep.

Mar 2014

•

Verified SHC Patient

I liked the fact that she printed out all the instructions.

Feb 2014

•

Verified SHC Patient

Good.

Feb 2014

•

Verified SHC Patient

Referring Physicians

PHYSICIAN HELPLINE

Phone: 1-866-742-4811
Fax: 650-320-9443
Monday – Friday, 8 a.m. – 5 p.m.

Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referring Physicians.

You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.

Send referrals online
View referral status
Access medical records

Learn More About PRISM » LOG INTO PRISM

New to MyHealth?

ALREADY HAVE AN ACCESS CODE?

DON'T HAVE AN ACCESS CODE?

NEED MORE DETAILS?

MyHealth for Mobile

Mindie H. Nguyen, MD, MAS, AGAF, FAASLD

Hepatologist, Transplant hepatologist

Get In Touch

Biography

Professional Summary

Professional Education

Honors & Awards

Administrative Appointments

Publications

Clinical Trials

Specializing In

Practice Locations

Liver Transplant Program in San Jose, O'Connor Drive San Jose, CA

Liver Transplant Program in San Jose, O'Connor Drive

Liver Transplant Program in San Jose, Jose Figueres Avenue San Jose, CA

Liver Transplant Program in San Jose, Jose Figueres Avenue

Liver (Hepatology) Clinic in Redwood City Redwood City, CA

Liver (Hepatology) Clinic in Redwood City

Digestive Health Center in Redwood City Redwood City, CA

Digestive Health Center in Redwood City

Important Information about Our Organizations and Physician Affiliation

Patient Ratings

How Our Ratings Work

Patient Reviews

(111 reviews)

Referring Physicians

PHYSICIAN HELPLINE

New to MyHealth?

ALREADY HAVE AN ACCESS CODE?

DON'T HAVE AN ACCESS CODE?

NEED MORE DETAILS?

MyHealth for Mobile

WELCOME BACK

Mindie H. Nguyen, MD, MAS, AGAF, FAASLD

Hepatologist, Transplant hepatologist

Get In Touch

Biography

Professional Summary

Professional Education

Honors & Awards

Administrative Appointments

Publications

Clinical Trials

Specializing In

Practice Locations

Liver Transplant Program in San Jose, O'Connor Drive San Jose, CA

Liver Transplant Program in San Jose, O'Connor Drive

Liver Transplant Program in San Jose, Jose Figueres Avenue San Jose, CA

Liver Transplant Program in San Jose, Jose Figueres Avenue

Liver (Hepatology) Clinic in Redwood City Redwood City, CA

Liver (Hepatology) Clinic in Redwood City

Digestive Health Center in Redwood City Redwood City, CA

Digestive Health Center in Redwood City

Important Information about Our Organizations and Physician Affiliation

Patient Ratings

How Our Ratings Work

Patient Reviews

(111 reviews)

Referring Physicians

PHYSICIAN HELPLINE